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ABSTRACT 
Hsin-Lei Yao: The Hepatic Stem Cell Niche and Paracrine Signaling by Mesenchymal Cells 
in Support of Human Hepatic Stem Cells 
(Under the direction of Lola M. Reid) 
 
 Paracrine signaling is important for tissues both during embryonic development and 
in regulation of the tissue’s cell lineages in adults.  In liver, the mesenchymal cells adjacent 
to hepatic parenchymal cells secret soluble factors as well as extracellular matrix (ECM) 
molecules that regulate hepatic parenchymal cells to grow and/or to differentiate in order to 
form a functional liver. Human hepatic stellate cells (hHpSTCs) with classic stellate cell 
markers (vitamin A+, desmin+ and α-smooth muscle actin+) and liver sinusoidal endothelial 
cells (VEGFr+, von Willebrand factor+ and CD31+) are two major mesenchymal cell types in 
the liver.  They were found present in primary cultures of human hepatic stem cells (hHpSCs) 
derived from fetal livers and were found to be critical as “companion cells” for survival and 
expansion of the hHpSCs. Many of the markers are shared by hHpSCs and the other 
pluripotent hepatic progenitors in human livers, hepatoblasts (hHBs) including expression of 
albumin, epithelial cell adhesion molecule (EpCAM), cytokeratins 8, 18 and 19, hedgehog 
proteins, and telomerase but not hematopoietic markers (CD45, CD34, CD38) or 
mesenchymal markers (those of endothelia or HpSTCs). However, they can be distinquished 
in that hHpSCs express neuronal cell adhesion molecule (NCAM) and claudin 3 but are 
negative for intercellular adhesion molecule-1 (ICAM-1) and α-fetoprotein (AFP), whereas 
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hHBs express intercellular cell adhesion molecule (ICAM-1), AFP, higher levels of albumin 
but not claudin 3 or NCAM.  
The hHpSCs behave differently depending on type of feeder cells are used. Feeders of 
angioblasts or endothelia resulted in maintenance of hHpSCs as stem cells; feeders replete 
with HpSTCs resulted in lineage restriction of hHpSCs to hepatoblasts; and STO feeders 
caused even more differentiation to both hepatoblasts and committed progenitors. 
Representative feeders of angioblasts/endothelia versus HpSTCs were characterized 
for expression of matrix genes and proteins; those matrix components identified were then 
tested as substrata for effects on the hHpSCs. The hHpSCs remained as stem cells on 
substrata of type III collagen or culture plastic; they differentiated into hepatoblasts on 
substrata of laminin or on top of collagen type IV; they differentiated into hepatoblasts and 
committed progenitors on the surface of type I collagen and into hepatocytes when embedded 
into type I collagen gel.  
 STO feeder cells secret inflammatory cytokines and factors, many of them identified 
in other studies as being produced following liver injury.  A number of the factors were 
induced to be secreted to higher levels by co-culture of STO cells with human hepatic 
progenitors. These included several members of the interleukin family (e.g. IL-4, IL-5, IL-6, 
IL-10, IL-11 and IL-13), eotaxin, transforming growth factor-β1 (TGF-β1), interferon-γ 
(IFN-γ), macrophage inflammatory protein-2 (MIP-2), and others. Some of these factors have 
been found in preliminary studies to have potent effects on human and rodent hepatic 
progenitors but have not yet been fully characterized. They are assumed to play 
complementary roles to those of the matrix components in regulating hHpSCs. Analyses of 
these role(s) will be part of future studies.   
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CHAPTER I 
BACKGROUND 
 
A. The Epithelial-Mesenchymal Relationship 
 Epithelial and mesenchymal cells are distinguished by the morphology of the 
multicellular structures they form. The epithelium is a sheet of cells with individual epithelial 
cells contiguous to each other. Cell-cell junctions and adhesions between neighboring 
epithelial cells hold them tightly together and reduce the movement of individual cells away 
from the cellular sheet. Epithelial cells have apical, lateral, and basal surfaces, and thus are 
polarized. Mesenchymal cells have irregular cell shape and tend to be more extended and 
elongated relative to epithelial cells. Adhesions between mesenchymal cells are weaker than 
epithelial cells, allowing them to migrate easily (Lee et al., 2006). Epithelial cells can be 
derived from any of three germ layers whereas mesenchymal cells are originated only from 
mesoderm. For example, both kidney epithelial and mesenchymal cells are derived from 
mesoderm, whereas hepatocytes and liver-derived non-parenchymal cells are derived from 
endoderm and mesoderm respectively.  Plasticity issues for stem cells have been much 
discussed in recent years.  The net sum of findings suggests that cells committed to fates of a 
given germ layer do not cross over to fates of another germ layer.  For example, 
mesodermally-derived epithelial cells can transition to other mesodermal cell types (Perez-
Pomares and Munoz-Chapuli, 2002). Precardiac epithelium derived from mesoderm can 
transition to generate endocardial progenitors (Lough and Sugi, 2000).  
 1. General Introduction 
The epithelial-mesenchymal relationship is an evolutionarily ancient cell-cell 
relationship known to govern all metazoan tissues. It can be mimicked ex vivo by co-
culturing of epithelial cells and mesenchymal cells. The direct communication between the 
epithelium and mesenchyme promotes cellular proliferation and differentiation during 
development of several organs, such as kidney, lung, intestine, liver and pancreas (Table 1.1). 
Interruption or inhibition of this relationship leads to impaired organ formation. 
Mesenchymal cells/stromas affect proliferation and differentiation of their adjacent epithelial 
cells both in vitro and in vivo, but the mechanism of interaction is not fully understood. 
Soluble cytokines and growth factors as well as the extracellular matrix molecules expressed 
by the mesenchymal cells play important roles in mediating this interaction.  
Additional variables mediating the mesenchymal-epithelial interaction include 
mechanical forces, pH, electromagnetic gradients, and the levels of oxygen and C02. 
Differentiation can occur when cells are under different mechanical stresses. Human 
mesenchymal stem cells were found to express bone morphogenetic protein (BMP-2) and 
differentiate into osteogenic pathway when stimulated by 10% uniaxial cyclic tensile strain 
(Sumanasinghe et al., 2006). When subjected to smaller (5%) cyclic strain, the same cell 
types increased expression of calponin 1, a smooth muscle cell marker, and decreased 
expression of cartilage markers, such as types X and XI collagens, biglycan and cartilage 
oligometric matrix protein (COMP) (Kurpinski et al., 2006).  
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2. Kidney 
Development of the kidney is achieved by the reciprocal induction of two 
mesodermal derivatives: the ureteric bud (epithelium) and the metanephric mesenchyma 
(mesenchyme). This interaction triggers the process of nephrogenesis and culminates in the 
formation of the mature kidney. Around the fifth week of gestation in humans, the ureteric 
bud induces the mesenchyma to form tubular and glomerular epithelia. In turn, the 
mesenchyma stimulates the ureter to continue to grow, differentiate, and branch into it. The 
uninduced mesenchyma secretes glial cell line-derived neurotrophic factor (GDNF), a 
glycoprotein ligand for the c-Ret receptor located on the mesonephric duct. GDNF 
phosphorylates the Ret receptor and induces branching of the ureteric bud. Appropriate 
branching of the ureteric bud is obtained by the accurate distribution of these two molecules 
(Gomez and Norwood, 1999).  
In vivo, nephrogenesis is coordinated with renal vascularization. The ureteric bud 
induces the mesenchyma, which condenses around the ureteric tip and eventually 
differentiates into the epithelial segment of the nephron (Sakurai and Nigam, 1998). Many of 
the mesenchymal cells around the condensate are precursors for endothelial, smooth 
muscle/mesangial, or renin-producing cells. Vascular precursors, epithelial progenitors, and 
mesenchymal cells communicate with one another in a highly organized fashion and through 
complex interactions to yield a mature and functional kidney.  
 
3. Mammary Gland 
Development of the mammary glands is initiated in the embryo, but the major part of 
their development occurs in the adult. Mutual and reciprocal epithelial-mesenchymal 
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interactions are critical for both phases of development. Specific steps such as the formation 
of the bud, the first appearance of hormone receptors, formation of the primary sprout and 
ductal elongation have been shown to be governed by epithelial-mesenchymal signaling. In 
the mouse embryo, mammary buds are formed between embryonic day 10 and 11. At this 
time, the mesenchyme underlying the mammary bud appears in no way distinct from the rest 
of the dermis. The mesenchymal cells bordering the mammary buds orient themselves only 
slowly around the epithelium. By E14, the epithelial gland buds are surrounded by a slightly 
denser mesenchyme consisting of several concentric layers of fibroblasts oriented around the 
epithelium. Upon formation of the primary sprout the epithelium pushes through this sheath 
of mesenchymal cells and penetrates the future fat pad, a secondary stroma of the gland 
supporting ductal morphogenesis in the late fetal and the entire postnatal period (Robinson et 
al., 1999).  
Primary mammary mesenchyme induces hyperplastic growth in experimentally 
associated E17 mammary epithelium. Mesenchyme from the prospective fat pad of E14 mice 
is able to support organotypic development of E14 salivary gland, glandular stomach, 
intestine and colon and E12 pituitary gland and pancreas. Mesenchyme from the fat pad of 
older stages gradually loses this supportive capacity (Sakakura et al., 1979 and 1987). Cunha 
et al. later showed that E13 mouse mesenchyme was able to induce rat midventral or dorsal 
epidermis to form functional mammary epithelium (Cunha et al., 1995). Although the basis 
for these differences is unknown these observations may indicate a developmentally 
regulated expression of growth factors and trophic signals in these mesenchymal cells. 
Interactions between epithelium and mesenchyme are also involved in the regulation 
of ductal outgrowth of the mammary glands in the postnatal period. Activins and inhibins, 
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members of the transforming growth factor beta family, are important in mammary gland 
tissue interaction. Mice lacking the gene encoding the β-subunit of activins and inhibins have 
poorly developed mammary glands and are unable to nurse their pups. These results show 
that expression of the β-subunit is dispensable in the mammary epithelium but is required in 
the mesenchyme. The mesenchymal cell-derived activin and/or inhibin β appear to play a 
paracrine role in development of both the ducts and alveoli (Robinson and Hennighausen, 
1997).  
 
4. Placenta 
The major components of the mammalian placental membranes are an epithelial 
surface layer, the trophoblasts, and a heavily vascularized mesenchyme, the allantoic 
mesenchyme. A placental epithelial-mesenchymal interaction involves paracrine signals from 
allantoic mesenchyme acting on adjacent trophoblast. The expression patterns of several 
growth factors and their receptors, including hepatocyte growth factor-scatter factor (HGF-
SF) and its receptor, c-met, constitute some of these signals. In nearly all tissues examined, 
both during development and in the adult, HGF-SF is expressed by mesenchymal tissues and 
c-met is expressed by adjacent epithelia (Sonnenberg et al., 1993). For example, in the liver, 
HGF-SF is expressed by nonparenchymal cells and c-met by hepatocytes; in the developing 
mammary gland, fibroblasts express HGF-SF, whereas the luminal and myoepithelial cells 
express c-met (Hu et al., 1993; Niranjan et al., 1995). In accordance with these results, the 
mouse and human HGF-SF promoter sequences are active in mesenchymal, but not epithelial 
cells (PlascKMe-Schlutter et al., 1995).  Other mesenchymal cells expressed cytokines 
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including insulin-like growth factor II (IGF-II) and colony-stimulating factor a (CSF-1) 
(Stewart 1996). 
 
5. Anterior Eye 
During development of the anterior eye segment, cells that originate from the surface 
epithelium or the neuroepithelium need to interact with mesenchymal cells,which 
predominantly originates from the neural crest. In human embryos, migrating mesenchymal 
cells are seen during the 6th week of development, forming several layers of loosely 
aggregated cells and filling the space between surface epithelium and lens epithelium. In 
mouse embryos at E15.5, mesenchymal cells migrate along the inner surface of the primary 
stroma to form the corneal endothelium. The surface ectoderm that covers the anterior side of 
the mesenchyme will become the corneal epithelium. Mesenchymal cells between the corneal 
epithelium and endothelium start to differentiate into corneal stroma fibroblasts or 
keratocytes, which synthesise the highly specialized extracellular matrix of the corneal 
stroma. As a result, the cornea finally becomes transparent (Cvekl and Tamm, 2004).  
Transcription factors coordinate the complex interaction and communication between 
the two types of cell populations during morphogenesis of the anterior eye. Pax6, which is 
expressed in all cell types that contribute to anterior eye development, although at different 
times and with different intensity, appears to be the critical factor that synchronizes the 
critical events during formation of the anterior eye (Ashery-Padan and Gruss, 2001; Gehring 
and Ikeo, 1999). Failure of proper interaction results in anterior eye segment dysgenesis, 
which comprises a complex of developmental disorders that may critically reduce visual 
function. 
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 6. Stomach 
Vertebrate digestive organs are composed of an epithelial lining that originates from 
endoderm and a surrounding mesenchyme that is derived from splanchnic mesoderm. During 
the organogenesis of the vertebrate digestive tract, epithelial-mesenchymal interactions are 
essential for both epithelial development and mesenchymal differentiation (Fukuda and 
Yasugi, 2000, 2002 and 2005; Kedinger et al., 1988). In both the chicken and mouse embryos, 
tissue grafting experiments have revealed that the source of the mesenchyme is important for 
gut endoderm differentiation (Kedinger et al., 1986; Mizuno and Yasugi, 1990). 
Birds are characterized by two stomachs: the rostral proventriculus (PV), which 
functions in chemical digestion, and the caudally localized gizzard (GZ) for mechanical 
digestion. The PV epithelium becomes divided into two parts: the glandular and the luminal 
epithelium. The glandular epithelium gradually forms complex glands and specifically 
expresses a gene encoding a zymogen of a digestive enzyme, chicken embryonic pepsinogen 
(ECPg) (Hayashi et al., 1988).  
Studies using tissue recombination cultures showed that both PV and GZ epithelia 
form glands and produce ECPg when cultured with PV mesenchyme. In contrast, epithelial 
preparations that are cultured with GZ mesenchyme never form glands and do not produce 
ECPg (Takiguchi et al. 1986). This finding revealed that the PV mesenchyme has inductive 
effects upon both gland formation and ECPg expression in the epithelium, whereas the GZ 
mesenchyme is inhibitory to these pathways. In addition, the inhibitory effects of the GZ 
mesenchyme upon ECPg expression in the epithelium is sufficiently strong that it can be 
obtained when GZ mesenchymal cells are mixed with PV mesenchyme at a 1:10 ratio (Urase 
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and Yasugi, 1993). Therefore, as the epithelium of both PV and GZ has the potential for 
gland formation and ECPg production, the strong inhibitory effects of the GZ mesenchyme 
may function to form a sharp boundary between the PV and GZ.  
Also, ECPg expression is induced in both PV and GZ epithelium cultured in laminin 
gel, with medium conditioned by PV mesenchyme. These results strongly suggest that both 
the components of basement membrane (e.g. laminin) and the secreted factors in the 
conditioned medium from PV mesenchyme are required for the PV epithelium to produce 
ECPg. It has also been reported by the same group that the GZ mesenchyme produces 
secreted factors which inhibit ECPg expression in the epithelium. A candidate secreted 
molecule found in the PV mesenchyme is BMP-2 (Narita et al., 2000). When BMP-2 is 
overexpressed in the PV mesenchyme using retroviral constructs, the PV epithelium formed 
more glands and expressed ECPg at a higher level than the control. On the other hand, when 
the activity of BMP is inhibited by overexpression of noggin in the PV mesenchyme, the 
formation of glands and the expression of ECPg are completely inhibited.  
One of the FGF members, FGF10, is also associated with the formation of the 
glandular epithelium as a mesenchymal factor in the chicken. FGF10 is expressed in the 
developing PV mesenchyme, whereas its receptors are expressed in the epithelium (Shin et 
al., 2005). FGF10 overexpression also results in a dramatic change in the PV epithelium to a 
highly proliferative epithelial structure with an increase in epithelial cell number. Moreover, 
inhibition of FGF10 using overexpression of a secreted dominant negative form of FGFR2b, 
suppresses cell proliferation and gland formation in the PV epithelium. These results suggest 
that FGF signaling is required for proliferation and gland formation in the PV epithelium. 
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Epithelial-mesenchymal interactions are essential not only for epithelial 
differentiation but also for mesenchymal differentiation. The stomach epithelium of the 
chicken embryo regulates the concentric differentiation of mesenchymal components in the 
vertebrate gut. BMP4 expression in the mesenchyme is controlled by Shh expressed in the 
epithelium (Roberts et al., 1995). Shh has an important role in the control of the topology of 
mesenchyme differentiation.  
 
7. Pancreas 
During the development of the pancreas, pancreatic mesenchyme accumulates around 
the dorsal gut epithelium and induces pancreatic bud formation and branching (Kemp et al., 
2003). The appearance of endocrine cells is induced by the actions of morphogenetic factors 
derived from the lateral plate mesoderm, such as activin and BMPs, on progenitor cells 
expressing the characteristic transcription factor, Pdx-1 (Soria, 2001; Hill, 2005). Prior to its 
specification toward a dorsal pancreatic fate, the gut epithelium of the posterior foregut is 
adjacent to notochord, an axial mesoderm structure. The notochord, through its secreted 
molecular factors, including the TGF-β family member, activin-β, and FGF-2, is believed to 
condition the prospective pancreatic mesenchyme and activate pancreatic gene expression by 
repressing expression of the signaling protein, Sonic hedgehog (Shh) (Hebrok et al., 1998). 
Inhibition of hedgehog signaling in foregut endoderm and surrounding mesoderm in chick 
embryo cultures by the steroid alkaloid cyclopamine leads to an extension in pancreatic 
marker gene expression in the epithelium and formation of pancreatic structures in the distal 
stomach and duodenal endoderm (Kim and Melton, 1998). Signaling from the mesenchyme 
to the invading epithelium regulates the appropriate balance of endocrine and exocrine 
 9
development, such that removal of the surrounding mesenchyme leads to a disproportionate 
ratio of the two, by promotion of endocrine cell development and impairment of exocrine 
development (Gittes et al., 1996).  
Lammert et al. showed that signaling from embryonic blood vessel cells, derived 
from mesoderm, promotes pancreatic bud development (Lammert et al., 2001). Using a 
combination of mouse Flk-/- embryos lacking endothelial cells and tissue recombination 
experiments, Yoshitomi and Zaret showed that the initial induction of dorsal endoderm cells 
positive for the pancreatic and duodenal transcription factor Pdx-1 does not require aorta or 
endothelial cell interactions, but dorsal pancreatic bud emergence and maintenance of Pdx-1 
expression does (Yoshitomi and Zaret, 2004). The aorta itself, apart from the blood supply, 
causes the induction of Ptf1a in dorsal endoderm explants. Thus, endothelial cell interactions 
specifically promote early dorsal pancreatic development, at least in part, by inducing Ptf1a+ 
pancreatic progenitors. Signaling by endothelial cells is necessary for the induction of both 
the insulin and glucagon genes.  
Growth factors contribute to endocrine cell proliferation, vascular formation, and islet 
expansion in the pancreas and originate from multiple tissue compartments including the 
ductal epithelium, the surrounding mesenchyme, and the vascular endothelium. FGFs are 
involved in early pancreatic induction from gut endoderm, and the high affinity FGF receptor, 
FGFR1, has been localized to ductal epithelial cells and to small developing islets (Gonzalez 
et al., 1996). FGFR4 is expressed in fetal rat islet development in vitro. FGF-7, one of the 
major ligand for FGFR4, is expressed within the mesenchyme adjacent to the pancreatic 
ducts (Ye et al., 2005). FGF-10 has also been shown to be expressed within pancreatic 
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mesenchyme in the mouse embryo; its absence causes a failure of ductal branching and an 
absence of Pdx-1-expressing endocrine progenitor cells (Bhushan et al., 2001). 
Vascular endothelial cell growth factor, VEGF, is a potent mitogen for endothelial 
cells both in vitro and in vivo. Two of its high affinity tyrosine kinase receptors are Flt-1 and 
Flk-1. Flk-1 mRNA is expressed within RINm2F islet cells, as well as in fetal rat islets where 
VEGF is able to induce increased insulin content. Hepatocyte growth factor, HGF, is 
expressed within tissue mesenchyme in the embryo and fetus, and during postnatal tissue 
regeneration. Its receptor, the tyrosine kinase called met, is expressed within adjacent 
epithelial tissues which are target sites for mitogenic and morphogenic actions of hepatocyte 
growth factor, HGF. In human fetuses, met is found on cells within the pancreatic ducts, 
while in adult tissues, met mRNA and peptides are localized to islet β–cells. HGF mRNA is 
abundant in pancreatic stroma and is able to regulate the proliferation and differentiation of 
adjacent epithelial cells (Wang et al., 2004).  
 
8. Liver 
Hepatic genes are first induced in a segment of the definitive endoderm at about 8.5 
days of gestation in mouse embryos (Zaret, 2002). Before hepatic induction, the mesenchyme 
of the septum transversum surrounds the developing cardiac region near the ventral foregut 
endoderm and is the presumed source of multiple inductive signals triggering liver formation. 
After exposure to these inductive signals, the hepatic endodermal epithelium becomes more 
proliferative, and the cells begin to bud into the stromal environment (Zaret, 2002; Zhao and 
Duncan, 2005). Transplantation of endodermal tissue at the 4-6 somite stage into the 
precardiac mesoderm results in tissue that morphologically resembles the liver. Interaction 
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between endodermal and mesodermal tissues is important for hepatic development (Lemaigre 
and Zaret, 2004).  
Zaret et al. searched for locally acting factors expressed in the cardiac mesoderm at this 
stage and identified a number of members of the FGF family proteins (FGF1, 2 and 8) as 
potential candidates. In contrast, FGFR-1 and FGFR-4, receptors for these FGF species, were 
found to be expressed on endodermal cells, indicating that the FGF-FGFR signaling pathway 
is active between endoderm and mesoderm. Treatment of endodermal cells with FGF-1 and 
FGF-2 in the absence of the cardiac organ were capable of inducing the expression of 
albumin mRNA (Jung et al., 1999). Different thresholds of FGFs were needed? for patterning 
the ventral foregut into liver or lung in the absence of cardiac mesoderm (Serls et al., 2005). 
Ventral foregut endoderm explants from E8-9.5 mouse embryos respond to exogenous FGF1 
and FGF2 in a dose-dependent manner, with lower concentrations activating liver-specific 
genes and higher concentrations activating lung-specific genes (Serls et al., 2005). Moreover, 
inhibiting FGF signaling pathway using neutralizing antibodies against FGFR-1 and FGFR-4 
strongly inhibited the expression of albumin mRNA. FGF-FGFR signaling, therefore, is 
critical for the initial process of liver development. 
It has been known that the members of the bone morphogentic family of proteins, the 
BMP family, also play a role in liver organogenesis. Zaret et al. used a mouse BMP4-null 
mutation and an inhibitor of BMPs to show that BMP signaling from the septum transversum 
mesenchyme is necessary to induce liver genes in the endoderm and to exclude a pancreatic 
fate (Rossi et al., 2001). In the BMP4-deficient embryos, the liver bud failed to enlarge and 
albumin was not expressed. Suppression of BMP signaling by an extracellular antagonist, 
noggin, inhibited albumin induction in the explants assay. Expression of a liver-enriched 
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transcription factor, GATA4, was also found to be reduced in liver explants derived from 
BMP4-null mice. GATA factors are known to regulate the transcription of other liver-
enriched factors such as HNF4-α in hepatic cells. Thus, BMPs function by affecting the 
levels of the GATA4 transcription factor and act synergistically with FGF signals to induce 
hepatic specification.  
 
B. Stem Cell Niches 
1. Introduction 
Stem cell niche is a specific location in a tissue where stem cells reside for an 
indefinite period of time and produce progeny cells while self-renewing (Ohlstein et al., 
2004). The cells, matrix glycoproteins and the three-dimensional spaces they form provide 
ultrastructure for the niche. The contact between these elements allows molecular 
interactions that are critical for regulating stem cell function. Stem cell niches must ensure 
that daughter cells differentiate appropriately as they leave the niche.  
Currently, the best-characterized stem cell niche at the histological and molecular 
level is the germline stem cell (GSC) niche in the ovary and testes of Drosophila and 
Caenorhabditis elegans. Additionally, four mammalian stem cells niches have been described 
for the bone marrow, central nervous system, intestinal crypt and skin (Naveiras and Daley, 
2006).  Investigators in the Reid lab have been redefining the stem cell niche for the liver 
(Schmelzer et al, 2007; Zhang et al, submitted). The studies from this thesis are part of those 
efforts.  
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2. Stem cell niches control stem cell activity 
      Stem cells in different tissues are often associated with specific partner or companion 
cells. Hematopoietic stem cells (HSCs) reside in niches located in trabecular bone where they 
are in contact with osteoblasts. Epidermal stem cells with the potential to replenish basal 
keratinocytes, hair and sebaceous glands are found in the hair follicle bulge with dermal 
papillae. Neural stem cells are closely associated with other astrocytes, neuroblasts, 
ependymal cells, endothelial cells and a factor-rich basal lamina.   
Cancers have long been recognized as transformed stem cells or early progenitors. 
The cancers are comprised of aggregates of early progenitors and, therefore, can be used as 
model stem cell systems (albeit with recognition of critical distinctionswith their normal 
counterparts).  The stem cells giving rise to certain brain tumors have a niche in which the 
transformed neuronal stem cells are closely associated with vascular cells needed to promote 
the long-term growth and self-renewal of the malignant neuronal cells. The relationship 
between transformed stem cells and the endothelial cells may be bidirectional (Yang and 
Wechsler-Reya, 2007). 
Inside the niche, stem cells are often quiescent. The niche’s microenvironment, in the 
quiescent state, is both proliferation- and differentiation-inhibitory. Proliferation and 
differentiation of stem cells can often be induced in vitro or in vivo after injury. How stem 
cells get activated in their niche is an important question in stem cell biology. One theory is 
that as the niche becomes occupied, excess stem cells are displaced as or shortly after they 
divide, thereby loosening connections with the niche. In this case, when faced with a new 
environment, the expelled stem cells or their recently divided progeny progress to 
differentiate. Alternatively, stem cells might simply remain inactive within the niche until 
 14
they have to become functional, for example in response to injury. In this case, an 
environmental change from the tissue might actively signal to the niche to mobilize their 
residents (Fuchs et al., 2004).   
 An alternative hypothesis is that proposed with respect to extracellular matrix 
components described below. The ability of the niche to retain its stem cells is also likely to 
play a role in recruiting stem cells, a process referred to as “homing”. Although the 
molecular details of this process are still unknown, it seems likely that niches develop 
concomitantly with input from both stem cells and the surrounding tissue. Once established, 
they seem to be able to survive at least transiently as signaling centers to attract stem cells. In 
vertebrae, transplanted HSCs from one animal can find their way into the irradiated bone 
marrow of a host animal. Studies in Drosophila showed that when germline stem cell niches 
are experimentally emptied of their stem cells, the niches still persist and can even signal 
incoming somatic stem cells to take up foreign residence and at least transiently maintain 
some of their stem cell features (Kai and Spradling, 2003).  
 
3. The role of extracellular matrix (ECM) as paracrine signals   
Components in the extracellular mtrix (ECM), such as the proteoglycans, are critical 
in dictating fate of the stem cells.  Recent reports by Bruce Caterson suggest that stem cell 
niches in all tissues assayed have a unique extracellular matrix chemistry that includes forms 
of chondroitin sulfate proteoglycans (CS-PGs) (personal communication with Dr. Bruce 
Caterson). The proteoglycan chemistry shifts to heparan sulfate proteoglycans (HS-PGs) 
immediately outside the niche. All sulfated proteoglycans bind growth factors, but CS-PG 
binds them with less affinity than HS-PGs and has a 3-dimensional structure that results in 
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many of the sulfated residues internalized within the molecules’ rod shape or globular shape.  
By contrast HS-PGs are structured such that the sulfate groups are externalized and available 
for binding to growth factors that are then presented to cells as a stable signaling scaffold.  
Therefore, the stem cell niche has a matrix chemistry that shields the stem cells from growth 
factor signaling, thereby keeping the cells from signals that would lineage restrict them to a 
more mature fate.  More on aspects of the matrix chemistry of the stem cell niche is given 
below.  
Other extracellular matrix components (ECM) can also regulate stem cells. In skin, β-
1 integrins are known to participate in constrained localization of a stem cell population 
through interaction with matrix glycoprotein ligands (Jensen et al., 1999). In nervous system, 
absence of tenascin C alters neural stem cell number and function in the subventricular zone 
(Garcion et al., 2004). Tenascin C seems to modulate stem cell sensitivity to fibroblast 
growth factor 2 (FGF-2) and bone morphogenetic protein 4 (BMP-4), resulting in increased 
stem cell propensity to generate glial offspring. In hematopoietic system, deletion of tenascin 
C has also been shown to affect progenitor cell populations (Ohta et al., 1998). In Drosophila, 
the posterior mid-gut populations of cells have the capacity to produce two types of daughter 
cells: enterocytes and enteroendocrine cells. These cells sit on a basement membrane that 
divides them from surrounding muscle cells. Basement membrane itself might participate in 
the specialized microenvironment, giving an opportunity for shifting location of the stem cell, 
sliding along a continuum of the intestine.  
A matrix protein, osteopontin (OPN), has been shown to contribute to HSC regulation. 
OPN interacts with several receptors known to be on HSCs: CD44, and α4 and α5β1 
integrins (Nilsson et al., 2005). It is produced by multiple cell types including osteoblasts that 
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contribute to the HSC niche. Animals deficient in OPN have an increased HSC number. 
Without OPN, increased stem cell expansion occurred under stimulatory conditions (Stier et 
al., 2005). Thus, OPN seems to act as a constraint on HSC number, limiting the number of 
stem cells under homeostatic conditions or with stimulation. These results suggest that matrix 
components can contribute positively or negatively on the stem cell pool.  
 
4. The soluble paracrine signals  
In addition to ECM molecules, soluble signals provided by the niches are also 
considered to be a major factor regulating stem cell activity. In Drosophila testis, Unpaired 
(UPD) is secreted by niche (hub) cells and induces stem cell self-renewal via Janus kinase 
(JAK)-signal transducer and activator of transcription (STAT) signaling (Kiger et al., 2001; 
Tulina and Matunis, 2001). In the Drosophila ovary, Decapentaplegic (Dpp) and a BMP 
analog, Glass bottom boat (Gbb), are produced by niche (cap) cells. These stimulate SMAD 
signaling in the germline stem cells (GSCs) and result in suppression of differentiation, 
maintaining the self-renewing stem cell state (Chen and McKearin, 2003; Song et al., 2004; 
Xie and Spradling, 1998). 
Hedgehog (hh) family members have a role in topographic organization and 
formation of stem cell niches in development. In Drosophila ovary, hh is secreted by cap 
cells and mediates proliferative effects on not only germ line stem cells, but also the 
surrounding somatic cells composing the niche itself (Forbes et al., 1996; King et al., 2001). 
Sonic hedgehog (shh) is essential for hair follicle formation, and distinguishes the 
localization of specific subsets of epidermal stem cells to either the follicular niche or the 
interfollicular epidermis (Levy et al., 2005). In the developing intestine, shh and Indian 
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hedgehog (ihh) contribute to architectural patterning and regularity of the crypts where stem 
cells reside (Madison et al., 2005). Other paracrine signals that are developmentally critical 
include TGF-β/BMPs, FGFs, Notch and Wnts. During embryonic development, BMPs and 
FGFs are secreted by the septum transversum mesenchyme and cardiac mesoderm 
respectively to initiate liver induction (Zaret, 2002). The Wnt/Frizzled/β-catenin pathway is 
responsible for intestinal stem cell proliferation. Notch levels fine-tune the fate of the stem 
cell progeny, thereby determining the lineage of differentiating cells. The ability of one 
neighbor to activate and the other to repress Notch signaling sets up a boundary that allows 
the cells to choose between alternative fates. Osteoblasts may maintain HSC self-renewal and 
suppress differentiation by expressing Notch ligands that stimulate receptors on the HSC 
surface (Calvi et al., 2003).  
 
5. Niche-regulated symmetric and asymmetric cell divisions 
Regulating the balance between symmetric and asymmetric stem cell divisions 
becomes critical in maintaining proper stem cell number within the niche and in satisfying 
the demand for differentiated cells within its surrounding tissue. Such niche may participate 
in orienting asymmetric divisions precisely in order to orchestrate the flow and directionality 
of the committed daughter cells. In a hypothetical model, interactions between the basal 
lamina (basal surface) and neighboring stem cells (lateral surface) establish the polarity of 
the stem cells that in turn leads to the concentration of cell differentiation factors at the apical 
surface (Perez-Moreno et al., 2003). These factors direct the orientation of the spindle, 
referred as “spindle-polaring”. Depending upon the relative strength of these spindle-
polarizing signals, the ensuing stem cell divisions will either asymmetrically or 
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symmetrically partition the cell differentiation determinants and/or stem cell factors. If the 
strongest spindle-polarizing signal localizes at the basal lamina pole, the cell determinants 
will be asymmetrically partitioned following mitosis. By contrast, if the strongest spindle-
polarizing signal localizes at sites of cell-cell contact pole, the determinants are partitioned 
equivalently, leaving two identical daughter cells. Therefore, the key in assessing whether a 
division will be asymmetric or symmetric is whether the orientation of the mitotic spindle is 
parallel to or perpendicular to the major cell polarity axis that aligns the cell fate 
determinants 
      
6. Germline stem cell (GSC) niche 
In Drosophila, the GSC niche is formed by a tight cluster of stromal cells sitting on 
the apex of gonads. In the testis they are called hub cells, and in the ovary they are termed 
cap cells. They both intimately contact GSCs, providing the critical membrane-membrane 
interactions required for self-renewal. The molecular events start with homologous DE-
cadherin interactions at the adherens junction connecting stromal and germinal cells; this 
triggers activation of the Armadillo pathway on the GSCs. Conversely, the nuclear 
translocation of β-catenin, the vertebrate homologue of Armadillo, has been reported to be 
sufficient to drive mammalian stem cell self-renewal (Lin, 2002).  
A soluble factor in Drosophila, Decapentaplegic (Dpp), is the homologue of BMP2 
and BMP4 in mammals and is required for maintaining the GSC population in the ovary 
through inhibition of Bam (Chen and McKearin, 2003). A gradient of decreasing Dpp and 
increasing Bam (bag of marbles) indicates GSC differentiation when moving away from the 
cap cells along the axis of the ovary. A similar mechanism was seen in C. elegans. In the C. 
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elegans gonad, a gradient of the pro-differentiative factor GLD-1 distal to the tip cells and its 
inhibitor GLP-1/Notch proximal to the tip are necessary for homeostatic GSC maintenance 
(Hansen et al., 2004). Hedgehog (hh) signaling appears to regulate the commitment to 
differentiation of germ cell progeny.  
  
7. Hematopoietic stem cell (HSC) niche 
HSC niches are located in the endosteum, the inner surface of the bone that interfaces 
with the bone marrow. The endosteum is covered with osteoblasts and osteoclasts, which are 
thought to secret a variety of factors that regulate HSC function. Experiments that increase 
osteoblast population in mice also increase the number of HSCs in bone marrow (Calvi et al., 
2003; Zhang et al., 2003). Some factors, such as angiopoietin, that appear to regulate the 
maintenance or the numbers of HSCs in bone marrow are expressed by osteoblasts (Arai et 
al., 2004). Osteoclast activity and the high amounts of calcium generated by bone resorption 
have also been considered to be involved in promoting HSC maintenance and localization 
near the endosteum (Adams et al., 2006; Kollet et al., 2006). 
The endosteum, however, is not the only niche for HSCs. When osteoblasts are 
ablated from the bone marrow, HSC population actually increases over time (Visnjic et al., 
2004). Moreover, HSCs can be maintained for long periods of time in extramedullary tissues 
like the spleen and liver, which do not contain endosteum or bone. Therefore, cells other than 
osteoblasts must be capable of creating HSC niches. The localization of HSCs in 
hematopoietic tissues showed that about two-thirds of HSCs in the bone marrow and in the 
spleen are adjacent to sinusoids (Kiel et al., 2005). Sinusoids are surrounded by reticular cells 
that secrete CXCL12 (also called stromal cell-derived factor (SDF)-1), a chemokine that is 
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required for HSC maintenance. HSCs localized around sinusoids and to the endosteum are 
usually associated with CXCL12-secreting reticular cells. The main receptor for CXCL12 is 
CXCR4 expressed by HSCs (Peled et al., 1999). CXCL12-CXCR4 signaling is required for 
the colonization of bone marrow by HSC during development and regulates the engraftment 
of HSCs after transplantation. 
 
 8. Neural stem cell (NSC) niche 
In the adult rodent brain, neural stem cells (NSCs) are concentrated in subventricular 
zone (SVZ) of the lateral ventricle wall and the dentate gyrus subgranular zone (SGZ) of the 
hippocampus. Astrocytes in both regions have been considered as NSCs (Alvarez-Buylla and 
Lim, 2004; Doetsch, 2003). SVZ astrocytes are in intimate contact with all other SVZ cell 
types, including the rapidly dividing transient amplifying cells and the committed migratory 
neuroblasts. Astrocytes, in addition to functioning as primary precursors for the new neurons, 
also participate in the creation of the microenvironment that stimulates neurogenesis. There 
is a relationship between vasculogenesis and neurogenesis in the adult brain. In the SGZ, 
bursts of endothelial cell division are spatially and temporally related to clusters of 
neurogenesis (Palmer et al., 2000).  
Ependymal cells are important regulators in the SVZ and promote a neurogenic niche. 
These cells produce noggin, an antagonist of BMP signaling, which prevents glial 
differentiation of SVZ cells induced by BMPs (Lim et al., 2000). In the adult, ependymal 
cells and SGZ precursors express CXCR4. Its ligand, SDF-1, is required for cerebellar and 
hippocampal development (Lu et al., 2002; Stumm et al., 2002). SDF-1 acts as an attractant 
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to hold cerebellar precursors in the external granule layer and cooperates with shh to increase 
their proliferation (Klein et al., 2001). 
Stem cell maintenance and differentiation are often related to their proximity to a 
basal lamina (BL). Astrocytes are interdigitated with BL and the SVZ BL is rich in laminin, 
collagen type I, tenascin-C, heparin sulfate and chondroitin sulfate proteoglycans, as well as 
integrins. The BL tethers factors, anchors cells and provides spatial cues within the stem cell 
niche. ECM-bound or cell surface-bound molecules can be cleaved to release active ligands 
or soluble inhibitors. Perhaps the extensive attachment to the BL is important for 
maintenance of neural stem cell properties. 
 
9. Epidermal and intestinal stem cell niches 
In the skin, multipotent stem cells reside in the hair follicle, in a region known as the 
bulge. The bulge is located below the sebaceous gland and at the juncture of the arector pili 
muscle. The entire follicle is surrounded by a basement lamina, which is surrounded in turn 
by a dermal sheath. The bulge also possibly receives inputs from the nearby sensory nerve 
endings and blood vessels. Bulge stem cells give rise to transient amplifying matrix cells, 
which proliferate and then differentiate to produce the hair shaft and the channel that 
surrounds it. The hair follicle bulge (the niche) receives a periodic stimulus from specialized 
mesenchymal cells, known as dermal papilla (Fuchs et al., 2004). FGF18 and BMP6 have 
been shown to slow keratinocyte cell growth without inducing terminal differentiation 
(Christiano, 2004). 
The intestine is compartmentalized into crypts. Intestinal stem cells (ISCs) reside near 
the base of each crypt and give rise to four different progeny: paneth cells, enteroendocrine 
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cells, goblet cells, and adsorptive villus cells. The crypt epithelium is separated by a basal 
lamina that is surrounded externally by gut mesenchyme. The mesenchymal cells emit 
signals that participate in regulating stem cell activity. The pericryptal mesenchyme has been 
shown to secret various factors such as hepatocyte growth factor (HGF), TGF-β family 
proteins and keratinocyte growth factor. Corresponding receptors for these factors are located 
on the neighboring epithelial cells (Rizvi and Wong, 2005; Moore and Lemischka, 2006).  
 
10. Hepatic stem cell (HpSC) niche : 
The stem cell niche in liver has long been assumed to be the fetal liver parenchyma, 
the hepatoblasts, with their signature feature of alpha-fetoprotein (AFP) expression. In the 
adult tissue it has been thought that there are no stem cells since AFP+ cells are so rare 
(<0.01%) and AFP+ cells do not appear in increased numbers in adult liver except in certain 
disease states (e.g. cirrhosis).  However, recent studies from Dr Reid’s laboratory (group) 
(Schmelzer et al, 2006; Schmelzer et al, 2007; Zhang et al, submitted) have indicated that the 
stem cell niche in fetal and neonatal livers is the ductal plate (also called limiting plate). This 
entity is the antecedent to the canals of Hering, the presumptive stem cell niche in adult livers. 
Given that studies in this thesis are part of that effort to redefine the liver’s stem cell niche, 
the findings and conclusions will be presented as results in the thesis. 
The canal of Hering was first described by Ewald Hering who identified a link between 
the hepatocyte canalicular system and bile ducts in 1867 (Roskams et al., 2004). It is a 
channel partly lined by hepatocytes and partly by cholangiocytes, and continues into a 
channel lined entirely by cholangiocytes, called the ductule. Cells of morphology and 
immunophenotype intermediate between hepatocytes and cholangiocytes are found at 
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canal of Hering, but not in other regions of the liver (Theise et al., 1999). These cells are 
considered as bipotent liver progenitor cells with a diameter larger than 6 microns but 
less than 40 microns. They have been reported to express some biliary antigens 
(cytokeratins 19 and 7 and OV-6), some hepatocyte antigens (e.g. albumin, α1-antitrypsin 
and occasionally AFP, and neuronal cell adhesion molecule or NCAM/CD56) (Roskams 
et al., 2003).  
One of the earliest cellular responses to chemical hepatocarcinogens includes the 
proliferation of epithelial cells that are different in morphology and biochemistry than 
mature hepatocytes (Factor et al., 1994). These highly proliferative stem-like cells are 
called oval cells due to the shape of their nuclei, and are able to give rise to a new system 
of oval cell ducts spreading into the acinus and to differentiate into hepatocytes inside the 
ducts in the periportal areas in mouse livers. Several injury models have been developed 
to study the origin and properties of oval cells. Factor et al. injected the DNA-alkylating 
agent Dipin (1,4-bis[N,N’-di(ethylene)-phosphamide]-piperazine) intraperitoneally 
followed by two-thirds partial hepatectomy to induce generation of oval cells in mouse 
livers (Factor et al., 1994). Wang et al. used Nycodenz gradient centrifugation to separate 
the oval cells from the mature hepatocytes after DDC-(3,5-diethoxycarbonyl-1,4-
dihydrocollidine) treatment to the wild-type (WT) adult mice, and subsequently 
transplanted the purified oval cells into the Fah-/- (fumaryl-acetoacetate hydrolase 
deficient) recipient mice followed by a long-term NTBC (2-(2-nitro-4-trifluoro-
methylbenzoyl)-1,3-cyclohexanedione) withdraw (Wang et al., 2003). The recipient mice 
had significant donor-derived hepatocyte repopulation and phenotypic rescue. It has been 
reported that mouse A6-positive hepatic oval cells expressed AFP and several 
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hematopoietic stem cell markers, such as CD34, CD45, and Sca-1 (Petersen et al., 2003). 
Since these highly proliferative stem-like cells were induced by carcinogens, long-term 
monitor of these oval cells following hepatocarcinogen treatment to adult mice should be 
conducted to investigate the possibility of transformation of these stem-like cells to the 
hepatic cancer cells. It is still unclear whether oval cells found in the mouse liver after 
carcinogen-induced injury are normal hepatic stem cells or are heterogenically composed 
of normal as well as tumorigenic progenitor cells. 
 The matrix chemistry within the liver has been defined broadly and for the entire 
liver acinus but not yet for the stem cell niche.  The matrix components are present in the 
Space of Disse, located between the parenchyma and the endothelia.  They form a gradient in 
the matrix chemistry that begins at the portal triads and transitions to that near the central 
vein (Reid et al., 1992; Sigal et al, 1992; Martinez-hernandez, 1993; Zern and Reid, 1993). 
The periportal zone contains hyaluronans, collagen types III, IV and V, laminin, and fetal 
forms of proteoglycans, such as chondroitin sulfate proteoglycan (CS-PG) and heparin 
sulfate proteoglycan (HS-PG). It transitions to a matrix chemistry in association with the 
most mature parenchymal cells near the central vein and comprised of type I collagen, 
fibronectin, and heparin proteoglycan (HP-PG).  
       
C. Companion Cells Located in or near the Hepatic Stem Cell Niche 
The major non-parenchymal cells that are companion cells to the HpSCs and in or 
near the niche include hepatic stellate cell precursors and angioblasts.  The liver acinus,  
outside of the niche, contains sinusoidal endothelial cells, mature hepatic stellate cells, and 
hemopoietic cells, particularly the Kupffer cells, a form of macrophage.  These “companion” 
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cells regulate development, proliferation and differentiation of hepatic parenchymal cells by 
secretion of cytokines as well as synthesis and remodeling of extracellular matrix molecules. 
Although characterization of these companion cells in the mature liver has been well-
documented, little is known of the biology of the companion cell precursors found in the 
stem cell niche.   
 
1. Hepatic Stellate Cells (HpSTCs) 
Hepatic stellate cells (HpSTCs) are mesenchymal cells in the subendothelial space of 
Disse, separating the apical surface of hepatocytes from the ablumenal side of sinusoidal 
endothelial cells. These close cell-cell contacts between neighboring cells are important for 
efficient paracrine transport of growth factors and cytokines. HpSTCs play a pleiotrophic 
role in regulation of liver growth via extracellular matrix production and remodeling, growth 
factor and cytokine synthesis and changes in sinusoidal porosity. HpSTCs are thought to be 
fibroblastic mesenchymal cells based on their significant induction of α-smooth muscle actin 
(α-SMA), matrix molecules, and matrix metalloproteinases during activation. They also 
exhibit many neuroendocrine features, including the expression of synaptophysin, glial 
fibrillary acidic protein (GFAP), neural cell adhesion molecule (NCAM), nestin, 
neurotrophins, dopamine-β-hydroxylase (DBH), and tyrosine hydrozylase (Sicklick et al., 
2005). 
HpSTCs express at least three major hepatocyte mitogens: transforming growth 
factor-α (TGF-α), epidermal growth factor (EGF) and hepatocyte growth factor (HGF) 
(Ankoma-Sey and Friedman, 1998; Bachem et al., 1992; Maher, 1993; Mullhaupt et al., 
1994). HGF is a heparin-binding protein stored within the extracellular matrix. During 
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regeneration after partial hepatectomy, HGF mRNA is increased in the liver reaching its peak 
level at 10-12 hours after surgery (Selden et al., 1990). HpSTCs also synthesize and release a 
variety of inhibitory growth factors including TGF-β which also promotes liver fibrosis via 
induction of MMP-2 and TIMPs. Activin A, a member of the TGF-β superfamily, is 
produced by HpSTCs after CCl4 treatment (Date et al., 2000). Expression of Activin A 
receptors is down-regulated maximally at 24 hours after toxic injury and returns to normal by 
96 hours. Down-regulation of Activin A receptors prevents Activin A from transducing its 
anti-proliferative stimulus. Activin A also promotes fibronectin synthesis in HpSTCs. Bone 
morphogenetic protein-6 (BMP-6), also a member of the TGF-β superfamily, is expressed in 
HpSTCs and Kupffer cells (KCs) (Knittel et al., 1997).  
Stem cell factor (SCF) and acidic fibroblast growth factor (FGF-a) have been 
identified in HpSTCs in rat livers during regeneration after partial hepatectomy (Fujio et al., 
1994; Marsden et al., 1992). Insuline-like growth factor I and II (IGF-I and –II), their binding 
proteins and their receptors, are also produced by HpSTCs (Pinzani et al., 1990; Zindy et al., 
1992). Expression of heparin-binding growth factor-2 is localized to HpSTCs in CCl4-treated 
rat livers (Charlotte et al., 1993). Using transgenic animals expressing a reporter gene 
controlled by the erythropoietin gene, Maxwell et al. reported expression of the 
erythropoietin gene in HpSTCs (1994). Pro-inflammatory mediators MCSF and monocyte 
chemotactic peptide 1 (MCP-1) are also secreted by HpSTCs (Marra et al., 1993; Pinzani et 
al., 1992). MCSF production is stimulated by PDGF and FGF-b. MCP-1 production is 
stimulated in vitro by interleukin-1α (IL-1α) and interferon-γ (IFN-γ). IL-6 mRNA is 
expressed in primary HpSTC and HpSTC lines derived from normal rat livers (Greenwel et 
al., 1993).  
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HpSTCs express hedgehog (hh) ligands and multiple components of the hh pathway 
including Sonic hedgehog (shh), Indian hedgehog (ihh), Ptc, Smo, Gli1, Gli2, and Gli3 
(Sicklick et al., 2005). Freshly isolated HpSTC fraction from adult mouse livers had a 313-
fold higher expression of Shh and a 7-fold higher expression of ihh than total non-
parenchymal cell fraction. Clonally derived HpSTC line 5H from adult rat livers had 
significantly higher apoptotic (caspase 3/7) activity and lower cell viability in the presence of 
Shh-neutralizing antibody (5E1) (10 µg/ml) for 48 hours. This finding suggests that hh 
pathway activity prevents apoptosis of HpSC and modulates HpSTC activation. HpSCs can 
be activated in vitro and in vivo after liver injury. Previously reported markers of the 
activated HpSTCs include actin-α2 (ACTA2), collagen types I-α1 and -α2 and IV-α1, -α2, -α5 
and -α6, galectin 1, laminin-α5 chain, tissue inhibitor of metalloprotease-2 and -4 (TIMP-2 
and -4), TGF-β1 and IL-10 receptor (Kannangai et al., 2005).  
 
2. Endothelial cells (ECs) 
Endothelial cells (ECs) forming the fenestrated walls of the liver sinusoids are 
characterized by a thin cytoplasm, flattened nuclei and, in zone 2 and 3 (but not zone 1) of 
the liver acinus, numerous fenestrae grouped in sieve plates, enabling direct communication 
between the sinusoid and space of Disse (Winwood and Arthur, 1998). During embryonic 
development of the liver and in hepatic regeneration, the formation of hepatic sinusoids by 
ECs is a relatively late event. A network of continuous capillaries with a basement membrane 
feeds differentiating hepatocytes. The liver development is induced in a step-wise process 
with the signals from cardiac mesoderm and then from the ECs (Lammert et al., 2003). 
Endodermal cells are induced by cardiac mesoderm to differentiate into hepatic stem cells 
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within the ventral endoderm at E8.5 of mouse gestation (Gualdi et al., 1996). Initial stages of 
hepatogenesis require FGFs secreted from pre-cardiac mesoderm and BMPs from the septum 
transversum mesenchyme (STM) (Duncan, 2003). At E9.5, newly specified hepatic cells 
delaminate and migrate into the surrounding STM and intermingle with ECs. ECs remain in  
contact with hepatic cells throughout development. In flk-1 mutant mouse embryos, which 
lack ECs, initial hepatic induction occurs, but no hepatic cells proliferate into the surrounding 
STM at E9.5, indicating the importance of ECs for normal hepatic outgrowth during early 
stages of liver organogenesis prior to blood vessel function (Matsumoto et al., 2001; Shalaby 
et al., 1995).  
ECs in normal liver express TGF-β (Braun et al., 1988). TGF-β mRNA was enriched 
in the EC fraction isolated from adult rat livers, but at much lower levels than the message 
detected in Kupffer cells (KCs). TGF-β inhibits EGF-induced DNA synthesis in vitro in 
hepatocytes from normal or regenerating liver after partial hepatectomy. HGF has been 
reported to be produced by ECs during liver regeneration (Maher, 1993). In normal liver, 
HGF and its mRNAs were abundant in HpSTCs, with lesser amounts detected in sinusoidal 
KCs and ECs (108.8, 17 and 6.2 U/million cells respectively). In regenerating liver, HGF 
gene expression increased exclusively in ECs. HGF mRNA levels rose 6-fold in ECs, 
peaking at 6 hours after carbon tetrachloride treatment, and returning to near normal by 24 
hours. The rise in HGF mRNA was accompanied by a 5.4-fold increase in HGF secretion as 
indicated by enzyme-linked immunosorbent assay (ELISA) experiment. 
ECs have the potential to synthesize matrix components. Jarnagin et al. examined the 
cell-specific expression of two fibronectin isoforms, EIIIA and EIIIB, during experimental 
hepatic fibrosis induced by ligation of the biliary duct (1994). Both isoforms were 
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undetectable in normal liver at mRNA level. EIIIA-containing fibronectin mRNA increased 
rapidly in sinusoidal ECs within 12 hours of injury. In contrast, EIIIB-containing isoform 
appeared only after a lag of 12-24 hours and was localized to hepatic stellate cells. At the 
protein level, EIIIA-containing fibronectin increased significantly within two days of injury 
and distributed at sinusoidal region. Secretion of this form by sinusoidal ECs accelerated the 
activation of normal hepatic stellate cells (HpSCs) to myofibroblast-like cells. Pretreatment 
of matrices with monoclonal antibody against the EIIIA segment blocked this activation of 
HpSTCs.  
 
3. Kupffer cells (KCs) 
Kupffer cells (KCs) are located in the hepatic sinusoids and are involved in the 
metabolism of various compounds, immunological responses and inflammatory reactions. 
Primitive macrophages first develop in the murine and human yolk sac and then differentiate 
into fetal macrophages and migrate into the fetal liver. The resident macrophages expand 
quickly and transform into KCs in the late stage of ontogeny and after birth. Hepatocytes 
provide a microenvironment for the development, differentiation and proliferation of 
macrophages in fetal liver by producing colony-stimulating factors (CSFs) (Naito et al., 
1997). Human fetal liver (13-19 weeks of gestation)-derived KCs have been isolated using 
density gradient separation method and cultured in RPMI 1640 supplemented with 10% fetal 
calf serum (FCS) on plastic (Kutteh et al., 1991).  Human fetal KCs are able to phagocytose 
0.8µm latex beads and respond to bacterial lipopolysaccharide (LPS) with production of 
TNF-α, IL-6 and IL-1β. Both dexamethasone and cortisol inhibited the production of LPS-
stimulated IL-6 (Kutteh et al., 1991). Similar to human KCs, cultured KCs isolated from 
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adult rat livers have been shown to produce IL-1, IL-6, IL-8 and prostaglandin E2 (PGE2) in 
vitro in serum-supplemented media (Goss et al., 1993; Maher, 1995). 
Both pro-proliferative and anti-proliferative cytokines are produced and released from 
KCs. Boulton et al. showed that following KC depletion the early phase of liver regeneration 
after partial hepatectomy was enhanced, as indicated by a greater proportion of hepatocytes 
undergoing DNA synthesis, and a higher mitotic index (1998). KCs were selectively 
eliminated in rat livers by liposome encapsulated dichlormethylene bisphosphonate 
(Cl2MBP). HGF and TGF-β mRNA were reduced in KC-depleted animals, and IL-1β mRNA 
was absent. In the control rats without partial hepatectomy, depletion of KCs increased 
proliferation of hepatocytes in resting liver undergoing DNA synthesis. Conditioned medium 
prepared from LPS-stimulated KCs induced time-dependent increase in IL-8 mRNA levels in 
SK-hepatoma cells over a 24-hour period (Thornton et al., 1991).  
IL-10 is produced by KCs. In KC-depleted rat livers, IL-10 expression was decreased 
significantly and TNF-α was constitutively overexpressed compared with normal animals 
(Rai et al., 1997). Less IL-10 from KCs allows more sustained TNF-α release from other 
cells, leading to increased hepatocyte proliferation. During liver regeneration after partial 
hepatectomy, TNF-α activates TNF receptor-1 which then increases hepatic levels of the 
transcription factor NFκβ at 1-4 hours, followed by an increase in IL-6 at 2-6 hours (Malik et 
al., 2002). 
KCs may play a role in remodeling the newly deposited matrix during liver 
regeneration. Human and rat KCs synthesize and release gelatinase B/type IV collagenase in 
primary culture (Winwood et al., 1995). Gelatinase B is a member of the family of matrix 
metallopropeinases that has specific degradative activity against denatured collagens 
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(gelatin), collagen types IV and V and elastin. The physiological function of KC-derived 
gelatinase B is unknown. It is thought to facilitate migration and proliferation of KCs at 
space of Disse in normal liver during injury.   
 
D. Use of Feeders (Co-cultures) for ex vivo Maintenance of Stem Cells 
1. Early experiments on feeder effects   
In 1955, Puck and Marcus published the first “feeder” paper in which they provided a 
method of clonal growth of HeLa cells with the aid of irradiated HeLa cells, the feeder cells 
(Puck and Marcus, 1955).  Unirradiated HeLa cells tend more often to form closely packed 
colonies in the presence of a “feeder” system than in its absence. Consequently, the need for 
the feeders should decrease as growth proceeds. Feeder cells may help to promote growth of 
dependent cells by providing necessary diffusible factors and/or by removing toxic actions of 
some metabolites in the media (Fish and Puck, 1956; Puck et al., 1956). However, they 
reported that medium previously conditioned by the growth of unirradiated cells was not 
effective in promoting colony formation.  
     Stoker and Sussman set up a half-feeder cultures with irradiated mouse embryonic (ED17) 
fibroblasts occupying only one side of a petri dish and found that the dependent cells, 
BKM21 (hamster fibroblasts) cells, formed large colonies confined to the half of the dish 
with attached feeder cells (Stoker and Sussman, 1965). A few small colonies were formed on 
the bare side, and there was a very sharp boundary at the edge of the feeder cells. They also 
found that the feeder layer had no effect on attaching and spreading of added cells. The 
feeder effect, once established, depends on the continued integrity of the feeder cells. It is 
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maximal within 0.2 mm of the feeder cells and is detectable with dimishing effect up to 1.5 
mm from the feeder cells.  
 
2. Culture of keratinocytes.    
Culture of keratinocytes on a feeder-layer of murine fibroblasts has been reported 
(Rheinwald and Green, 1975; Tenchini et al., 1992). The stromal cell line, NIH 3T3, derived 
from murine embryos, turned out to be the most effective for this purpose. The most widely 
used procedure to obtain non-proliferating NIH 3T3 cells is to expose them to high dose 
(6000 rads) of gamma rays. Alternatively, treatment with Mitomycin-C can be used, but 
since this compound is a mutagen, irradiation is generally preferred. The 3T3 cells have also 
been used as feeder cells to generate various epithelial cell sheets, such oral mucosal cells, 
corneal cells, and retinal pigment epithelial cells (Hata et al., 1995; Kobayashi et al., 2005; 
Pellegrini et al., 1997) 
  
3. Cultures of primordial germ cells 
Most available culture methods for primordial germ cells (PGCs) rely upon the 
presence of feeder cell layers, such as irradiated STO and mouse Sertoli cell-derived cell 
lines (De Felici and Dolci, 1991; Donovan et al., 1986). Isolated PGCs recovered from 11.5 
and 12.5 day post-cotium (dpc) embryonic mouse gonads did not survive at 37°C without 
somatic cell support, and undergo rapid apoptotic degeneration (De Felici and McLaren, 
1983; Farini et al., 2005). The addition of single growth factors to the culture medium only 
slowed down PGC apoptosis and did not substitute for the feeder cell layers (Pesce et al., 
1993). Lee and Piedrahita compared the numbers of colonies of porcine PGCs after 8-10 
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days of culture on different feeder cells including STO (mouse embryonic fibroblast cell line), 
TM4 (mouse Sertoli cell-derived cell line), Sl/Sl4 m220 (mouse homozygous null Sl/Sl4 
embryonic cell line), PEF (porcine embryonic fibroblasts isolated from day 25-30 fetuses), 
and COS-7 cells (African green monkey kidney cell line) (Lee and Piedrahita, 2000). STO, 
TM4, and Sl/Sl4 m220 supported survival of porcine PGCs during culture and there were no 
differences among them. However, the numbers of AP-positive colonies cultured on PEF and 
COS-7 cells were significantly lower than the other three cell lines. The three supportive 
feeder cells were known to express membrane-bound SCF (stem cell factor) while the other 
two were not. This result indicates that colony formation ability of PGCs is feeder cell-
specific.  
Kubota and Brinster developed a culture system for mouse spermatogonial stem cells 
using a serum-free defined medium and growth-arrested STO feeder cells (Kubota and 
Brinster, 2006). The cultured mouse spermatogonial stem cells express Oct-4 and alkaline 
phosphatase, markers similar to undifferentiated embryonic stem cells. The serum-free 
medium contains glial-cell-line-derived neurotrophic factor (GDNF), soluble GDNF-family 
receptor α1 and basic fibroblast growth factor (FGF-b). These three factors are required for 
self-renewal of both murine and rodent spermatogonial stem cells in vitro (Ryu et al., 2005). 
 
4. Culture of hematopoietic stem cells (HSCs) and neuronal progenitors.   
Use of endothelial cells as feeder cells for supporting HSCs has been reported. 
Auerbach et al. derived 3 endothelial cell lines (C165, C166, and C167) from murine 
embryonic (ED12) yolk sacs and irradiated them with 25Gy using a 137Cs source (Auerbach 
et al., 1996; Auerbach et al., 1998; Lu et al., 1996; Wang et al., 1996). HSCs isolated from 
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mouse embryonic (ED10) yolk sacs (YS-HpSCs) were dispensed on top of the yolk sac-
derived endothelial cell (YS-EC) monolayers (Huang and Auerbach, 1991). YS-EC line 
C166 permitted a 16- to 36-fold increase in the total number of nonadherent YS-HpSCs 
generated after 1 week with an antigenic profile of Sca-1+ and major histocompatibility 
complex (MHC) class I+. These expanded YS-HpSCs are able to differentiate into B-cells, T-
cells, and various myeloid cells in vitro and to reconstitute hematopoietic lineages in mildly 
irradiated BALB/c scid mice when transplanted. These results showed that expansion with 
retention of stem cell properties can be accomplished by using a co-culture system consisting 
of a cloned endothelial cell line derived from the yolk sac of mid-gestation (12-day) embryos. 
However, this endothelial feeder failed to maintain the more primitive hematopoietic stem 
cell phenotype from day-10 embryonic yolk sac with an antigenic profile of Sca-1-negative 
and MHC class I- and II-negative.  
Feeder cells have also been utilized to promote neurogenesis. Hermann et al. 
cocultured human adult hippocampal neuroprogenitor cells (hNPCs) with fetal cortical 
cultures containing astrocytes and neurons, mouse embryonic fibroblasts, or PA6 stromal 
cells, and showed increases of neurogenesis of hNPCs on all three types of feeders (Hermann 
et al., 2006).  
 
5. Transformation assays   
In addition to promoting growth of dependent cells, feeder cells have also been used 
in transformation assays. Marquardt and Heidelberger plated irradiated rat or mouse 
embryonic fibroblasts 24 hours prior to the plating of G23 (mouse ventral prostate fibroblasts) 
cells, which poorly metabolize carcinogenic hydrocarbons (Marquardt and Heidelberger, 
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1972). The feeder cells increase the yield of malignant transformation because of their ability 
to metabolize and activate the hydrocarbons. Feeder cells have also been shown to increase 
colony forming efficiency of X-irradiated human colon cancer cells in tissue culture dishes 
(Leith et al., 1991). However, feeder cells do not affect the radiation survival parameters of 
those tumor cell lines. The question of whether some types of cancer cells may be altered in 
their post-irradiation survival responses by feeder cells must relate to the conditioning factors.  
 
6. Use of feeder cells for human embryonic stem (ES) cell growth.   
The human ES cells were first isolated in 1994 (Bongso et al., 1994). The first 
continuous human ES cell lines were established in 1998, and were derived and propagated 
by direct contact on murine embryonic fibroblasts (Thompson et al., 1998). Since then 
various feeder systems have been developed for the growth of human ES cells (Cowan et al., 
2004; Reubinoff et al., 2000; Rose-John, 2002). Although mouse embryonic fibroblasts allow 
long-term culture of human ES cells, xeno-coculture introduces complications for the 
delivery of safe therapies for clinical programs in the future. The human ES cells might be 
infected by some murine viruses possibly active in the animal feeders. Certain mouse 
glycoprotein molecules, such as Neu5Gc, has been found to be incorporated metabolically 
into human ES cells and derived embryoid bodies co-cultured with mouse embryonic 
fibroblasts (Martin et al., 2005). It is also possible that cell fusion might occur between 
human and murine cells (Stacey et al., 2006).  
Approaches to use human feeder cells have also been reported. Richards et al. 
compared 11 different human adult, fetal, and neonatal feeders as well as mouse embryonic 
fibroblasts which were Mitomycin-C-inactivated for human ES cell support and ranked them 
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as supportive and non-supportive (Richards et al., 2003). Fibroblast cell lines established in-
house from human fetal skin, human adult abdominal skin biopsies, and human fetal muscles 
supported prolonged undifferentiated human ES cell growth for over 25, 30, and 50 weekly 
passages respectively in serum-free medium supplemented with 20% serum-replacement. 
Compared with human feeders, human ES cells growing on murine embryonic fibroblasts 
showed lower percent of completely undifferentiated colonies generated after 8 days of 
culture (55%-75% on mouse vs. 85%-90% on human). Other human feeder cells shown to 
supported long-term growth of human ES cells include newborn foreskin fibroblasts, 
placental fibroblasts, adult uterine endometrial cells, adult breast parenchymal cells, 
embryonic fibroblasts, and adult bone marrow-derived stromal cells (Amit et al., 2003; 
Cheng et al., 2003; Choo et al., 2004; Genbacev et al., 2005; Hovatta et al., 2003; Lee et al., 
2004, 2005). 
  
E. Feeder-Free Conditions  
The contribution of feeder cells in stem/progenitor cell culture is not entirely 
understood. It has been suggested that feeder cells provide both a suitable attachment 
substrate and important soluble factors for the maintenance and differentiation of 
undifferentiated stem/progenitor cells in vitro. However, the soluble factors as well as the 
extracellular matrix (ECM) molecules produced by the feeders remain poorly defined 
components of co-culture of feeder cells and supported cells. Feeder-free cultures would 
eliminate the difficulties of standardization and optimization procedures, thus making 
analyses of stem/progenitor cell properties easier. 
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1. Human embryonic stem (ES) cells  
Traditionally, human embryonic stem (ES) cells have been cultured with mouse 
embryonic fibroblast (MEF) feeder layers, which allow them to grow continuously in an 
undifferentiated state (Amit and Itskovitz-Eldor, 2006). Mouse ES cells maintain their stem 
cell features and remain undifferentiated when grown on gelatin without MEF feeder and 
within medium supplemented with LIF (Smith et al., 1988; Williams et al., 1988). However, 
LIF failed to support feeder-free culture of hESCs (Thomson et al., 1998). The mechanism 
for self-maintenance of human ES cells is still unclear. The first feeder-free culture for 
human ES cells was reported by Xu and coworkers (2001). Four human ES cell lines have 
been successfully cultured on Matrigel in MEF-conditioned medium supplemented with 20% 
serum replacement and 4 ng/ml of hFGF-b. The longest culture has been maintained for over 
130 population doublings (180 days). All long-term cultured cells retained morphology and 
karyotype of human ES cells, and expressed markers such as SSEA-4, Tra 1-81, OCT-4 and 
hTERT. 
A combination of the BMP signaling antagonist Noggin and high concentration of 
FGF-b has been reported to be sufficient to maintain undifferentiated human ES cells in 
feeder-free conditions (Xu et al., 2005). BMPs have previously been shown to induce human 
ES cell differentiation into trophoblast (Xu et al., 2002). In contrast, in mouse ES cells, 
BMP4 synergizes with LIF to maintain self-renewal of mouse ES cells in the absence of 
serum (Ying et al., 2003). DMEM/F12 supplemented with 20% serum replacement, 1 mM L-
glutamine, 1% nonessential amino acids, 0.1 mM 2-mercaptoethanol, 500 ng/ml noggin and 
40 ng/ml FGF-b sustained undifferentiated proliferation of human ES cells. The same group 
recently reported a detail protocol of serum-free condition used for culturing human ES cells 
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(Ludwig et al., 2006). Cloned zebrafish FGF-b (100 ng/ml), TGF-β1 (0.6 ng/ml), insulin (20 
µg/ml) and bovine holo-transferrin (11 ug/ml) were included in the medium and Matrigel 
was used as matrix to coat the plates.  
Although feeder-free conditions have been developed for culturing human ES cells, it 
has been reported that human ES cells cultured in feeder-free conditions may gain 
chromosomal changes (Draper et al., 2004). When a subline of H7 human ES cells was 
cultured on Matrigel without MEF feeders or MEF-conditioned medium for over 25 passages, 
a clone of these feeder-free H7 cells was found to carry an isochromosome, i(12p), the 
characteristic karyotypic marker of human embryonic carcinoma cells. It was hypothesized 
that enzymes used in passaging may push cells to too demanding culture conditions that may 
induce abnormalities (Skottman and Hovatta, 2006). 
 
2. Neural stem cells and adult skin-derived multipotent cells 
Neural stem/progenitor cells derived from embryonic and adult central nervous 
system have been cultured as neurospheres in the presence of EGF and FGF-basic in feeder-
free condition (Jesseberger et al., 2007; Uchida et al., 2000). Neurosphere assay has been 
used as a tool for isolating and understanding the biology of neural stem cells (NSCs) 
(Reynolds and Rietze, 2005). Uchida et al. used flow cytometry to sort CD133+ NSCs from 
human fetal spinal cord and brain tissues and cultured them in neurosphere initiation medium 
consisting of Ex Vivo 15 medium with N2 supplement, FGF-b (20 ng/ml), EGF (20 ng/ml) 
and LIF (10 ng/ml). Neurosphere formation and clonal expansion from single CD133+ cells 
were observed in 6-8 weeks. Progeny of single cell-derived neurospheres can be 
differentiated into neurons (β-tubulin+) and astrocytes (GFAP (glial fibrillary acidic protein)+) 
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in the medium with growth factors, brain-derived neurotrophic factor (10 ng/ml), glial-
derived neurotrophic factor (10 ng/ml) and laminin (10 µg/ml) on polyornithine-coated 
chamber slides (Uchida et al., 2000). 
Ray and Gage isolated NSCs from whole brain tissues of adult mice and cultured 
these cells in serum-free N2 medium containing FGF-b (20 ng/ml), EGF (20 ng/ml) and 
heparin (5 µg/ml) with seeding density of 20,000 cells/cm2 on uncoated tissue culture plastic 
plates (Ray and Gage, 2006). Proliferating clusters of cells, attached to the plates, started to 
appear by 2 weeks. Similar condition has also been used for culturing rat NSCs except that 
EGF and heparin were not added. Proliferating clusters of cells, attached to the plates, started 
to appear in about 1-2 weeks. This result showed that NSCs can be cultured to form 
monolayers instead of neurosphere. Cells within neurospheres are tightly packed. Properties 
of these cells (morphology, proliferation and differentiation) can only be examined after 
dissociation and replating of neurospheres. Culturing cells to form monolayers can eliminate 
these limitations.  
Multipotent stem cell-like cells has been isolated from adult trunk skin of mice and 
humans. These cells were cultured in DMEM/F12 containing B-27 supplement, FGF-b (20 
ng/ml), EGF (10 ng/ml) and LIF (10 ng/ml) with high seeding density 100,000-160,000 
cells/cm2 on uncoated cell culture flask (Wong et al., 2006).  Formation of floating spheres 
from these cells was observed within 4-7 days and the expression of neural crest stem cell 
(NCSC) markers, p75 (low affinity neurotrophin receptor) and Sox10 (transcription factor), 
was detected on these cells. On dishes coated with fibronectin, neurogenesis, gliogenesis, and 
smooth muscle formation were observed after 3-7 days. Chondrocyte formation was 
observed after 9 days in DMEM containing 10% FCS (fetal calf serum), ascorbic acid (50 
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µg/ml) and FGF-b (10 ng/ml), followed by DMEM containing 10% FCS, ascorbic acid (50 
µg/ml) and BMP-2 (10 ng/ml) for another 3 days. Adipocytes were occasionally observed 
when cultured in DMEM/F12 containing B-27 supplement and BMP-2 (10 ng/ml). 
Melanocytes were observed when cultured in DMEM containing 10% FCS, murine SCF (50 
ng/ml) and endothelin-3 (100 nM).  
 
3. Hematopoietic stem cells (HSCs) and endothelial progenitor cells (EPCs)  
Suspension cultures of hematopoietic stem cells (HSCs) without bone marrow stroma 
has been reported to be relatively ineffective in sustaining HSCs for long term in vitro. This 
may be due to the absence of natural three-dimensional topography and poorly defined 
characteristics of the bone marrow environment in vivo. Rosenzweig et al. used a tantalum-
coated porous biomaterial to culture CD34+ bone marrow-derived HSCs and showed that this 
material may help in maintaining HSCs, multipotency, long-term survival, and retroviral 
transduction in vitro. The number of CD34+/CD38- cells was relatively higher on this 
material compared with bone marrow stroma (Ehring et al., 2003; Rosenzweig et al., 1997). 
They also found that addition of exogenous cytokines, IL-3 (100 ng/ml), IL-6 (20 ng/ml) and 
SCF (100 ng/ml), to cultures significantly inhibited T cell differentiation. A serum-free 
condition with recombinant human GM-CSF (100 ng/ml), TNF-α (50 U/ml) and SCF (20 
ng/ml) has also been reported to be capable of maintaining human CD34+ HSCs (Strobl et al., 
1996). The same condition with addition of TGF-β1 (0.5 ng/ml) strongly induces dendritic 
cell differentiation.  
CD133+/VEGFR2+ human endothelial progenitor cells (EPCs) can be isolated from 
peripheral blood, cord blood and human fetal livers at 14 to 16 weeks of gestation, and have 
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been cultured in feeder-free condition with high serum (20% FBS) and high seeding density 
(500,000 cells/cm2) on fibronectin- or collagen type I-coated plates (Peichev et al., 2000; 
Powell et al., 2005). EPC colony-forming units, defined as a central core of rounded cells 
surrounded by elongating and spindle-shaped cells, were observed in one week on human 
fibronectin-coated plates and were positive for endothelial markers, such as CD31, vWF (von 
Willebrand factor) and VE-cadherin. When supplied with recombinant human FGF-b (5 
ng/ml) and heparin (5 units/ml) on collagen type-I-coated dishes, monolayers of mature 
endothelial cells appeared in 2 weeks.  Reyes et al. isolated multipotent adult progenitor cells 
(MAPCs) from human bone marrow and induced these cells to differentiate into vWF+ 
endothelial cells in a serum-free defined medium with VEGF (10 ng/ml) on fibronectin-
coated culture dishes without feeder cells (Reyes et al., 2002). When replated in Matrigel 
with VEGF, vascular tube formation was observed from the MAPC-derived endothelium 
within 6 hours.  
 
4. Hepatic stem cells and hepatoblasts 
It has been reported that hepatic stem cells (HpSCs) as well as hepatoblasts can be 
isolated from human fetal livers obtained from mid-gestational stages (16-20 weeks) and 
cultured under feeder- and serum-free defined condition (Schmelzer et al., 2006; ). Human 
fetal liver-derived HpSCs and hepatoblasts were expanded on tissue culture plastics for more 
than 3 months in a hormonally defined medium (HDM) supplemented with insulin (5 µg/ml), 
iron-saturated transferrin (10 µg/ml), hydrocortisone, nicotinamide (4.4 mM), selenium (30 
nM), L-glutamine, mixture of six free fatty acids (7.6 µM), 2-mercaptoethanol (50 µM) and 
bovine serum albumin (0.1%). The hHpSCs have an antigenic profile positive for EpCAM 
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(epithelial adhesion molecule), NCAM (neuronal adhesion molecule), albumin, cytokeratin-
19 (CK19), CD133/1 (also known as prominin in mouse) and claudin-3 and negative for 
ICAM-1 (intercellular adhesion molecule-1) and AFP (alpha-fetoprotein). They can give rise 
to more differentiated bipotent hepatoblasts with an antigenic profile positive for EpCAM, 
ICAM, AFP, albumin, CK19 and CD133/1 and negative for NCAM.  
Although feeder cells are not necessary for in vitro expansion of human HpSCs, non-
parenchymal cells, such as endothelial cells and hepatic stellate cells, have been found to 
exist in culture with HpSC colonies. These companion cells possibly form aggregates with 
HpSCs during isolation process and survived in the feeder- and serum-free condition. 
Perhaps these non-parenchymal cells are meant to co-exist with HpSCs as naturally designed 
feeders to support growth of HpSCs in vitro and as components of liver stem cell niche to 
maintain HpSCs in vivo during quiescent state. Human hepatoblasts have also been 
maintained in three-dimensional hyaluronan hydrogel scaffold in feeder- and serum-free 
condition (Turner et al., 2007). 
 
5. Germline stem cells (GSCs) 
Murine spermatogonial stem cells can be cultured for extended periods in the 
presence of serum and feeder cells (Kanatsu-Shinohara et al., 2003; Kubota et al., 2004). 
Spermatogonial stem cells from neonatal testis were able to proliferate for more than 5 
months on mouse embryonic fibroblasts (MEFs) in the medium supplemented with GDNF 
(glial cell line-derived neurotrophic factor), FGF-b, EGF, LIF and FCS (fetal calf serum). 
Recently, Kanatsu-Shinohara et al. reported feeder-free condition that can support mouse 
GSCs to expand in the presence of recombinant rat GDNF (10 ng/ml), mouse EGF (20 
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ng/ml), mouse LIF (1000 U/ml), human FGF-b (10 ng/ml) and 1%FCS on laminin-coated 
plates (Kanatsu-Shinohara et al., 2005). They grew exponentially for at least 6 months and 
produced normal, fertile progeny following transplantation into infertile mouse testis. 
However, the murine GSCs could not expand when both serum and feeder cells were absent. 
 
F. Cytokines/Growth Factors/Hormones Important in Normal Liver Development 
The possible paracrine signals secreted from mesenchymal cells in septum 
transversum mesenchyme and cardiac mesoderm to induce hepatic specification in ventral 
endoderm in the embryos include fibroblast growth factor-1 (FGF-1 or FGF-acidic), FGF2 
(or FGF-basic), FGF8, bone morphogenetic protein-2 (BMP-2), and BMP-4 (Jung et al., 
1999; Rossi et al., 2001; Zaret, 2002). Although the exact mechanisms through which 
bipotential hepatoblasts decide to become hepatocytes or cholangiocytes are still unclear, it 
has been hypothesized that transforming growth factor-beta (TGF-β) and hepatocyte growth 
factor (HGF) may orchestrate to control bipotency and cell-fate decisions in the early liver. 
Oncostatin M (OSM), glucocorticoid, epidermal growth factor (EGF), and activins are also 
possible factors regulating cell-fate decision of hepatoblasts. Hedgehog (Hh) signaling is 
required for endodermal commitment and hepatogenesis.  
 
1. Stem cell factor (SCF)    
Stem cell factor (SCF), also termed Kit ligand, steel factor or mast cell growth factor, 
is the ligand of the c-kit protooncogene product. It is a glycoprotein existing in both soluble 
and membrane bound forms after alternative splicing and proteolytic cleavage (Reber et al., 
2006). Binding of SCF homodimers to c-kit induces homodimerization and intermolecular 
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tyrosine phosphorylation of the receptor, creating docking sites for a number of Src-
homology2 (SH2)-containing signal transduction molecules. Kit has the potential to 
participate in multiple signal transduction pathways as a result of interacting with several 
enzymes and adaptor proteins (Roskoski Jr., 2005). Growth factor receptor-bound protein-2 
(Grb2) is an adaptor protein that associates with the son-of-sevenless protein (sos). This 
complex interacts with and activates the small G-protein Ras which leads to activation of 
Raf-1, MAP kinase p38, ERK1/2 and c-JunN-terminal kinase (JNK). 
  SCF also induces phosphatidyl-inositol-3 kinase (PI3-kinase) pathway. PI3-kinase 
recruitment leads to Akt activation and to the subsequent phosphorylation of the pro-
apoptotoc factor Bad, which promotes cell death. Src and Janus kinase/Signal Transducers 
and Activators of Transcription (JAK/STAT) pathways can also be activated by SCF. Src 
kinase and PI3-kinase signaling pathways converge to activate Rac1 and JNK after SCF 
stimulation in bone marrow-derived mast cells (BMMC), promoting cell proliferation. SCF-
induced JAK/STAT activation is associated with proliferation and differentiation of fetal 
liver hematopoietic progenitor cells. Protein kinase C (PKC), protein phosphatase SHP-1 as 
well as suppressors of cytokine signaling (SOCS)-1 and -6 can downregulate c-kit signaling.  
 
2. Hedgehog Signaling 
During embryonic development, the Hedgehog (Hh) signaling pathway regulates 
proliferation and differentiation in a time- and position-dependent fashion so that developing 
tissues reach their correct size with appropriate cell types. The Hh ligands and their signaling 
pathway components have been found to be expressed in murine and human hepatic 
progenitor cells (Sicklick et al., 2006). Indian Hh (Ihh) but not Sonic Hh (Shh) was expressed 
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in the stem cell compartments of human fetal livers and colocalized with CK19, EpCAM and 
α-fetoprotein (AFP). Freshly isolated EpCAM+ cells from neonatal and adult human livers 
expressed Ihh, Shh and Patched (Ptc). In both murine and human hepatic progenitor cells, 
manipulation of Hh activity influences their survival.  
Hh proteins are secreted signaling proteins that were first discovered in Drosophila. 
They are highly hydrophobic molecules which, once secreted, can diffuse and establish 
gradients in tissues. Three Hh homologues have been identified in human: Sonic hedgehog 
(Shh), Indian hedgehog (Ihh) and Desert hedgehog (Dhh). The Hh signaling pathway is 
initiated by Hh binding to the Patched (Ptc) protein. In the absence of Hh ligans, Ptc 
repressed the activity of Smoothened (Smo), a G-protein-coupled receptor (GPCR)-like 
receptor, presumably by preventing its localization to the cell surface. It is thought that an 
endogenous intracellular small molecule that acts as an agonist for Smo is transported outside 
the cell by Ptc so that it is unavailable to bind to Smo (Rubin and Sauvage, 2006). Upon 
binding an Hh ligan, Ptc is internalized and destabilized and is no longer capable of 
transporting the Smo agonist molecule outwards. This allows the Smo agonists to accumulate 
intracellularly and activate Smo, which itself translocates to the plasma membrane, 
concentrating in cilia in at least some types of cells.  
Hh signal is transmitted via a protein complex that includes Costal 2 (Cos2), Fused 
(Fu), Suppressor of Fused (SuFu) and the zinc-finger transcription factor cubitus interruptus 
(Ci). The activator and repressor forms of Ci have been divided between three separate zinc-
finger proteins in vertebrates, with Gli1 and Gli2 functioning as activators and Gli3 as a 
repressor (Fuccilo et al., 2006). Ci is regulated at several levels via phosphorylation through 
kinases such as protein kinase A (PKA), glycogen synthase kinase 3β (GSK3β) and casein 
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kinase 1α (CK1α), which have a crucial role in processing, activity and nuclear localization 
of Ci. In the absence of Hh signaling, Ci is cleaved and its amino-terminal fragment acts as 
an inhibitor of Hh target gene transcription. After initiation of Hh signaling, cleavage of Ci is 
prevented and the ful-length molecule becomes an activator of Hh target gene transcription.   
 
3. Epidermal growth factor/Transforming growth factor-α (EGF/TGF-α) 
Epidermal growth factor (EGF) and transforming growth factor-α (TGF-α) are two 
potent mitogens for hepatocytes that stimulate hepatocellular DNA synthesis. Accumulation 
of pro-TGF-α has been found in human and rat hepatocyte nuclei suggesting that pro-TGF-α 
plays a role in mitosis (Breuhahn et al., 2006). EGF and TGF-α bind EGF receptor (EGF-R) 
and activate its downstream signaling pathways. The mammalian EGF/TGF-α family 
includes EGF, TGF-α, heparin-binding EGF-like growth factor (HB-EGF), amphiregulin 
(AR), beta-cellulin (BTC), epiregulin (EPR) and epigen (EPI). Each of the mature peptide 
growth factors is characterized by a consensus sequence consisting of six spatially conserved 
cystine residues that form three intracellular disulfide bonds. This EGF motif is critical for 
binding members of the EGF-R tyrosine kinase family (Singh and Harris, 2005). EGF-R is a 
receptor tyrosine kinase (RTK) whose intrinsic kinase upon ligand binding is activated. EGF-
R tyrosyl phosphorylates itself and many effector molecules.  
The downstream signaling pathways of EGF-R include those that involve 
phospholipase C-γ (PL C-γ), Ras, MAP kinase, small GTPases such as Rho and Rac, 
multiple STAT isoforms, heterotrimeric G proteins, PI3 kinase and phospholipase D (PLD). 
In polarized epithelial cells, EGF-R is localized at the basolateral surfaces, allowing for 
epithelial-mesenchymal communication from mesenchyme-derived TGF-α and other matrix-
 47
associated EGF-R ligands. Following ligand binding, EGF-R receptors are rapidly 
internalized from the cell surface. Ligand-induced internalization and degradation results in 
signal reduction with removal of both ligand and EGF-R or ligand alone. Different ligands 
can dictate the strength and lifespan of EGF-R signals. In vitro studies on fetal (E13) rat 
liver-derived hepatoblasts and adult rat liver-derived hepatocytes showed that the colony size 
of the hepatoblasts increased in the absence of EGF, whereas adult, diploid hepatocytes gave 
rise to large colonies in the presence of EGF (Kubota and Reid, 2000). EGF is a strong 
mitogen for mature hepatocytes, but has negative effects on the growth of embryonic 
hepatoblasts. It is thought to lineage restrict the hepatoblasts into hepatocytes.  
 
4. Hepatocyte growth factor (HGF) 
Hepatocyte growth factor (HGF) is the most potent growth factor for hepatocytes. It 
binds to high affinity receptor tyrosine kinase (RTK) c-met, resulting in receptor 
autophosphorylation and paraphosphorylation of adaptor proteins (e.g. Shc, Gab-1 and Grb2), 
followed by activation of downstream effectors (e.g. PLC-γ, STATs, PI3 kinase and ERK1/2). 
Overexpression of the adaptor protein, Shc, results in increased cellular proliferation and 
migration in response to HGF (Pellicci et al., 1995). GTP-binding proteins Ras, Rac and Rho 
are involved in the regulation of HGF responses pathway (Stuart et al., 2000). HGF is 
secreted in an inactive proform that needs proteolytic cleavage for full biological activity. 
Availability of pro-HGF-activating proteins such as HGF activator inhibitor type 1 and uPA 
are required for ligand-induced onset of the HGF signaling. HGF increases Raf and mitogen-
activated peptide (MAP) kinase activity in hepatocytes through a protein kinase C (PKC) and 
calcium-dependent pathway. MAP kinase subsequently phosphorylates several nuclear 
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transcription factors, including c-myc and CCAAT/enhancer binding protein (C/EBP) β, as 
well as pp90rsk and RSK (S6 kinase). 
 
5. Fibroblast growth factors (FGFs) 
It is widely accepted that human ES cells require exogenous FGF-2 to sustain self-
renewal and the ability to differentiate into variety of somatic cell types. FGF-2 pathway is 
one of the most significant regulators of human ES cell self-renewal and cancer cell 
tumorigenesis. Jung et al. searched for locally acting factors expressed in the cardiac 
mesoderm at this stage and identified FGF family proteins (FGF-1, -2 and -8) as potential 
candidates (Jung et al., 1999). In contrast, FGFR-1 and FGFR-4, receptors for these FGF 
species, were found to be expressed on endodermal cells, indicating that the FGF-FGFR 
signaling pathway is active between endoderm and mesoderm. Treatment of endodermal 
cells with FGF-1 and FGF-2 in the absence of the cardiac organ were capable of inducing the 
expression of albumin mRNA (Jung et al., 1999).  
FGF-10 has been reported to prevent the differentiation of the proximal pancreas and 
liver into hepatic and pancreatic cells respectively (Dong et al., 2007). In zebrafish mutants 
deficient in FGF-10, the hepatopancreatic ductal epithelium is severely dysmorphic. Cells of 
the hepatopancreatic ductal system and adjacent intestine misdifferentiate toward hepatic and 
pancreatic fates. These results suggest that FGF-10 signaling from the mesenchyme adjacent 
to foregut endoderm is crucial for refining the boundaries between the hepatopancreatic duct 
and organs.  
Different thresholds of FGFs for patterning the ventral foregut into liver and lung in 
the absence of cardiac mesoderm have been reported (Serls et al., 2005). Ventral foregut 
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endoderm explants from E8-9.5 mouse embryos respond to exogenous FGF1 and FGF2 in a 
dose-dependent manner, with lower concentrations activating liver-specific genes and higher 
concentrations activating lung specific genes. Moreover, inhibiting FGF signaling pathway 
using neutralizing antibodies against FGFR-1 and FGFR-4 strongly inhibited the expression 
of albumin mRNA. FGF-FGFR signaling, therefore, is critical for the initial process of liver 
development. 
     Binding of FGF-2 to its receptor is extracellularly modulated by non-signaling 
heparin/heparan sulfate (HP-/HS-) proteoglycans involved in the processing of FGF-2. The 
signaling pathway downstream of FGFRs involves tyrosine phosphorylation of the docking 
protein FRS2 followed by recruitment of multiple Grb2/Sox complexes, leading to activation 
of the Ras/MAPK signaling pathway (Dvorak et al., 2006; Eswarakumar et al., 2005). 
Targeted disruption of the FRS2α gene causes severe impairment in mouse development and 
is embryonic lethal at E7-7.5. In addition to MAPK pathway, FGFs can also induce 
recruitment of PI3K by Gab1, resulting in activation of the Akt dependent anti-apoptotic 
pathway.  
 
6. Bone morphogenetic proteins (BMPs) and transforming growth factor-β 
(TGF-β) superfamily 
Bone morphogenetic proteins (BMPs) are members of the transforming growth 
factor-β (TGF-β) superfamily, which includes TGF-βs, activins/inhibins, Nodal, myostatin, 
anti-Mullerian hormone (AMH) and more than 20 BMP-related proteins (Miyazono et al., 
2005). BMP ligands and their signaling molecules are expressed in the extraembryonic 
tissues of the mouse embryos, contributing to the embryonic patterning (Kishigami and 
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Mishina, 2005). BMP-4 is highly expressed in the extraembryonic ectoderm and primitive 
streak before and during gastrulation. BMP-4 mutant embryos showed a ventrally projected 
bulge in the posterior region of the primitive streak (Fujiwara et al., 2002). BMP-2 starts to 
present at E6 in the extraembryonic region and then in the extraembryonic mesodermal cells 
lining the chorion and amnion after gastrulation. BMP-2 mutant embryos can gastrulate, but 
they develop abnormally in the extraembryonic region and die by E8.5 (Zhang and Bradley, 
1996). BMP antagonist, activin A, induced endodermal differentiation of human and mouse 
ES cells in vitro (D’Amour et al., 2005; Gouon-Evans et al., 2006; Yasunaga et al., 2005). 
These findings suggest that BMPs are important cytokines during embryogenesis as well as 
fate determination in vitro. 
The BMP family of proteins bind to two different receptors, type II and type I 
serine/threonine kinase receptors, both of which are required for signal transduction. After 
binding, the type II receptor phosphorylates the type I receptor, resulting in the recruitment of 
Smads (R-Smads, Smads 1, 5 or 8). After phosphorylation, the R-Smads are released from 
the receptor and recruit the common mediator Smad (Co-Smad, Smad 4) into the complex. 
This complex migrates into the nucleus and activates the transcription of specific target genes. 
In addition to Smad pathways, BMPs are believed to activate several kinase pathways 
including MAPK, PI3K and PKC. The signaling of the BMPs is modulated by numerous 
proteins. BMP antagonists, such as Cerbarus, Dan, Gremlin and Noggin, bind only specific 
BMPs and regulate the initiation of the signaling cascade. At the receptor level, the 
oligomerization status of the receptors determines the specificity of the activation of the 
signaling pathway. Inside the cells, the signal can be modulated by the activation of 
inhibitory Smad proteins such as Smad 6 and Smad 7 (Nohe et al., 2004).  
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 7. Interleukin-6 (IL-6) family 
Interleukin-6 (IL-6) is a critical component of the regenerative response in liver. Mice 
deficient in IL-6 gene are developmentally normal but have impaired liver regeneration after 
hepatectomy, indicated by liver necrosis and failure (Cressman et al., 1996). Blunted DNA 
synthetic responses were observed in hepatocytes from the mutant animals but not in non-
parenchymal cells. Absence of STAT3 activation and depressed AP-1, Myc and cyclin D1 
expression suggested cell cycle abnormalities in G1 phase. Moreover, supplying a single 
preoperative dose of IL-6 to the mutant mice returned STAT3 binding, gene expression and 
hepatocyte proliferation to near normal and prevented liver damage.  
The propagation of mouse ES cells is dependent on leukaemia inhibitory factor (LIF) 
or related cytokines (Williams et al., 1988). LIF can be provided by a feeder layer of 
embryonic fibroblasts or as a recombinant protein. LIF is a cytokine of IL-6 family which 
includes IL-6, IL-11, LIF, oncostatin M (OSM), ciliary neurotrophic factor (CNTF), 
cardiotrophin-1 (CT-1) and cardiotrophin-like cytokine (CLC). Receptors involved in 
signaling of IL-6 type cytokines include non-signaling α-receptors (IL-6Rα, IL-11Rα and 
CNTFRα) and the signal transducing receptor (gp130, LIFR and OSMR). IL-6 and IL-11 are 
the only IL-6 type cytokines that signal via gp130 homodimers. The rest of the IL-6 family 
signal via heterodimers of either gp130 and LIF-R (LIF, CNTF, CT-1 and CLC) or gp130 
and OSMR (OSM) (Heinrich et al., 2003).  
The complex of LIF, LIF-R and gp130 activates associated Janus-associated (JAK) 
tyrosine kinases that phosphorylate the receptor chains. The phosphorylated tyrosines then 
act as docking sites for proteins containing Src homology 2 (SH2) domains that can also be 
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phosphorylated by the JAK. The signal transducer and activator of transcription (STAT) 
family of transcription factors are key substrates for JAK. Recruitment and activation of 
STAT3 is required for self-renewal of EC cells. Inhibition of STAT3 in ES cells forces 
differentiation. STAT3 activation is not only necessary but also sufficient to block 
differentiation of ES cells (Matsuda et al., 1999). Activation of this chimaeric molecules 
sustains ES cell self-renewal without LIF.  
Signaling downstream of IL-6 family receptor, gp130, is not limited to activation of 
STAT3 but includes stimulation of the Ras/ERK/mitogen-activated protein kinase (MAPK) 
pathway. ERK activation has a pro-differentiation effect and is antagonistic to ES cell self-
renewal. The overall balance of activation of STAT3 and ERKs might determine the 
efficiency of ES cell self-renewal.  
Activation of gp130 also results in activation of phosphatidylinositol-3 phosphate 
kinase (PI3K). The PI3K signaling pathway is important during ES cell propagation. Mouse 
ES cells deficient in PTEN (phosphatase and tensin homolog) accelerated proliferation and 
viability (Sun et al., 1999). PTEN is a lipid phophatase and a tumor suppressor functioning as 
a negative regulator of the PI3K pathway by removing phosphate from the 3’ position of 3-
phospoinositides. In addition to JAK-STAT3, SH2-ERK and PI3K signaling downstream 
from gp130, Src family of non-receptor tyrosine kinases (SFK) Yes and Hck are regulated by 
LIF and serum and are downregulated following differentiation (Anneren et al., 2004). 
Inhibition of Yes decreases growth and expression of marker genes for self-renewal, such as 
Oct-3/4, alkaline phosphatase and Nanog (Kristensen et al., 2005).  
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8. Signaling crosstalk in the control of stem cell fate 
Wnt signaling is detected in undifferentiated mouse ES cells and is subsequently 
downregulated on differentiation (Sato et al., 2004). The Wnt and TGF-β pathways can 
interact directly to maintain human ES cells in vitro (Labbe et al., 2000; Varga and Wrana, 
2005). LIF activates the pro-self-renewal JAK-STAT pathway, but also pro-differentiation 
MAPK pathway. BMPs activate the MAPK pathway and the induction of Id genes which 
block neurogenesis. Together LIF and BMP can drive ES cell self-renewal in a serum-free 
medium. LIF alone is insufficient to drive self-renewal as it blocks differentiation of 
mesoderm and endoderm but only weakly blocks differentiation into neuroectoderm. BMP 
signaling blocks neurogenesis. However, its potential to induce differentiation into other 
lineages is blocked by LIF/STAT3 signaling. The interplay between these two pathways 
leads to self-renewal (Friel et al., 2005; Ying et al., 2003).  
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TABLE 
Table 1.1 Known Cellular Components in Stem Cell Niches (with focus on endodermal 
tissues) 
Cellular Components  
Mesenchymal Cells 
 
 
Germ 
Layer 
 
Represen-
tative 
Tissue 
Types 
 
 
Epithelial Stem 
Cells*  
Blood 
Vessel 
Precursors 
Pigmented/ 
steroidogenic 
“Nurse” Cells** 
 
 
Other 
Skin Epidermal stem 
cells  
Angioblasts Melanocytes ---  
Ectoderm 
Brain Neuronal stem 
cells 
Angioblasts Ependymal Cells --- 
Gut Intestinal stem 
cell 
Angioblasts Paneth Cells --- 
Pancreas Pancreatic stem 
cells 
Angioblasts Pancreatic 
Stellate Cells 
--- 
Liver Hepatic stem cells Angioblasts Hepatic Stellate 
Cells 
Hemopoietic 
Stem Cells 
Endoderm 
Lung Lung stem cells  
(Clara cells) 
Angioblasts Pulmonary 
Neuroendocrine 
cells 
 
--- 
Mesoderm Bone 
Marrow 
Hemopoietic 
Stem Cells 
Angioblasts Adipocytes Osteoblasts 
Ovary Oogonia Angioblasts Granulosa cells ---- Mixed 
germ layer 
origins 
Testis Spermatogonia Angioblasts Sertoli cells ---- 
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* All of the stem cells are “label retaining cells” that retain label in pulse chase labeling 
studies indicating that they divide very slowly.  They do not respond to mild or moderate 
injuries to the tissue but rather only to massive loss of mature cells in the tissue.  The cells 
responding to mild or moderate injuries are “transit amplifying” cells that are the immediate 
descendents of the stem cells.  In the liver these are the hepatoblasts with their signature 
feature of α-fetoprotein.   
 
** It is unknown if the pigmented cells found in stem cell niches are themselves stem cells.  
Typically they produce steroidogenic signals, retinoids, a variety of growth factors and 
matrix molecules.   
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CHAPTER II                                                                                    
METHODS AND MATERIALS  
 
Methods and Materials for Chapter III 
Rats 
Pregnant Fisher 344 rats were obtained from the Charles River Breeding Laboratory 
(Wilmington, MA). The morning on which the plug was observed was designated day 0. 
Male Fisher 344 rats (200-250g) were used for isolation of adult HpSTCs. All animal 
experiments were conducted under the institutional guidelines. The University of North 
Carolina Institutional Animal Care and Use Committee approved all experimental procedures. 
 
Cell preparation 
Fetal livers were isolated from 13~14 dpc rats and digested with 800 U/ml 
collagenase (Sigma) followed by further digestion with Trypsin-EDTA solution (Sigma). 
Subsequently, the cell suspension was treated with 200 U/ml DNase I (Sigma) (Kubota and 
Reid, 2000). Two litters of fetal rats were used to isolate cells, and average cell number 
obtained from 13 dpc or 14 dpc fetal livers was 4.5 x 105 cell/liver (mean, n=302) or 2.4 x 
106 cell/liver (mean ± SEM, n=130), respectively. Isolation of HpSTCs from adult livers was 
performed using a standard protocol described elsewhere (Hellerbrand et al., 1996). 
 
Cell culture 
Fetal liver cells were cultured on STO cell feeders and in a serum-free hormonally 
defined medium (HDM) as described previously (Kubota and Reid, 2000).  HDM was 
consisted of a 1:1 mixture of Dulbecco's modified Eagle's medium and Ham's F12 
(DMEM/F12, Invitrogen) to which was added 2 mg/ml bovine serum albumin (Sigma), 5 
µg/ml insulin (Sigma), 10-6 M dexamethasone (Sigma), 10 µg/ml iron-saturated transferrin 
(Sigma), 4.4 x 10-3 M nicotinamide (Sigma), 5 x 10-5 M 2-mercaptoethanol (Sigma), 7.6 µeq/l 
free fatty acid (Chessebeuf and Padieu, 1984), 2 x 10-3 M glutamine (Invitrogen), 1 x 10-6M 
CuSO4, 3 x 10-8M Na2SeO3 and antibiotics (penicillin and streptomycin) (Kubota and Reid, 
2000).  STO feeder cells were prepared as previously described using STO5 transfected with 
pEF-Hlx-MC1neo (Kubota and Reid, 2000). For long-term culture of sorted vitamin A-
specific autofluorescent cells, cells were cultured on STO feeders and in HDM supplemented 
with 10 ng/ml human leukemia inhibitory factor (LIF; Boehringer Mannheim) and 10 ng/ml 
epidermal growth factor (EGF; Collaborative Biomedical Product). Medium was changed 
every other day, and cells were subcultured to fresh STO feeders every week. 
 
Immunocytochemistry 
Staining procedures for cultured cells were described previously (Kubota and Reid, 
2000). For nestin or desmin expression, cells were stained with anti-nestin antibody (Rat-401, 
Developmental Studies Hybridoma Bank, The University of Iowa) or anti-desmin antibody 
(D33, Dako) followed by Alexa488-anti-mouse IgG (Molecular Probes).  
 
Flow cytometry 
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Cells were analyzed and sorted by a FACStar Plus cell sorter (BD Biosciences) 
equipped with dual Coherent I-90 lasers. To detect vA-specific autofluorescence, cells were 
excited at 351 nm, and fluorescence emission was detected with the use of 450DF20 filter 
(Omega Optical Inc, Brattleboro, VT). Fluorescence-conjugated antibodies were excited at 
488 nm, and their fluorescence emission was detected by standard filters. All antibodies were 
obtained from BD biosciences unless otherwise indicated. Monoclonal antibodies used for 
analysis of rat cells were FITC-anti-RT1Aa, b, l (rat MHC Class I antigen; B5), phycoerythrin 
(PE)-anti-rat ICAM-1 (1A29), anti-rat VCAM-1 (5F10, Babco), anti-rat CD44 (OX-49), PE-
anti-rat VCAM-1 (MR109), PE- or biotin-anti-rat β3-integrin (2C9.G2), biotin-anti-rat 
PECAM-1 (TLD-3A12), biotin-anti-rat Thy-1 (OX-7). For staining with unconjugated anti-
VCAM-1 antibody (5F10), fetal liver cells were incubated with the anti-VCAM-1 antibody 
followed by staining with biotin-anti-mouse IgG2a monoclonal antibody (R19-15). 
Streptavidin-Cy-Chrome (BD biosciences) was used to detect biotin-conjugated antibodies. 
For the experiments of fluorescence-activated cell sorting (FACS) to isolate long-term 
cultured cells derived from sorted vA-specific autofluorescenct cells, all cells in the culture 
were harvested and stained with biotin-anti-mouse CD98 (H202-141) followed by 
streptavidin-Cy-Chrome to separate cultured rat cells and STO feeder cells (Kubota and Reid, 
2000). To block non-specific antibody binding, cells were incubated with 20% goat serum 
(Invitrogen), 1% teleostean gelatin (Sigma), and anti rat CD32 antibody (D34-485) solution 
prior antibody staining in FACS experiments. 
 
Colony forming assay (CFA) 
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The protocol for a CFA was described for hepatoblasts previously [10]. Briefly, 
sorted cells were placed on STO feeders in triplicate at 500 or 2500 cells/well (3.8cm2) in a 
12-well plate and cultured in HDM for 14~15 days with medium changes every other day. To 
identify if the hepatoblasts are pluripotent, double immunofluorescence staining of albumin 
and CK19 was performed. The colonies were stained by Diff-Quick (Baxter) to count the 
number of the colonies per well.  
 
Cell proliferation assay.  
Vitamin A-specific autofluorescenct cells isolated by FACS were placed in triplicate 
at 500 cells/well in a 96-well plates with HDM supplemented with laminin (Collaborative 
Biomedical Products) at the final concentration of 8 µg/ml. LIF and EGF were added at 
concentrations indicated. Five days after plating cells cultures were rinsed twice to remove 
floating cells and added fresh medium with the tetrazolium salt WST-1 (Boehringer 
Mannheim) to measure the number of viable adherent cells (Kubota and Reid, 2000). After 4 
hours, the absorbance was determined according to the manufacturer's protocol. 
 
Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) 
The primer sequences used for PCR are shown in Supplemental Table. The procedure 
of RT-PCR for sorted cells by FACS was described previously (Kubota et al., 2002). cDNAs 
synthesized from total RNAs of sorted cells were normalized by the cell number.. 
 
Immunohistochemistry 
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Frozen sections (8µm) were prepared of whole rat fetuses obtained from Dr. M. 
Dabeva (Albert Einstein) and were mounted on slides and stored at -80°C. For 
immunostaining, sections were air dried, fixed with cold acetone, and stained with primary 
antibodies. Primary antibodies used were mouse anti-rat VCAM-1 (MR109) and Armenian 
hamster anti-rat β3-integrin (2C9.G2). Goat Texas-Red-anti-Armenian hamster IgG and goat 
Alexa488-anti-mouse IgG1 were used for secondary antibodies, respectively.  The sections 
were counter stained with 4’,6-diamino-2-phenylindole (DAPI) for visualization of cell 
nuclei and analyzed by confocal microscopy.  
 
 
Methods and Materials for Chapter IV 
Human Liver Sourcing.  
Fetal Livers. Liver tissue was provided by an accredited agency (Advanced 
Biological Resources, San Francisco, CA) from fetuses between 18-22 weeks gestational age 
obtained by elective terminations of pregnancy. The research protocol was reviewed and 
approved by the IRB for Human Research Studies at the UNC.   
Postnatal Livers. Intact livers from cadaveric neonatal, pediatric and adult donors 
were obtained through organ donation programs via UNOS.  Those used for these studies 
were considered normal with no evidence of disease processes. Informed consent was 
obtained from next of kin for use of the livers for research purposes, protocols received 
Institutional Review Board approval, and processing was compliant with Good 
Manufacturing Practice.  
Mice   
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C57Bl/6 SCID/nod mice were purchased from Jackson Laboratories (Bar Harbor, 
Maine) and were housed in a barrier facility on the campus of the University of North 
Carolina-Chapel Hill (UNC-CH), NC . Animals received care according to the Division of 
Laboratory Animal Medicine, UNC-CH guidelines, ones approved by AALAC.  
 
Liver Processing.  
Fetal livers.  All processing and cell enrichment procedures were conducted in a cell 
wash buffer composed of a basal medium (RPMI 1640) supplemented with 0.1% bovine 
serum albumin  (BSA Fraction V, 0.1%, Sigma, St. Louis, Mo.), insulin and iron saturated 
transferrin both at 5 ug/ml (Sigma St Louis MO ) trace elements (selenious acid ,300 pM and  
ZnSO4, 50 pM), and antibiotics ( AAS, Gibco BRL/Invitrogen Corporation, Carlsbad, 
California).   Liver tissue was subdivided into 3 mL fragments (total volume ranged from 2-
12 mL) for digestion in 25 mL of cell wash buffer containing type IV collagenase and 
deoxyribonuclease (Sigma Chemical Co. St Louis, both at 6 mg per mL) at 32 EC with 
frequent agitation for 15 – 20 minutes.   This resulted in a homogeneous suspension of cell 
aggregates that were passed through a 40 gauge mesh and spun at 1200 RPM for five minutes 
before resuspension in cell wash solution.  Erythrocytes were eliminated by either slow speed 
centrifugation (54, 55) or by treating suspensions with anti-human red blood cell (RBC) 
antibodies (Rockland, #109-4139)  (1:5000 dilution) for 15 min followed by LowTox Guinea 
Pig complement (Cedarlane Labs, # CL4051) (1:3000 dilution) for 10 min both at 37°C. 
Estimated cell viability by trypan blue exclusion was routinely higher than 95%. See 
supplemental data for further details.  
Postnatal livers. The livers were perfused through the portal vein and hepatic artery 
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for 15 min with EGTA-containing buffer and then with 600 mg/L collagenase (Sigma) for 30 
min at 34oC. The organ was then mechanical dissociated in either collection buffer; the cell 
suspension passed through filters of pore size 1,000, 500, and 150 microns; the single cells 
collected and then live cells fractionated from dead cells and debris using density gradient 
centrifugation (500 x g for 15 min at room temperature) in Optiprep-supplemented buffer in a 
Cobe 2991 cell washer. The resulting hepatic cell band residing at the interface between the 
OptiPrep/cell solution and the RPMI-1640 without phenol red was collected. 
 
Magnetic Immunoselection  
Isolation of cells expressing EpCAM from human liver cell suspensions was carried 
out using monoclonal antibody HEA-125 coupled to magnetic microbeads, and separated 
using a a miniMACS™ ,  a midiMACS TM , an autoMACS™ or CliniMACS® magnetic 
column separation system from Miltenyi Biotec (Bergisch Gladbach, Germany), following 
the manufacturer’s recommended procedures.  Similar protocols were used for sorts for 
NCAM+, CD117+, VEGFR2 (KDR) +,  CD34+ and CD146+ cells.  
 
Colony Formation 
Cells were plated in serum-free, hormonally defined medium, “Kubota’s Medium 
(KM),  in 6-well tissue culture dishes seeded with monolayers of Mitomycin-treated STO 
feeder cells, as described by Kubota and Reid (Kubota and Reid, 2000; Macdonald et al., 
2002). Medium was changed every 2 to 4 days. Colonies were observed within a 7-10 days 
and were followed for up to six months using an inverted microscope.  
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Histology 
Human or mouse liver specimens were fixed in 4% buffered paraformaldehyde for 12 
hours and subjected to immunohistochemical staining by the methods noted in supplemental 
data. 
 
Flow Cytometry 
For cell surface markers 1 x 106 cells were labeled, following standard procedures, 
with 1 µg of each monoclonal antibody directly conjugated with fluorescein (FITC) or 
phycoerythrin (PE). For intracellular markers, cells first were fixed with 2% 
paraformaldehyde in PBS for 10 min at room temperature and then incubated in 
permeabilization/blocking buffer (2% Triton X-100, 10% goat serum, 2% teleostean fish gel 
in PBS) for an additional 30 to 60 min, prior to incubation with a monoclonal antibody, 
washing, and incubation for 30 min with a fluorescent-labeled secondary antibody. Analysis 
was performed using a FACSCalibur flow cytometer (BD Biosciences, San Jose, CA) and 
FlowJo software (Tree Star, Inc., Palo Alto, CA). Nonspecific binding with isotype-matched 
control antibodies (BD Pharmingen, San Jose, CA) was used to establish gating. Monoclonal 
antibodies, labeled with fluorescein (F) or R-phycoerythrin (PE), were: EpCAM-F (clone 
Ber-EP4, DakoCytomation); CD133/1-PE (clone AC133, Miltenyi Biotec); CD34-PE (BD 
Pharmingen); CD45-PE (BD Pharmingen); CD14-PE (BD Pharmingen); CD38-PE (BD 
Pharmingen); CD4-PE (BD Pharmingen). For detection of intracellular antigens, primary 
mouse monoclonal antibodies of IgG2a isotype to human serum albumin (clone HAS-11, 
Sigma Aldrich),  a- fetoprotein (clone 4A3, Biodesign), or cytokeratin 19 (CK19, clone 
A53B/A2, Zymed) were utilized and detected using secondary Alexa Fluor® 647-goat anti-
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mouse IgG2a (InVitrogen, Carlsbad, CA), which does not react with the IgG1 EpCAM-F 
monoclonal antibody. 
 
In vivo Engraftment  
C57Bl/6 NOD/scid mice were purchased from Jackson Laboratories (Bar Harbor, 
Maine) and used at 5 weeks of age. Mice were anesthetized with Ketamine-HCl (Vedco Inc, 
St. Joseph, Mo) and Xylazine-HCl (ProLab LTD., St. Joseph, Mo) and injected 
intrasplenically with 8 x 105 cells. The spleen was exteriorized through a small left flank 
incision (5 – 10 mm), and 70 µl of cell suspension was injected slowly into it using a 26-
gauge needle on a Hamilton syringe. The spleen was returned to the abdominal cavity and the 
incision site was closed.  Seven  days following transplantation animals were euthanized 
under sedation and the livers were recovered.  In parallel, half the animals were treated with 
carbon tetrachloride at 0.6 ul/gm body weight.  In some experiments the cells were injected 
after CCl4 treatment, and in others were injected prior to CCl4 treatment.  A portion of tissue 
was frozen in liquid N2 and stored at -80° C for isolation of RNA. The remainder was fixed 
for histological analysis. 
 
Fluorescent Staining of Cultured Cells 
Cells were fixed with acetone/methanol (1:1) for 2 hrs at ambient temperature, rinsed 
with Hank’s Balanced Salt Solution (HBSS), incubated with 20% goat serum in HBSS for 
4 – 6 hours, and rinsed. Fixed cells were incubated with monoclonal antibodies to albumin 
and CK19 for 6 – 12 hrs, washed, incubated for 4 – 6 hrs with labeled isotype-specific 
secondary antibodies, and washed, always at 4º C. Stained cells were preserved with 2% 
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formaldehyde in HBSS and viewed using an inverted fluorescence microscope. 
 
Confocal Microscopy  
Immunofluorescence was observed using a Zeiss 510 Meta Laser Scanning Confocal 
Microscope (Zeiss; Jena, Germany) or Leica SP2 Laser Scanning Confocal Microscope 
(Leica; Wetzlar, Germany).  
 
Immunhistochemistry 
Fetal livers (16 – 20 weeks of gestation) were fixed in 4% para-formaldehyde over 
night and stored in 70% ethanol. Tissues were embedded in paraffin and cut into 5 µm 
sections. Sections were de-paraffinized with xylene and re-hydrated with decreasing alcohol 
series. Antigens were retrieved by boiling sections for 25 min in a pressure cooker in 
Retrieval Buffer (Dako, Carpinteria, CA). Endogeneous peroxidases were blocked by 
incubation for 30 min in 0.3% H2O2 solution. Sections were blocked in Serum Block (Dako); 
primary antibody was applied in Diluent (Dako), using rabbit anti-human telomerase reverse 
transcriptase (Calbiochem/EMD Biosciences, San Diego, CA). Secondary antibody and 
ABC-staining were performed using the RTU Vectastain Kit (Vector Laboratories, 
Burlingame, CA). DAB (Dako) was used as substrate and sections were counterstained with 
hematoxylin QS for nuclei staining (Vector Laboratories). Sections were de-hydrated with 
increasing alcohol series, fixed in xylene and embedded in Eukitt Mounting Media (Electron 
Microscopy Sciences, Hatfield, PA). Sections were analyzed using a Leica DMIRB inverted 
microscope and pictures were taken with a MicroPublisher camera (Q-Imaging, Burnaby, BC, 
Canada) controlled by SimplePCI (Compix Imaging Systems) software. 
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 Telomerase Activity Measurement 
Measurement of telomerase activity was done using a modified, real-time PCR 
Telomeric Repeat Amplification Protocol (TRAP) adapted for the use in the Roche 
LightCycler and Roche SYBR Green DNA kits (Roche). Collected cell pellets were 
resuspended in 20 µl ice cold CHAPS buffer (Chemicon, Temecula, CA) containing 20 U 
RNase out (Invitrogen), tissue was homogenized in 150 µl ice cold buffer using glas potter 
and pestle. Extracts were incubated for 30 min on ice. After centrifugation (20 min, 4°C, 
20,000 g) supernatants were frozen on dry ice immediately and kept at -80°C. Total protein 
measurement was done using the DC-protein assay (Bio-Rad Laboratories, Hercules, CA). 
Extracts from cultured HeLa cells (American Type Culture Collection, Manassas, VA) were 
used as positive controls, CHAPS buffer with RNase out served as negative control, and 
heart tissue was used as reference. HeLa extracts were used to create standard curves in 
quantitative real time PCR, using the LightCycler (Roche) and SYBR Green Fast Start 
Master DNA kit (Roche). Extracts containing 0.2 µg total protein were incubated with SYBR 
green mix and oligonucleotide sequences (primer TS: 5’ AAT CCG TCG AGC AGA GTT 3’; 
ACX: 5’ GCG CGG CTT ACC CTT ACC CTT ACC CTA ACC-3’) and incubated for 20 min 
at 25°C in the dark. Two step PCR was performed with 10 min denaturation at 95°C, and 35 
cycles at 95°C for 20s and at 60°C for 90s. Standard curves were linear applying extracts 
from 1, 10, 100, 1,000 and 10,000 HeLa cells. 
 
Quantitative RT-PCR 
The assays were done as described previously (Van Den Heuvel et al., 2001). Gene 
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specific primers used included the following:  
 
Gene  Gene Bank 
Acc. No. 
Forward 
Primer 
 (5’?3’) 
Reverse 
Primer 
 (5’?3’) 
Tm F/R 
Primer (°C) 
Product 
length 
(bp) 
 AFP NM_001134 accatgaagtg
ggtggaatc 
Tggtagccag
gtcagctaaa 
59.64/58.53 148 
ALB NM_000477 gtgggcagca
aatgttgtaa 
tcatcgacttcc
agagctga 
59.59/59.66 188 
C3A4 NM_017460 gcctggtgctc
ctctatcta 
ggctgttgacca
tcataaaagc 
57.11/60.86 187 
CK19 NM_002276 ccgcgactac
agccactact 
gagcctgttccg
tctcaaac 
60.47/59.85 152 
c-kit NM_000222 gatgacgagtt
ggccctaga 
caggtagtcga
gcgtttcct 
60.22/59.50 233 
EpCAM NM_002354 ctggccgtaaa
ctgctttgt 
agcccatcattg
ttctggag 
60.30/60.07 182 
GAPD NM_002046 atgttcgtcatg
ggtgtgaa 
gtcttctgggtg
gcagtgat 
59.81/60.12 173 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Methods and Materials for Chapters V and VI 
Kubota’s Medium (KM) 
All cultures were put into serum-free Kubota’s Medium (KM) (Kubota and Reid, 2000), 
a serum-free medium tailored for hepatic progenitors.  It was prepared as described 
previously (Macdonald et al., 2002). 
 
Sourcing of Cell Lines  
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Bone marrow-derived human mesenchymal stem cells (hMSCs) were obtained from a 
26-year-old male donor (Cambrex Bio Science, Walkersville, MD). The human umbilical 
vein endothelial cells (HUVECs) were obtained from Dr. Cam Patterson (University of North 
Carolina; Chapel Hill, NC). A clone of murine embryonic stromal cells, STO cells, was 
prepared from STO cells obtained from the ATCC.  
 
Sourcing of Human Liver Tissue 
Human fetal liver tissues, 16-20 weeks gestational age, were obtained from Advanced 
Biological Resources (ABR, San Francisco, California). Protocols for procurement were 
approved by the IRB for Human Studies at the UNC.  
 
Isolation and culture of hHpSCs 
Human fetal livers were processed as previously described (Schmelzer et al., 2006 and 
2007; Sicklick et al., 2006). The freshly isolated parenchymal cells were put into KM and on 
culture plastic or on top of pre-plated feeders of hUVECs, hMSCs, STO cells, or primary 
cultures of human fetal liver-derived cells at a plating density of 5,000 cells/cm2. The cells 
were in KM plus 2% FBS overnight and then switched to serum-free KM thereafter. The 
cultures on plastic and in serum-free KM yield colonies of hHpSCs surrounded by 
angioblasts and hepatic stellate cell (hHpSTCs) precursors that are not activated (Schmelzer 
et al., 2007).  
 
Preparation of feeders  
All stocks of mesenchymal feeders were cultured on culture plastic and in Endothelial 
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Growth Medium, EGM-2 (Cambrex, Walkersville, MD) with 2% FBS, conditions optimal for 
endothelial and mesenchymal cells (Bagley et al., 2003; Lin et al., 2000; Santhanam et al., 
2007). The exceptions were the hMSCs and the adult liver-derived HpSTCs grown as 
described below.  All were grown to confluence, growth arrested with Mitomycin-C, and then 
switched to serum-free KM for use in co-cultures with hHpSCs. Below are the variationused: 
• Human bone marrow-derived mesenchymal stem cells (hMSCs) were plated onto tissue 
culture dishes with DMEM plus 1% antibiotics, ascorbic acid, 2mM L-glutamine and 
10% FBS (Invitrogen).  
• Purified preparations of HpSTCs from adult rat and adult human livers were prepared by 
Dr. YiWei Rong (Core service for Center for Gastrointestinal and Biliary Disease Biology 
at UNC) by protocols published previously (Schnabl et al., 2001; Schwabe et al., 2003). 
The stocks of feeders were cultured on plastic and in KM + 5% FBS.  
• STO5 feeders were prepared as described previously (Kubota and Reid, 2000; Macdonald 
et al., 2002). Cloned subpopulations of STO cells, obtained from the ATCC, were tested 
for their efficacy on rodent hepatic progenitors. STO5 proved the most active, were 
expanded, aliquoted, and the stocks frozen. The STO5 stocks were thawed and grown in 
KM to which 5% fetal bovine serum (FBS, Invitrogen, Carlsbad, CA) was added.  
• Primary cultures of human fetal liver-derived mesenchymal cells: The livers were 
enzymatically digested using 0.45 mg/ml collagenase type IV and 0.3 mg/ml 
deoxynuclease (Sigma, St. Louis, MO) and then mechanically dissociated into single cell 
suspensions by cross scalpels.  After washing away excess enzymes, the cells were put 
through 3 rounds of slow-speed centrifugation (20 X g) for 5 minutes followed by 
collection of the supernatant and resuspension of the cells with RPMI-1640 plus selenium 
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(10-9M), 1% antibiotics and 0.1% BSA. The cells were then plated onto culture plastic 
and in KM supplemented with 10% FBS.  The mesenchymal cells attached within 
minutes to hours and quickly transitioned into stromal feeders comprised of activated 
hHpSTCs recognizable by having high levels of desmin, CD146 and αSMA.  
• KDR+ or CD31+ cells were isolated from the fetal liver cell suspensions by 
immunoselection with the magnetically activated cell sorting (MACS) system using 
monoclonal anti-human KDR mouse IgG1 (Cell Sciences, Canton, MA), goat anti-mouse 
IgG coupled to magnetic microbeads or using monoclonal anti-human CD31 mouse IgG1 
conjugated to magnetic microbeads. Plating density for KDR+ and CD31+ cells was 
20,000 cells/cm2.  
• Feeders depleted of stromal cells were prepared by negative selection for fibroblasts 
using monoclonal anti-human fibroblast mouse IgG2a conjugated to magnetic 
microbeads for depleting fibroblasts according to manufacturer’s instructions (Miltenyi 
Biotec, Auburn, CA). The plating density for fibroblast-depleted supernatant cells was 
500,000 cells/cm2. 
 
Purified Matrix Substrata 
Fibronectin: Fibronectin (Sigma, F0895) was prepared at three different concentrations. The 
dishes were precoated with concentrations of 0.5, 1.0, or 2 ug/cm2 and neutralized to pH 7.4.  
 
Laminin: Laminin (Sigma, L2020) was prepared at two different concentrations. The dishes 
were coated with concentrations of 0.52 or 1.0ug/cm2 at pH 7.4.   
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Collagen Types III and IV: Collagen coatings were prepared on dishes utilizing 1 of 5 
different protein concentrations (2.1, 4.2, 6.3, 8.3, and 10.4 µg/cm2).  The matrix attached 
during a 10-hour period with conditions of 37°C and 5% CO2. Matrix components were 
added in acidic buffers in dishes.  After 10 hours, the matrix molecules attach and stabilize, 
are sterilized by UV irradiation for 2 hours, and then rinsed 3 times with PBS (Gibco, 
#14190-144).  Collagen III (Sigma, C-3511) was formed with pH 3 acetic acid and Collagen 
IV (Sigma, C-5533) with 0.5M acetic acid. 
 
Collagen Type I:  Vitrogen 100 (Cohesion Technologies, Palo Alto, CA) was modified into 
liquid collagen type I by adding specific ratios of 10x DMEM and 0.1M NaOH.  It was 
important to prevent air bubble formations within the collagen I suspension, because air 
bubbles make the gel unstable. The collagen type I was used for monolayers of cells or as a 
sandwich to embed cells between two layers of collagen. 
 
Monolayers of Cells on Collagen type I: Liquid collagen type I was maintained at 4°C 
prior to distributing 0.4mls into each well of the 6-well plates. After coating, the collagen was 
gelled at 37°C and 5% CO2 for 1 hour. Cells were seeded on top of the gelled collagen.  
 
Sandwich (Embedded cells) Model: Cells were sandwiched between layers of collagen.  
After the 10-hour cell attachment period, unattached cells were removed, and a second 0.4ml 
layer of collagen type I added. The system was allowed to gel at 37°C and 5% CO2 for 1hour 
to solidify the top collagen layer.  
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Immunohistochemistry on human hepatic progenitor cells and human fetal liver-derived 
feeder cells 
After 1-2 wks of culture, the cells were fixed with 4% paraformaldehyde for 
immunostaining procedures. The antibodies used were as follows: FITC-conjugated anti-
human vWF sheep IgG (US Biologicals, Swampscott, MA), PE-conjugated anti-human 
CD56 (NCAM) mouse IgG1, anti-human CD31 mouse IgG1, PE-conjugated anti-human 
CD54 (ICAM-1) mouse IgG1 (BD, San Jose, CA), anti-human αSMA mouse IgG2a, anti-
human type I collagen mouse IgG1, anti-human type III collagen mouse IgG1, anti-human 
laminin mouse IgG1, anti-chondroitin sulfate proteoglycan mouse IgM (Sigma, St. Louis, 
MO), anti-human fibronectin mouse IgG1 (Oncogene Research Products, Cambridge, MA), 
rabbit anti-human type IV collagen IgG (Research Diagnostics Inc., Flanders, NJ), rat anti-
human perlecan IgG2a (Lab Vision, Fremont, CA), rabbit anti-human AFP IgG (Zymed-
Invitrogen, South San Francisco, CA), anti-human KDR mouse IgG1 (Cell Sciences, Canton, 
MA), Alexa Fluor 488 goat anti-rabbit IgG, Alexa Fluor 568 goat anti-rabbit IgG, Alexa Fluor 
568 goat anti-mouse IgG1 and Alexa Fluor 488 goat anti-mouse IgG2a (Molecular Probes-
Invitrogen, Eugene, OR).  
The markers for the non-parenchymal cells included: KDR, (VEGFR2), expressed on 
angioblasts and endothelia); CD31, also called PECAM, a marker on endothelia; it is 
expressed at low levels on angioblasts.  CD146, also called MCAM, A32, MUC18, Mel-
CAM , or S-endo , and was found on endothelia, melanomas, smooth muscle, intermediate 
trophoblast, and a subpopulation of activated T cells.  Desmin, an intermediate filament 
molecule expressed by hepatic stellate cells (HpSTCs) and by smooth muscle cells; α-
Smooth Muscle Actin (αSMA), a signature feature of HpSTCs; its expression becomes 
 73
greatly elevated in activated HpSTCs.  
 
Quantitative Real-Time PCR 
Total RNA was extracted from each of three cell types, HUVECs and human fetal liver-
derived CD31+ endothelial and αSMA+ fibroblast-like cells, using RNeasy Mini (Qiagen, 
Valencia, CA). The extracted RNA was then reverse-transcribed into cDNA using 
SuperScript II RT (Invitrogen, Carlsbad, CA). Quantitative real-time PCR was performed 
using sequence specific primers and probes shown in the table below and analyzed by the 
ABI Prism 7000 Sequence Detection System (Applied Biosystems, Foster City, CA, USA). 
Ribosomal RNA (18S) from each cell type was used as internal control. The mRNA 
expression levels relative to 18S were determined and the fold changes were calculated using 
the 2-∆∆CT method (Livak and Schmittgen, 2001). The primers used are as given below: 
Primers used for RT-PCR: 
Genes ABI assay number 
Ribosomal RNA (18S) 4308329
type I collagen-α1 chain (COL1A1) Hs00164004_m1
type III collagen-α1 chain (COL3A1) Hs00164103_m1 
type IV collagen-α1 chain (COL4A1) Hs00266237_m1
type V collagen-α1 chain (COL5A1) Hs006090088_m1
fibronectin module 1 (FN1) Hs01549972_m1 
laminin-α2 chain (LAMA2) Hs00166308_m1 
laminin-α4 chain (LAMA4) Hs00158588_m1 
laminin-α5 chain (LAMA5) Hs00245699_m1 
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laminin-β1 chain (LAMB1) Hs00158620_m1 
laminin-γ1 chain (LAMC1) Hs00267056_m1 
syndecan-1 (SDC1) Hs00174579_m1 
syndecan-2 (SDC2) Hs00299807_m1 
glypican-3 (GPC3) Hs00170471_m1 
glypican-5 (GPC5) Hs00270114_m1 
 
 
Methods and Materials for Chapter VII 
Preparation of mesenchymal cell conditioned media 
Each of different feeder cell types was plated onto tissue culture dishes at a density of 
16,000 cells/cm2 in the media suitable for attachment of corresponding cell types. On the 
next day, the media were changed to serum-free hormonally-defined medium (HDM) for 
every cell type with an amount of 5 ml per million cells seeded. HDM comprises of RPMI 
1640 basal medium (Invitrogen, Carlsbad, CA) plus fatty acid-free bovine serum albumin 
(BSA, 0.1%), insulin (5 µg/ml), holotransferrin (10 µg/ml), free fatty acid mixture (7.6 µeq/L, 
Sigma, St. Louis, MO), selenous acid (300 pM, Johnson Matthey Chemicals, London, UK) 
and antibiotics (Invitrogen).  The culture was then incubated for 2 days, followed by 
collection of used media. The collected media were centrifuged at 400xg for 10 minutes and 
the supernatant were filtered through a 0.2 µm pore size Acrodisc. The filter media were then 
diluted 1:2 with fresh serum-free KM to make conditioned media. For the purpose of 
enzyme-liked immunoabsorbent assay (ELISA), used and filtered serum-free HDM were not 
diluted before sending to the Cytokine Core Lab. 
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 Sources, maintenance and derivation of feeder cells 
Feeder cell types used for producing conditioned media include mouse embryonic 
fibroblast cell line (STO cells), human fetal lung fibroblast cell line (MRC5 cells), 
immortalized human stellate cell line (h-tert-HSCs) and primary human fetal liver-derived 
stromal cells. STO cell line was derived by Dr. Hiroshi Kubota. H-tert-HSCs were produced 
by retrovirally infecting the primary adult human hepatic stellate cells and provided by Dr. 
David Brenner. The primary human liver stromal cells were derived from human fetal livers 
in mid-gestation stage (16-18 weeks) obtained from Advanced Bioscience Resources Inc. 
(San Francisco, CA). After enzymatic digestion of the human fetal liver samples, the cell 
suspension was centrifuged at 50xg for 5 minutes and the supernatant was collected and 
plated onto tissue culture dishes to produce primary human fetal liver stromal feeder. Both 
STO cells and human fetal liver-derived stromal cells were maintained in RPMI 1640 
(Invitrogen) plus 10% FBS (fetal bovine serum, Hyclone, Logan, UT) and antibiotics 
(Invitrogen). H-tert-HSCs were maintained in RPMI 1640 plus 10% FBS and G418 
(200µg/ml, Invitrogen). MRC5 cells were maintained in RPMI 1640 plus 20% horse serum 
(Hyclone).  
 
Colony formation assay for rat hepatic progenitor (rter6) and human hepatoblastoma 
(HepG2) cells 
Rter6 cells were derived from E13 Fisher 344 rat fetal liver (Kutoba and Reid, 2000). 
For testing the effect from STO conditioned medium, rter6 cells were plated at seeding 
densities of 400, 200 and 100 cells/cm2 on pre-prepared growth arrested STO or MRC5 
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feeder cell layer (250,000 cells/cm2). On the next day, the medium was changed to STO 
conditioned medium and the culture was incubated for 10 days with medium change every 3 
days. For testing the effect from cytokines, rter6 cells were plated at seeding densities of 250 
cells/cm2 on pre-prepared growth arrested STO feeder cell layer. On the next day, the 
medium was changed to serum-free hormonally-defined medium (HDM) supplemented with 
test cytokines with concentration of manufacturers’ suggested ED50 and the culture was 
incubated for 10 days with medium change every 3 days. Concentration for each of tested 
cytokines is: 0.5 ng/ml for leukemia inhibitory factor (LIF), 10 ng/ml for interleukin-11 (IL-
11), 0.05 ng/ml for transforming growth factor-β1 (TGF-β1), 0.01 ng/ml for IL-6, 1 ng/ml for 
IL-13, 10 ng/ml for growth related oncogene (GRO), 0.05 ng/ml for tumor necrosis factor-α 
(TNF-α) and 50 ng/ml for macrophage inflammatory protein-α (MIP-1α). 
HepG2 cells were propagated in RPMI 1640 (Invitrogen) plus 10% FBS (Hyclone) 
and antibiotics (Invitrogen). Cells with subconfluent density were trypsinized, centrifuged, 
and then resuspended with the same medium. The resultant cell suspension was then filtered 
through a sterile 30 µm pore size cell strainer, followed by cell counting and plating onto 
uncoated tissue culture plastic with a seeding density of 50-100 cells/cm2. On the next day, 
the medium was removed and the dishes were washed with phosphate-buffered saline (PBS) 
(Invitrogen), followed by addition of various test media (0.2 ml/cm2). To test the effect from 
cytokines and candidate growth stimulating molecules individually, serum-free hormonally-
defined medium (HDM) was supplemented with insulin-like growth factor-II (IGF-II, 2 
ng/ml, Sigma), human growth hormone (10 µU/ml, Sigma), epidermal growth factor (EGF, 
10 ng/ml, Collaborative Research, Waltham, MA), transforming growth factor-β1 (TGF-β1, 5 
ng/ml), interleukin-11 (IL-11, 10 ng/ml), IL-6 (10 ng/ml), IL-13 (1 ng/ml), tumor necrosis 
 77
factor-α (TNF-α, 10 ng/ml), or growth related oncogene (GRO, 10 ng/ml). 
HepG2 cells were incubated with the test media for 10 days and the media were 
changed every 5 days. Colony formation was scored at day 10 by staining with Diff-Quick 
and counting manually.  
 
Enzyme-liked immunoabsorbent assay (ELISA) 
Human fetal liver cells were seeded at 400,000 cells/cm2 on plastic or on STO feeder 
cells in HDM for three days. The used media were then collected , centrifuged to remove cell 
debris and stored at -80◦C until ELISA analysis. HDM incubated with STO feeder cells only 
for three days were also collected for ELISA test. The test media were sent to the Cytokine 
Core Lab at The University of Maryland at Baltimore. 
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CHAPTER III 
IDENTIFICATION AND CHARACTERIZATION OF VITAMIN A-STORING CELLS IN 
FETAL LIVER: IMPLICATION OF FUNCTIONAL IMPORTANCE OF HEPATIC 
STELLATE CELLS IN DEVELOPMENT AND HEMATOPOIESIS 
(Refereed article published in Stem Cells, 2007) 
 
 Liver development requires paracrine signals from the neighboring mesenchymal 
cells. Endothelial cells, hepatic stellate cells and Kupffer cells are three major non-
parenchymal cell types in the liver. Endothelial cells have been proven to be necessary in 
hepatic progenitor cell outgrowth during liver organogenesis. Hepatic stellate cells capable of 
producing several cytokines, growth factors and extracellular matrix (ECM) molecules, as 
well as remodeling ECM in the liver are important during development and regeneration of 
liver. Most studies on biology of hepatic stellate cells were done using adult liver-derived 
cells. However, hepatic stellate cells derived from adult livers did not support growth of 
human hepatic stem cells (hHpSCs). A hypothesis is that developmental paracrine signals are 
provided by mesenchymal precursors in the embryos. Hepatic stellate cells derived from fetal 
livers may possess different property than those derived from adult livers. To test this 
hypothesis, successful isolation and propagation of fetal liver-derived hepatic stellate cells 
are important. This chapter described the key efforts and findings in purification and clonal 
expansion of fetal rat liver-derived hepatic stellate cells. 
 
Hiroshi Kubota, Hsin-Lei Yao, and Lola M. Reid 
 
Departments of Cell and Molecular Physiology and Biomedical Engineering§
Program in Molecular Biology and Biotechnology 
University of North Carolina at Chapel Hill School of Medicine 
Chapel Hill, North Carolina 27599 
 
ABSTRACT 
Hepatic stellate cells (HpSTCs), or “vitamin A-storing lipocytes”, are major 
regulators of hepatic fibrogenesis in adults. However, their early development in fetal liver is 
largely unknown. To characterize fetal HpSTCs in the liver in which hepatic development 
and hematopoiesis occur in parallel, we determined the phenotypic characteristics of HpSTCs 
from rat fetal livers utilizing a strategy focused on vitamin A. Storage of vitamin A in the 
cytoplasm is a unique characteristic of HpSTCs, permitting identification of them by vitamin 
A-specific autofluorescence (vA+) when excited with UV light utilizing flow cytometry. A 
characteristic vA+ cell population was identified as early as 13-day post coitum liver and 
having a surface phenotype of RT1A- ICAM-1+ VCAM-1+ β3-integrin+. Although non-
specific autofluorescent cells were found with the antigenic profile of RT1A- ICAM-1+ 
VCAM-1+, they were β3-integrin- and proved to be hepatoblasts, bipotent hepatic 
parenchymal progenitors. In addition to expression of classical HpSTC markers, the vA+ 
cells were able to proliferate continuously in a serum-free hormonally defined medium 
containing leukemia inhibitory factor, which was found as a key factor for their replication. 
These results demonstrated that the vA+ cells are fetal HpSTCs with extensive proliferative 
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activity. Furthermore, the vA+ cells strongly express hapatocyte growth factor, stromal 
derived factor-1α, and Hlx, homeobox transcriptional factor, indicating that they play 
important roles for hepatic development and hematopoiesis. The ability to isolate and expand 
fetal HpSTCs enable further investigations into their roles in early liver development and 
facilitate identification of possibly novel signals of potential relevance for liver diseases. 
 
INTRODUCTION 
Hepatic stellate cells (HpSTCs) are liver-specific mesenchymal cells in the space of 
Disse, located between the plates of parenchymal cells and the flanking endothelia. A 
prominent characteristic of HpSTCs is the presence of cytoplasmic lipid droplets containing 
vitamin A. Indeed, a major role of HpSTC is uptake, storage, and release of vitamin A 
compounds, which are requisite for embryonic development and, in adults, for vision and 
reproduction (Blaner, 1994; Geerts et al., 1994; Blomhoff et al., 1990). In mammals, about 
50 to 80% of the total body vitamin A is stored in HpSTCs (Blomhoff et al., 1990).  
HpSTCs are key effectors in hepatic fibrogenesis in adult liver tissue (Geerts et al., 
1994; Ankoma-sey and Friedman, 1998). Although HpSTCs have been studied in adult livers, 
little is known about their embryonic origin and early development (Geerts, 2004; Cassiman 
et al., 2006).  In early liver development, endodermal cells in the foregut give rise to hepatic 
diverticulum around 10 days post coitum (dpc) of rats (Shiojiri, 1997). Subsequently, the 
hepatic diverticulum develops into the surrounding mesoderm called the septum transversum 
and forms hepatic cords. HpSTC are thought to derive from mesenchymal cells of the septum 
transversum, because histological analyses have suggested that mesenchymal cells in the 
septum transversum become trapped in the subendothelial space of the hepatic cords and are 
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hypothesized to develop into HpSTCs (Enzan et al., 1997; Wake, 1980). In rat liver at 13 dpc, 
the walls of sinusoids consist of two layers, endothelial cells and pericytes. The latter are 
dendritic cells and contain lipid droplets, and their cytoplasmic processes extend between 
parenchymal cells consisting of hepatoblasts, bipotent hepatic progenitors (Enzan et al., 
1997; Wake, 1980; Kubota and Reid, 2000). Although these dendritic cells are believed to be 
fetal HpSTCs, neither biological characteristics of the dendritic pericytes nor any HpSTC-
specific marker expression has been studied to confirm that.   
In the fetus, liver is a primary site for hematopoiesis. Therefore, fetal HpSTCs may 
have unique roles to support fetal liver hematopoiesis as well as hepatic development. 
Although the antigenic profiles of hematopoietic and hepatic cells in fetal livers have been 
studied (Kubota and Reid, 2000; Morrison et al., 1995; Suzuki et al., 2002), those of fetal 
HpSTCs have not. In this study, we determined the antigenic phenotype of fetal HpSTCs in 
the rat and revealed the unique phenotypic and biological characteristics.   
 
 
RESULTS 
Identification of vitamin A-specific autofluorescent cells in fetal liver  
Vitamin A-rich lipid droplets in the cytoplasm has been used as a unique 
characteristic for identification of HpSTCs. Vitamin A specifically produces a green-blue 
fluorescent when excited with light of 330-360 nm (ultra violet, UV) laser. Flow cytometric 
analysis (FCA), using a UV laser, is able to detect the vitamin A-specific green-blue 
fluorescent in the cytoplasm of HpSTCs in adult liver (Geerts et al., 1998). To identify fetal 
HpSTCs, we sought cells with the vitamin A-specific green-blue fluorescent characteristic in 
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fetal liver by flow cytometry. In a previous study, we identified hepatoblasts as RT1A- (rat 
major histocompatibility complex class Ia-) OX18low ICAM-1+ side scatter (SSC)high cells in 
13 dpc liver of rat fetus (Kubota and Reid, 2000). Hepatoblasts showed relatively high SSC 
characteristics among the cell population of the fetal liver. Therefore, an autofluorescent 
signal produced by hepatoblasts must be distinguished from vA-specific autofluorescent 
signal in FCA. Figure 3.1A shows the patterns of FCA of fetal liver cells at 13 dpc followed 
staining with antibodies against RT1A and ICAM-1.  Based on the SSC signal, two gates, R1 
and R2, were created (Figure 3.1A ALL), and the expression patterns of RT1A and ICAM-1 
were analyzed (Figure 3.1A R1 and R2). As expected, the majority of cells of R2 (SSChigh) 
were RT1A- ICAM-1+ cells (Figure 3.1A R2, lower right), identified previously as 
hepatoblasts (Kubota and Reid, 2000).  
Subsequently, we analyzed autofluorescent activities in the 13 dpc fetal liver cells. 
The vA-specific blue-green autofluorescent signal was measured by detecting the emission 
light with a 450 nm filter by excitation of a UV laser (351nm) (see Materials and Methods). 
To detect a non-UV laser-specific autofluorescent signal, a 488 nm laser and 530/30 nm 
bandpass filter was used.  NADH, riboflavines, and flavin coenzymes commonly cause 
intrinsic cellular autofluorescence (Aubin, 1979; Nokubo et al., 1988), and the peak 
autofluorescence emission of these molecules after 488 nm excitation overlaps with the 
detection region of FITC, which peak emission is 518 nm. Patterns of the autofluorescent 
signals, the UV laser-specific and non-UV laser specific autofluorescence, of whole fetal 
liver cell population as well as two subpopulations (R1 and R2 gates of Figure 3.1A) were 
shown in Figure 3.1B. In the pattern of the whole cell population (Figure 3.1B ALL), two 
distinct subpopulations with high autofluorescent characteristics were identified. One had an 
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autofluorescent signal specific for UV light (Figure 3.1B ALL, upper left), which is referred 
to here as vA+, whereas cells locating diagonally in the upper right quadrant indicate non-
specific autofluorescence, because the autofluorescent signals were detected with the 530 nm 
filter and the 450 nm filter when excited by the 488 nm laser and the UV laser, respectively. 
The subpopulation with non-specific autofluorescent characteristic (designated as ns-
autoflu+) exclusively derived from the SSChigh  gate (Figure 3.1A R2 and Fig.3.1B R2) while 
vA+ cells (Figure 3.1B, upper left) were detected in both R1 and R2. Figure3.1C shows the 
pattern of vA-specific autofluorescent signal and RT1A expression, which was detected by a 
FITC-conjugated antibody against RT1A. FCA indicated that vA+ cells as well as ns-autoflu+ 
cells had no RT1A expression, because those two populations did not shift in the stained 
sample (Figure 3.1C) compared to the control sample (Figure 3.1B). In addition, FCA 
indicated that the RT1A- ICAM-1+ SSChigh cells (Figure 3.1A R2, lower right), which 
represents the hepatoblast population, and RT1A- ns-autoflu+ cells (Figure 3.1C R2, arrow) 
are an overlapping population by this FCA (data not shown).  
To determine whether these autofluorescent signals were specific in fetal liver, fetal 
lung cells from the 13 dpc fetuses were isolated and analyzed by flow cytometry. The FCA 
showed there were neither ns-autoflu+ cells nor vA+ cells in the lung cells (Figure 3.1D), 
indicating that the autofluorescent signals in particular subpopulations in the fetal liver 
represent unique phenotypic characteristics. These results clearly indicate that flow 
cytometry was able to detect characteristic vA+ cells in rat fetal liver as early as 13 dpc and 
that the vA+ cells were RT1A- .   
 
Vitamin A+ cells express VCAM-1 and β3-integrin  
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VCAM-1 (CD106) has been identified as a unique surface marker of mature HpSTCs 
in adult liver (Knittel et al., 1999). Therefore, we analyzed VCAM-1 expression in fetal liver 
cells to investigate whether the vA+ cells express VCAM-1. By FCA, it appeared that about 
15 % of cells were VCAM-1+ in the 13 dpc fetal liver (Figure 3.2A). We next analyzed the 
pattern of autofluorescence and RT1A expression of the VCAM-1+ cells. Interestingly, the 
VCAM-1+ cells contained essentially all vA+ cells as well as the entire ns-autoflu+ cell 
population (Figure 3.2A), indicating that HpSTCs and hepatoblasts express VCAM-1. FCA 
of two monoclonal antibodies against rat VCAM-1 (5F10 and MR109) showed an identical 
pattern of VCAM-1 expression (data not shown). In addition, fetal liver VCAM-1+ cells were 
RT1A- ICAM-1+ cells because the R1 gate in Figure 3.2B included the VCAM-1+ cell 
population. These results indicate that fetal liver RT1A- ICAM-1+ VCAM-1+ cells consist of 
vA+ cells, hepatoblasts, and some autoflu- cells.  
We next investigated surface antigens to distinguish the two autofluorescent 
populations, the vA+ cells and the hepatoblasts, both of which were RT1A- ICAM-1+ VCAM-
1+ cells. Because it has been reported that β3-integrin (CD61) is expressed on adult HpSTCs 
(Zhou et al., 2004), two-color FCA of VCAM-1 versus β3-integrin were performed (Figure 
3.3B). The vA+ RT1A- cells expressed β3-integrin, whereas ns-autoflu+ RT1A- cells were 
clearly β3-integrin-. Autoflu- RT1A- cells contained some VCAM-1+ β3-integrin+ cells. The 
remaining major population (Figure 3.3B, R4) was VCAM-1- and appear to be correspond to 
R2 cell population in Figure 3.2B. These cells were non-adherent when they were cultured on 
plastic dishes (data not shown). We also analyzed expression of PECAM-1 (CD31), which is 
known as an endothelial cell marker. FCA indicated that PECAM-1 expression in vA+ RT1A- 
cells and ns-autoflu+ RT1A- cells is negligible, while PECAM-1+ cells were detected in the 
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autoflu- RT1A- and non-adherent cell populations (Figure 3.3B). In addition, we analyzed 
expression of Thy-1 (CD90). Thy-1 is a surface marker for oval cells that appear in adult 
livers after oncogenic insults (Petersen et al., 1998). Oval cells share some characteristics 
with hepatoblasts in fetal liver (Sigal et al., 1992; Shiojiri et al., 1991). Nonetheless, FCA 
showed that ns-autoflu+ RT1A- cells are Thy-1-. By contrast, vA+ RT1A- cells, autoflu- 
RT1A- cells and non-adherent cells express Thy-1 heterogeneously. We found that ns-
autoflu+ RT1A- cells were CD44lo whereas vA+ RT1A- cells were CD44- (data not shown). 
CD44 is a cell adherent molecule, and its ligand, hyaluronans, is a basic component of 
embryonic extracellular matrices (Aruffo et al., 1990). CD44 appeared to be expressed 
differentially in the vA+ RT1A- cells and ns-autoflu+ RT1A-; however, the expression on the 
cell surface was rather weak. Together, these data suggest that only β3-integrin antibody 
staining among all antibodies examined, facilitates distinguishing the vA+ cells and ns-
autoflu+ cells, both of which were RT1A- VCAM-1+ ICAM-1+ cell population in the fetal 
livers. 
To gain insight into in situ localization of vA+ cells in fetal liver, 
immunohistochemistry for VCAM-1 and β3-integrin was performed. Whereas VCAM-1 was 
detected throughout the liver parenchyma (Figure 3.4A), we observed only a few β3-integrin+ 
in the same field (Figure 3.4A). The β3-integrin+ co-expressed VCAM-1, and the VCAM-1+ 
β3-integrin+ cells showed a dendritic morphology with cytoplasmic processes extending 
between parenchymal cells. In addition, some of them located along the sinusoids, suggesting 
that they are fetal HpSTCs.  
 
Non-specific autofluorescent+ RT1A- VCAM-1+ β3-integrin - cells are hepatoblasts 
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In a previous study, we developed an in vitro CFA for hepatoblasts, which can 
differentiate to either hepatocytes or biliary epithelial cells depending upon the 
microenvironment (Kubota and Reid, 2000). In the CFA, a single hepatoblast can generate a 
colony of cells with both hepatocytic and biliary markers. Using the assay, we proved that 
almost all hepatic cells at 13 dpc of the rat are indeed bipotent (Kubota and Reid, 2000). To 
examine whether vA+ cells have any potential to generate hepatoblast colonies, the CFA was 
performed. Four cell populations were isolated by FACS and subjected to the CFA for 
hepatoblasts: 1) ns-autoflu+ RT1A- VCAM-1+ β3-integrin-, 2) vA+ RT1A- VCAM-1+ β3-
integrin+, 3) autoflu- RT1A-, and 4) VCAM-1- non-adherent cells. The CFA clearly indicated 
that hepatic colonies were generated exclusively from group 1, ns-autoflu+ RT1A- VCAM-1+ 
β3-integrin- cells (Table 3.1). More than 95% of the hepatic colonies derived from the group 
1-sorted cells contained both hepatocytic (albumin+ CK19-) and biliary epithelial (albumin- 
CK19+) cells (Figure 3.4B). The colony forming efficiency was approximately 31 % (Table 
3.1). A hepatic progenitor cell line (rhel4321) established in a previous study (Kubota and 
Reid, 2000) had a colony efficiency in the CFA of 42.5 ± 1.8 %. Therefore, the result of CFA 
in this experiment indicates that the group 1-sorted cells are nearly pure hepatoblasts, 
because the colony efficiency by established cell lines without sorting is assumed much 
higher than that of freshly isolated cells. These results clearly demonstrated that, while the 
ns-autoflu+ RT1A- VCAM-1+ β3-integrin- cells are hepatoblasts, the other groups of sorted 
cells, including the vA+ RT1A- VCAM-1+ β3-integrin+ cells, do not contain hepatoblasts. 
 
Gene expression of freshly isolated vitamin A+ RT1A- VCAM-1+ β3-integrin + cells  
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We next analyzed the gene expression pattern of the vA+ RT1A- VCAM-1+ β3-
integrin+ cells to examine whether they express various markers for HpSTCs. Five population 
were isolated by FACS, and RNAs were isolated from the five populations. RT-PCR for 
HpSTC markers was performed using cDNAs synthesized from the RNAs. The five 
populations were: 1) ns-autoflu+ RT1A- VCAM-1+ β3-integrin-, 2) vA+ RT1A- VCAM-1+ β3-
integrin+, 3) autoflu- RT1A- VCAM-1+, 4) autoflu- RT1A- VCAM-1-, and 5) VCAM-1- non-
adherent cell population. HpSTCs in adult liver express intermediate filaments, desmin and 
nestin (Yokoi et al., 1984; Niki et al., 1999), which are not expressed in other cell types in 
the liver. Vimentin is expressed broadly in mesenchymal cells, while smooth muscle α-actin 
(SMαA) is expressed in myogenic cells. Expression of vimentin and SMαA increase after 
activation of HpSTCs (Geerts et al., 1994; Ankoma-sey and Friedman, 1998). RT-PCR 
analyses showed that vA+ RT1A- VCAM-1+ β3-integrin+, autoflu- RT1A- VCAM-1+, and 
autoflu- RT1A- VCAM-1- cells expressed all four intermediate filaments (Figure 3.4C). ns-
autoflu+ RT1A- VCAM-1+ cells express albumin as well as Prox1 (Figure 3.4C), which is a 
transcriptional factor expressing specifically in hepatoblasts (Sosa-Pineda et al., 2000). This 
result was consistent with the data obtained from the CFA, which demonstrated they were 
hepatoblasts (Table 3.1). There was no expression of nestin, SMαA, or vimentin in the 
hepatoblasts. A weak expression of desmin in the hepatoblasts (Figure 3.4C) agree with the 
results of the prior immunolocalization study for desmin with confocal microscopy (Vassy et 
al., 1993). The expression of HpSTC specific intermediate filaments strongly suggests that 
vA+ cells are fetal HpSTCs. 
Subsequently, expression of hepatocyte growth factor (HGF), stromal cell-derived 
factor-1 alpha (SDF-1α), and divergent homeobox transcriptional factor Hlx were 
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investigated using RT-PCR. HGF is required for normal hepatic development, especially for 
proliferation and differentiation of hepatoblasts in the mouse (Schmidt et al., 1995). In adult 
liver HpSTCs are major producers of HGF (Schirmacher et al., 1992). SDF-1α is a potent 
chemokine for hematopoietic progenitors, and hematopoietic stem cells in fetal liver migrate 
in response to the chemokine (Christensen et al., 2004). Hlx is expressed in mesenchymal 
cells in developing fetal liver and plays an indispensable role in fetal liver hematopoiesis and 
hepatic development (Hentsch et al., 1996). Interestingly, vA+ RT1A- VCAM-1+ β3-integrin+ 
cells expressed HGF, SDF-1α and Hlx transcripts most strongly among all cell fractions 
examined (Figure 3.4C).  
 
Ex vivo clonal expansion of vitamin A+ RT1A- VCAM-1+ β3-integrin+ cells. 
Although HpSTCs isolated from adult liver can proliferate in vitro in serum-
supplemented media, they usually transform to myofibroblast cells and show only limited 
proliferative activity (Geerts et al., 1994). Fetal HpSTCs may have extensive proliferative 
potential, when cultured in an appropriate condition. Therefore, we investigated the ex vivo 
growth capability of the vA+ cells in fetal livers. When vA+ RT1A- VCAM-1+ β3-integrin+ 
cells isolated by FACS were cultured in HDM at a cell density of 500 cells/well of 96-well 
plates for 5 days in the presence of LIF, a pleiotrophic growth factor for different types of 
cells including embryonic stem cells or myogenic cells (Austin and Burgess, 1991; Smith et 
al., 1992), the cells expanded in a dose-dependent manor (Figure 3.5A). In addition, EGF 
potenciated the proliferation of fetal HpSTCs induced by LIF, but did not support the 
expansion on its own (Figure 3.5A).  
 89
The proliferation, however, did not persist in the culture conditions making use of 
plastic culture plates. We next placed the sorted vA+ RT1A- VCAM-1+ β3-integrin+ cells on 
STO feeders (Kubota and Reid, 2000). Although STO cells produce LIF, exogenous LIF and 
supplementation of EGF supported colony formation from sorted vA+ RT1A- VCAM-1+ β3-
integrin+ cells dramatically (Figure 3.5B). Proliferating cells in the culture expressed desmin 
and nestin, whereas STO feeders did not express either (Figure 3.5C). Three single colonies 
were picked and placed on fresh STO feeders. The single colony-derived cells continued to 
proliferate in the co-cultures with STO feeders supplemented with LIF and EGF for 2 months, 
indicating that they have extensive growth potential. Expression of desmin and nestin were 
maintained in the proliferating cells (Figure 3.5D). To compare further the characteristic 
phenotypes of 2 month-cultured cells with freshly isolated vA+ RT1A- VCAM-1+ β3-integrin+ 
cells, RT-PCR was performed. Single colony-derived cells (A428-3) that were maintained 
for 2 months in culture were separated from STO feeder cells by FACS, and the RNA was 
extracted for RT-PCR analysis. RNA was isolated from STO feeder cells that were sorted 
simultaneously as a control. In addition, RNA was isolated from adult HpSTCs to compare 
with those from A428-3 and STO cells. The results demonstrated that A428-3 expressed 
desmin, nestin, SMαA, vimentin, β3-integrin, SDF-1α, HGF, and Hlx, indicating the 
expression pattern was a similar to fresh vA+ RT1A- VCAM-1+ β3-integrin+ cells (Figure 3.5 
and Figure 3.6A). Furthermore, VCAM-1 expression was confirmed by FCA (Figure 3.6B). 
RT1A expression appeared to be induced in vitro culture (Figure 3.6B). The RT-PCR results 
of adult HpSTCs agreed with previous reports, in which the phenotype of normal adult 
HpSTCs is desmin+, glial fibrillary acidic protein (GFAP)+, HGF+, but SMαAlo/-. The results 
also showed that adult HpSTCs express SDF-1α, β3-integrin, and Hlx. There was neither 
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expression of GFAP in A428-3 cells (Figure 3.6A) or in any fractions tested in fetal liver 
(data not shown). 
  
DISCUSSION 
Vitamin A-storing cells in fetal liver were identified by flow cytometry using the 
specific auto-fluorescence generated by cytoplasmic vA rich lipid droplets. The surface 
phenotype of vA+ cells appeared to be uniform and consisted of cells that are RT1A- ICAM-
1+ VCAM-1+ β3-integrin+ PECAM-1-. VCAM-1 has been shown as a unique surface marker 
to distinguish HpSTCs from myofibroblasts in adult liver (Knittel et al., 1999). ICAM-1 and 
β3-integrin expression on HpSTCs also have been demonstrated in previous studies 
(Hellerbrand et al., 1996; Zhou et al., 2004). In addition to those surface markers, vA+ cells 
express intermediate filaments specific for HpSTCs including desmin, vimentin, SMαA, and 
nestin. These molecular markers have been used to identify HpSTCs in adult liver (Geerts et 
al., 1994; Ankoma-sey and Friedman, 1998; Yokoi et al., 1984; Niki et al., 1999). These 
results strongly supports that the vA+ cells are fetal HpSTCs.  
VCAM-1, an immunoglobulin gene superfamily of adhesion molecules, plays a key 
role in supporting adhesion of hematopoietic progenitors to bone marrow stromal cells 
(Miyake et al., 1991). Although fetal liver is a major hematopoietic organ in fetus, 
hematopoietic cells originally are generated in yolk sac and the aorta-gonad-mesonepheros 
region. Shortly after that, they colonize to fetal liver and produce large numbers of 
hematopoietic progenitors until birth (Dzierzak and Medvinsky, 1995). In the later 
developmental stage in utero, hematopoietic stem cells move to bone marrow, which 
becomes the primary hematopoietic organ throughout the postnatal life (Morrison et al., 
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1995). Adhesion molecules expressed on endothelial cells are important for homing process 
of hematopoietic stem/progenitor cells (Quesenberry and Backer, 1998). Studies using 
blocking antibodies for VCAM-1 or VLA-4, which is expressed on hematopoietic 
stem/progenitors, demonstrated that hematopoietic stem/progenitor cells failed to colonize to 
bone marrow when the VCAM-1/VLA-4 adhesion pathway was blocked (Papayannopoulou 
et al., 1995; Vermeulen et al., 1998). Therefore, VCAM-1 molecule in fetal liver is likely to 
involve establishment of fetal liver hematopoiesis.  
While FCA indicated that high VCAM-1 expression was detected on hepatoblasts and 
fetal HpSTCs, the later may play more important roles for hematopoietic cells, because they 
express SDF-1α as well. SDF-1α is a potent chemoattractant for hematopoietic stem cells, 
which express CXCR4, the receptor for SDF-1α (Wright et al., 2002). The chemokine plays a 
central role during the migration of hematopoietic stem/progenitor cells to bone marrow 
(Lapidot, 2001). It was shown that SDF-1α up-regulates VLA-4 dependent adhesion to 
VCAM-1 (Hidalgo et al., 2001). Therefore, it is possible that SDF-1α and VCAM-1 
expression on fetal HpSTCs are crucial to recruit hematopoietic stem/progenitor cells into 
fetal liver.  
Interestingly, our study reveals that VCAM-1 is expressed by hepatoblasts, as well as 
HpSTCs.  In addition to the surface antigenic profile and the cells’ mRNA expression, the 
culture assays clearly demonstrated that VCAM-1+ cells are hepatoblasts. This finding is 
unexpected because VCAM-1 is known as a surface marker for mesenchymal cells such as 
endothelial cells, myogenic cells, or HpSTCs (Knittel et al., 1999; Osborn et al., 1989; Rosen 
et al., 1992). The expression appears to be developmentally controlled because adult 
hepatocytes are VCAM-1- by FCA (data not shown), which agrees with previous studies (van 
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Oosten et al., 1995). Several lines of evidence demonstrated that VCAM-1 and VLA-4 
interaction occurs on myogenic cells and controls myogenesis in addition to the adhesion 
pathway between hematopoietic stem cells and endothelial cells; so, it is worthwhile to 
elucidate the biological functions of VCAM-1 on hepatoblasts. VCAM-1 expression has been 
found on mouse hepatoblasts as well (Kubota, unpublished data), suggesting that the 
physiological role might be conserved across species.  
Our data indicates that fetal HpSTCs are major HGF producers in the fetal liver. HGF 
is a crucial growth factor for hepatic development (Schmidt et al., 1995), and the factor is 
responsible for liver parenchymal cell growth during liver regeneration as well 
(Michalopoulos and DeFrances, 1997). In addition, it has been shown that HpSTCs, but not 
parenchymal cells, endothelial cells, or Kupffer cells, express HGF in adult liver 
(Schirmacher et al., 1992). Therefore, our data and previous studies suggest that HpSTCs are 
main HGF producers from fetuses to adults in the liver. Interestingly, a recent study indicated 
that HGF potentiated SDF-1α-mediated recruitment of hematopoietic progenitors to the liver 
(Kollet et al., 2003). The study suggested HGF produced from HpSTCs in injured adult liver 
is important for homing of hematopoietic cell into the livers. Likewise, fetal HpSTCs may 
play a crucial role for hepatic and hematopoietic development in the fetal liver because the 
cells are main producers for HGF and SDF-1α.  
A divergent homeobox protein, Hlx, is expressed in septum transversum and 
mesenchymal cells in fetal liver (Lints et al., 1996). A previous study of Hlx knockout mice 
demonstrated that the mutant mice have impaired hepatic development and fetal liver 
hematopoiesis (Hentsch et al., 1996). Transplantation experiment indicated that the 
hematopoietic defect was caused by the fetal liver microenvironment, but not by the 
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hematopoietic progenitors per se. Thus, Hlx+ cells are a crucial cell population in fetal liver 
for supporting hepatic and hematopoietic development. Our data indicated that fetal HpSTCs 
in the rat expressed Hlx strongly, and we have found that a cell population in the mouse fetal 
liver express desmin, nestin, VCAM-1, HGF, SDF-1α, and Hlx as well (H Kubota, 
unpublished data). Therefore, it is interesting to examine whether Hlx knockout mice have 
the cell population, which is a counterpart of rat fetal HpSTCs. Although relationship 
between Hlx expression and HpSTC development is not clear, loss of Hlx expression in fetal 
HpSTCs may cause defects in the biological function of HpSTCs in the developing liver of 
the mutant mice. Furthermore, considering the unique phenotypic and functional 
characteristics of fetal HpSTCs including expression of VCAM-1 and Hlx and production of 
HGF and SDF-1α, the cells might comprise a stem cell niche for hematopoietic stem cells, 
hepatic stem cells, or both in the liver.  
GFAP is a marker used to identify HpSTCs in adult liver (Gard et al., 1985). 
However, we did not detect GFAP mRNA by RT-PCR in any cell fractions examined as well 
as in the whole fetal liver sample. In addition, even after culture of isolated fetal HpSTCs, 
GFAP expression was not induced, whereas desmin and nestin expression were sustained in 
the cultured cells. This result suggests that differentiation of fetal HpSTCs will result in 
GFAP expression in a later developmental stage. We cannot, however, exclude another 
possibility, in which GFAP+ cells are derived from different precursors that do not exist in 
the 13 dpc fetal livers. Circulating cells in blood flow may be a source of the alternative 
cellular origin (Baba et al., 2004). However, the majority of HpSTCs express GFAP in adult 
liver; therefore, the minor contribution of circulating cells from the blood is unlikely to 
 94
become a dominant population in the liver. Thus, it seems more likely that acquisition of 
GFAP expression happens during maturation of HpSTC.  
Fetal HpSTCs that were purified by FACS proliferated under a serum-free condition 
supplemented with EGF and LIF. With the support of STO feeders, fetal HpSTCs replicated 
continuously more than 2 months. The phenotypes of fresh and in vitro cultured fetal 
HpSTCs were similar, indicating the culture condition did not transform HpSTCs to 
myofibroblast cells, which commonly happen in serum-supplemented conditions. Until now, 
HpSTCs from adult livers have been cultured in medium supplemented with animal serum. 
HpSTCs cultured in the serum-supplemented medium give rise to myofibroblastic cells, 
which acquired fibroblastic characteristics and lose the original HpSTC phenotypes. 
Although the myofibroblastic cells can replicate and expand in culture, they eventually cease 
proliferation. Therefore, the serum-supplemented medium conditions are not appropriate for 
the culture of HpSTCs. Recently, LIM homeobox protein Lhx2 was identified as a negative 
regulator for myofibroblastic transformation of HsSCs (Wandzioch et al., 2004). In addition, 
Lhx2 was found as a molecule important for maintenance of hair follicle stem cells, in which 
the transcriptional factor maintains the undifferentiated status of the stem cells (Rhee et al., 
2006). Thus, Lhx2 might play a similar role to maintain a fetal stage of HpSTCs. The culture 
system developed in this study will facilitate to investigate molecular mechanisms of 
proliferation and differentiation of HpSTCs.  
An interesting question is whether fetal type HpSTCs are also evident in adult livers. 
Given the surface markers we have identified, it is possible to try to immunoselect these cells 
from adult livers and then further able to characterize them using the serum-free culture 
system developed and that was found to maintain the unique characteristics of fetal HpSTCs  
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ex vivo. Transplantation of fetal liver-derived HpSTCs or fetal type HpSTCs is a plausible 
cell therapy to study to try to alter some of the aberrations described for adult fibrogenic 
livers. In addition, the fetal HpSTCs are likely to express novel factors that may prove 
regulatory of hematopoiesis or hempoiesis and therefore offer new directions for novel 
therapeutic approaches for liver diseases.   
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TABLE 
Table 3.1. The frequency of hepatic colonies from sorted rat fetal liver cells. 
 
  
Inoculated 
cell 
number 
Hepatic 
colony 
number 
Colony 
efficiency 
(%) 
ns-autoflu+ RT1A- VCAM-1+ β3-integrin- § 250 (6) 77.0 ± 6.7 30.8 ± 2.7 
vA+ RT1A- VCAM-1+ β3-integrin+ ¶ 2500 (6) 3.3 ± 0.9 0.1 ± 0.0 
autoflu- RT1A- 2500 (6) 5.5 ± 0.2 0.2 ± 0.1 
VCAM-1- † 2500 (3) 0.0 ± 0.0 0.0 ± 0.0 
Gates for fractionation of ns-autoflu+ RT1A-, vA+ RT1A- and autoflu- RT1A- cells were 
created as shown in Figure 3 R3, R1, and R2, respectively.  
§: VCAM-1+ β3-integrin- cells from the Figure 3 R3 were sorted.  
¶: VCAM-1+ β3-integrin+ cells from the Figure 3 R1 were sorted. 
†: VCAM-1- cells from the Figure 3 R4 were sorted. 
Flow cytometrically sorted cells were cultured on STO feeders at indicated cell numbers per 
well in a 12-well plate. The hepatic colony number is the average per well. Colony efficiency 
is expressed as the percentage of cells inoculated in culture and that went on to form colonies 
after 15 days of culture. Values are mean ± SEM. Number of total wells inoculated sorted 
cells is enclosed in parentheses. 
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FIGURE LEGENDS 
Figure 3.1. Flow cytometric analysis for autofluorescent cells in 13 dpc rat fetal liver 
and lung 
(A) The pattern of forward scatter (FSC) and side scatter (SSC) of the entire 
population (ALL). Based on the value of SSC, R1 and R2 gates were created and represented 
high (SSChi) and low (SSClo) SSC, respectively. Expression patterns of RT1A and ICAM-1 
in the R1 and R2 are also shown. RT1A- ICAM-1+ SSChi cells (R2, lower right) are 
hepatoblasts in the rat fetal liver [10]. The number indicates percentage of each quadrant. (B) 
The autofluorescent pattern of entire population (ALL), R1, and R2 were analyzed with UV 
laser and 488 nm laser. UV laser specific autofluorescent signal was detected with a 450 nm 
filter, while non-specific autofluorescent signal excited with a 488 nm laser was measured 
with a 530/30 bandpass filter. UV laser-specific autofluorescent cells were detected in R1 
and R2 (upper left). (C) Expression of RT1A and UV laser specific autofluorescent signal 
was studied. UV laser-specific autofluorescent cells were RT1A-. ns-autoflu+ RT1A- cells 
(allow) were identified and were correspond to rat hepatoblast population.  (D) UV laser 
specific autofluorescent signal was analyzed in 13 dpc fetal lung cells. There are no UV 
specific autofluorescent cells in the lung cell population. Most of  the cells are RT1A-, and no 
non-specific autofluorescent cells (comparable to the hepatoblast population in the fetal liver) 
were detected.  
 
Figure 3.2. VCAM-1 and ICAM-1 expression on vA+ cells 
(A) Histogram of flow cytometry for VCAM-1 expression on 13 dpc fetal liver. 
Approximately 15% of the cells express VCAM-1 on the cell surface. Closed and open 
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histograms represent stained cells and unstained cells, respectively. VCAM-1+ and VCAM-1- 
cells were analyzed by flow cytometry for their autofluoresent signals. All vA+ cells and ns-
autoflu+ cells are VCAM-1 positive. The numbers represent the percentage of each quadrant. 
(B) Two color analysis of 13 dpc fetal liver cells for RT1A and ICAM-1. R1 cell population 
(RT1A- ICAM-1+) contains all vA+ cells and ns-autoflu+ cells. These results indicate that vA+ 
and ns-autoflu+ cells are VCAM-1+ RT1A- ICAM-1+. 
 
Figure 3.3. Antigenic profiles of vA+, ns-autoflu+, and autoflu- RT1A- cells in 13 dpc 
fetal liver 
(A) Flow cytometric analysis for UV-autofluorescence and RT1A expression. In the 
RT1A- cell population, three gates, vA+ RT1A- (R1), autoflu- RT1A- (R2) and ns-sutoflu+ 
RT1A- (R3) were created based on the autofluorescent signals. R4 gate covered remaining 
cells in the fetal liver, which were non-adherent cells. (B) Two color analysis of VCAM-1 
versus β3-integrin, PECAM-1, or Thy-1 expression for each gated cell population (R1-R4). 
The numbers represent the percentage of each quadrant. Primarily R1 cells are VCAM-1+ β3-
integrin+, while R3 cells uniformly express VCAM-1, but none of β3-integrin, PECAM-1, or 
Thy-1. 
 
Figure 3.4. Characterization of VCAM-1+ cells in fetal liver 
(A) Conforcal microscopy of a rat 14 dpc fetal liver section immunostained with anti-
VCAM-1 (green) and anti-β3-integrin (red) antibodies. Nuclear DNA was counterstained 
with DAPI (blue). Scale bar is 50 µm. (B) Immunocytochemistry of a bipotent hepatblast 
colony. ns-autoflu+ RT1A- VCAM-1+ β3-integrin-  cells were isolated by FACS and placed on 
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STO feeder cells in HDM at a clonal cell density (250 cells in a well of 12-well plate; 66 
cells/cm2). After 15 days in culture, the cells were fixed and stained with antibodies against 
albumin (red) and CK19 (green). Each colony was generated from a single sorted cell. More 
than 95% (95.7 ± 0.4 %; mean ± SEM, n = 3) of hepatic colonies contained albumin+ CK19- 
and albumin- CK19+ cells, which represent hepatocytic and biliary differentiation, 
respectively. Scale bar is 500 µm. (C) RT-PCR analysis of 14 dpc fetal liver cells 
fractionated by FACS. lane 1, ns-autoflu+ RT1A- VCAM-1+ β3-integrin-; lane 2, vA+ RT1A- 
VCAM-1+ β3-integrin+; lane 3, autoflu- RT1A- VCAM-1+; lane 4, autoflu- RT1A- VCAM-1-; 
lane 5, remaining VCAM-1- cell population; lane 6, no cDNA. vA+ RT1A- VCAM-1+ β3-
integrin+ cells (lane 2) express SDF-1α and HGF strongly. The vA+ cells are positive for 
HpSTC markers (desmin, nestin, vimentin, SMαA) and negative for hepatoblast markers 
(albumin and Prox1). 
 
Figure 3.5. In vitro culture of vA+ RT1A- VCAM-1+ β3-integrin+ cells isolated by FACS  
(A) Effect of LIF and EGF on in vitro proliferation of vA+ RT1A- VCAM-1+ β3-
integrin+ cells. Five hundred vA+ RT1A- VCAM-1+ β3-integrin+ cells isolated by FACS were 
placed in a well of 96-well plate with HDM plus laminin supplemented LIF and/or EGF at 
the concentration indicated. After 5 days-culture, degree of cell proliferation was measured 
by the tetrazolium salt WST-1. LIF support proliferation of the vA+ cells at as low as 0.1 
ng/ml.  EGF slightly improved the vA+ cell proliferation. (B) Effect of LIF and EGF on vA+ 
RT1A- VCAM-1+ β3-integrin+ cells cultured with STO feeders. Two hundred fifty vA+ 
RT1A- VCAM-1+ β3-integrin+ cells isolated by FACS were seeded on STO feeder cells in 
HDM with EGF and/or LIF. Twelve-well plates were used. The cultures were stained with 
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Diff-Quick™ after 2-week culture period. Although STO cells express LIF, the amount of 
the production was not adequate to support clonal expansion of the cells in the absence of 
exogenous LIF supplementation. Exogenous LIF and addition of EGF dramatically improved 
clonal expansion of the vA+ cells. (C) Immunocytochemistry of colonies derived from vA+ 
RT1A- VCAM-1+ β3-integrin+ cells isolated by FACS. Cells were placed on STO feeders in 
HDM supplemented with EGF and LIF. Fifteen days after in vitro culture, cultures were 
stained with antibodies for desmin or nestin. Colony forming cells express nestin and desmin, 
whereas STO cells do not express either. Scale bar is 200 µm. (D) Immunocytochemistry of 
2-month cultured vA+ RT1A- VCAM-1+ β3-integrin+ cells isolated by FACS. Sorted cells 
were placed on STO feeders in HDM supplemented with EGF and LIF. Proliferating cells 
were subcultured 5 times on fresh STO feeders. Cultured cells were stained with antibodies 
for desmin or nestin. Proliferating cells maintain the expression of nestin and desmin during 
the entire culture period. Scale bar is 200 µm. 
 
Figure 3.6.  Phenotypic characteristics of 2-month cultured vA+ RT1A- VCAM-1+ β3-
integrin+ cells  
(A) RT-PCR analysis of cultured vA+ RT1A- VCAM-1+ β3-integrin+ cells. Cells were 
isolated by FACS and cultured on STO feeders in the HDM with EGF and LIF. After 2-
month culture cells were fractionated by FACS. Proliferating rat cells and mouse STO feeder 
cells were fractionated by FACS following antibody staining of mouse CD98 monoclonal 
antibody. CD98 is expressed on mouse STO cells, and the monoclonal antibody reacts 
specifically mouse CD98, but not rat CD98. RNAs were isolated from vA+-derived rat cells 
and STO cells. Normal rat HpSTCs were also used and isolated the RNA for a control. 
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cDNAs were synthesized from those RNAs and subjected to PCR with primers specific for 
various transcripts that expressed in HpSTCs. (B) Flow cytometry for cultured vA+ RT1A- 
VCAM-1+ β3-integrin+ cells. Cells used for RT-PCR were stained with anti-VCAM-1 or anti-
RT1A antibody and mouse CD98 antibody. The CD98 negative fraction was analyzed for 
VCAM-1 or RT1A expression. Continuously proliferating cells derived from vA+ cells in rat 
fetal livers express VCAM-1 and RT1A uniformly under the culture condition examined. 
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CHAPTER IV 
HUMAN HEPATIC STEM CELLS FROM FETAL AND POSTNATAL DONORS 
(Refereed article in press in the Journal of Experimental Medicine, 2007) 
 
In order to understand paracrine signaling between hepatic mesenchymal and 
epithelial cells, identification and characterization of both cell types are critical. Several 
methods have been developed to purify the highly proliferative hepatic cells from fetal and 
adult mice. In animal models, only one pluripotent hepatic progenitor cell type, hepatoblasts, 
has been identified, and expresses both albumin and alpha-fetoprotein. It was long assumed 
that this was the only pluripotent progenitor in human livers also.  In these studies we show 
that there are two pluripotent progenitors, the hepatic stem cells and their immediate 
descendents, hepatoblasts, found in fetal livers and in all ages of postnatal livers. This 
chapter details the identification and comprehensive characterization of two bipotent hepatic 
progenitor cell types found within human fetal, neonatal, postnatal and adult livers: hepatic 
stem cells or HpSCs (EpCAM+, NCAM+, claudin 3+, CK19+, albumin±, P450 3A7-, AFP-) 
and hepatoblasts or HBs (EpCAM+, ICAM-1+, albumin+,  CK19+, AFP+, P450 3A7+). 
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ABSTRACT 
Human hepatic stem cells (hHpSCs), pluripotent precursors of hepatoblasts and 
thence of hepatocytic and biliary epithelia, are located in ductal plates in fetal livers and in 
canals of Hering in adult livers. They can be isolated by immunoselection for EpCAM+ cells 
and constitute ~ 0.5-2.5% of liver parenchyma of all donor ages. Self-renewal capacity of 
hHpSCs is indicated by phenotypic stability after expansion for more than 150 population 
doublings in a serum-free, defined medium and with a doubling time of ~36 hours.  Survival 
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and proliferation of hHpSCs require paracrine signaling by hepatic stellate cells and/or 
angioblasts that co-isolate with them. The hHpSCs are ~9 µm in diameter, express 
cytokeratins 8, 18 and 19, CD133/1, telomerase, CD44H, claudin 3, and albumin (weakly). 
They are negative for α-fetoprotein, ICAM-1, and for markers of adult liver cells (e.g. 
cytochrome P450s), hemopoietic cells (e.g. CD45), and mesenchymal cells (e.g. VEGFr, 
desmin). If transferred to STO feeders, hHpSCs give rise to hepatoblasts, recognizable by 
cord-like colony morphology and up-regulation of α-fetoprotein, P450A7 and ICAM-1.  
Transplantation of freshly isolated EpCAM+ cells or of hHpSCs expanded in culture into 
NOD/SCID mice results in mature liver tissue expressing human-specific proteins.  The 
hHpSCs are candidates for liver cell therapies. 
 
INTRODUCTION 
The role of hepatic stem cells (hHpSCs), particularly in the maintenance and 
regeneration of the adult liver, has been a subject of debate without clear consensus 
(Michalopoulos and DeFrances, 1997; Thorgeirsson et al., 2004; Alison et al., 2004; 
Schmelzer et al., 2006; Oh et al., 2002). During embryonic development, endodermal cells in 
the mid-region of the embryo bulge into the cardiac mesenchyme, are affected by critical 
signaling from endothelia forming vasculature, and form the liver bud (Lemaigre and Zaret, 
2004; Matsumoto et al., 2001). The cells within the liver bud are recognized as hepatoblasts 
due to expression of a signature marker, α-fetoprotein (AFP) and are bipotent giving rise to  
hepatocytes and bile duct epithelial cells, cholangiocytes (Saxena and Theise, 2004). We and 
others have described the isolation and expansion in culture of AFP+ cells from fetal and 
adult livers of several species (Kubota and Reid, 2000; Tanimizu et al., 2003; Haruna et al., 
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1996). Clonogenic expansion assays of rodent hepatoblasts under wholly defined conditions 
have demonstrated that hepatoblasts are capable of extensive expansion ex vivo as well as 
differentiation to both hepatocytic and biliary lineages (Kubota and Reid, 2000). The findings 
from investigations of liver organogenesis as well as the ex vivo studies of hepatoblasts have 
led to a long-standing assumption that hHpSCs correspond to hepatoblasts, and that hHpSCs 
would express AFP. However, AFP+ cells are rare in normal adult livers (<0.01%) except in 
livers with severe injury or disease (Saxena and Theise, 2004; Kubota et al., 2002; Abelev, 
1971). In addition, the renowned replicative capacity of hepatocytes in vivo (Overturf et al., 
1999) has led to the opinion that adult livers do not have hHpScs and that all regenerative 
responses are from mature parenchymal cells except in certain disease states (Michalopoulos 
and DeFrances, 1997).   
Here we define a novel class of AFP-negative cells in fetal and adult human livers, 
that are precursors to hepatoblasts, and have properties consistent with hHpSCs. The hHpSCs 
are negative for AFP but positive for epithelial cell adhesion molecule, EpCAM (CD326, 
C017-1A antigen, GA733-2).  This protein, encoded by the tumor –associated calcium signal 
transducer 1 gene, is expressed by many carcinomas and serves a regulatory function in 
certain normal epithelia, including all of those derived from endoderm (e.g. liver, lung, 
pancreas, intestine) (Balzar et al., 1999; Balzar et al., 1998). By immunohistochemistry, 
deBoer and colleagues observed that hepatoblasts in embryonic human liver are EpCAM+, 
whereas mature hepatocytes are EpCAM- (Balzar et al., 1999). In adult livers, most (but not 
all) bile duct epithelia are EpCAM+. Also, expanded ductular structures, seen in cases of 
focal nodular hyperplasia or biliary cirrhosis, contain numerous EpCAM+ cells (Balzar et al., 
1999).   
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We have reported previously that EpCAM+, AFP-negative cells from human livers 
are hHpSCs and have compared their pattern of gene expression with that of hepatoblasts and 
mature liver parenchyma (Schmelzer et al., 2006). We now show that the hHpSCs are located 
in ductal plates in fetal and neonatal livers and in the proximal branches of the intrahepatic 
biliary tree, the Canals of Hering, in pediatric and adult livers of all donor ages, with the 
frequency of hHpSCs remaining relatively constant throughout life. We further document the 
immunoselection of these cells using monoclonal antibodies to EpCAM and test whether 
they meet the defining criteria for stem cells, namely, self-renewal and pluripotency.  
 
RESULTS 
In Vivo Localization of EpCAM+  Hepatic Stem Cells (hHpSCs) 
 Sections of fetal and adult livers were stained for EpCAM and for liver-specific 
markers (albumin, AFP, and CK19) (Figure 4.1). We found that ductal plates, a band of 
tissue encircling each of the portal triads in fetal and neonatal livers, have small cells (7-10 
µm) with a paucity of cytoplasm, and stained intensely both cytoplasmically and at the 
surface for CK19, EpCAM, and weakly for albumin but are negative for AFP. In non-
diseased, postnatal (pediatric and adult) livers, cells staining positively for EpCAM by 
immunohistochemistry appear exclusively in the canals of Hering in the vicinity of the portal 
triads of acini. Theise and colleagues (Theise et al, 1999) reported that cells lining these 
ductules express cytokeratin (CK) 19, present in biliary epithelia but not hepatocytes. Our 
data confirm their report and demonstrate that the CK19+ cells within the canals of Hering 
express EpCAM and that subpopulations of them also express albumin (Figure 4.1; yellow 
color is due to overlap of CK19 and albumin expression). The co-expression of CK19 and 
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albumin is consistent with hHpSCs and corroborates the hypothesis of others that the Canals 
of Hering comprise a niche for hHpSCs (Theise et al, 1999). Below are data from ex vivo 
studies of EpCAM+ cells supportive of the interpretation that they include hHpSCs.  
Most parenchymal cells of fetal and neonatal livers consisted of hepatoblasts, slightly 
larger cells (10-12 µm in diameter) that stained positively for albumin, AFP, and CK19. In 
hepatoblasts the distribution of CK19 is more particulate and less intense than that in ductal 
plate cells. EpCAM expression in AFP+ cells, both in fetal and postnatal livers, occurred at 
the membrane only. In pediatric and adult livers, hepatoblasts were found as individual cells 
or small clusters of cells tethered to the ends of the canals of Hering (Figure 4.1). The 
hepatoblasts in non-diseased, postnatal livers constitute fewer than 0.01% of cells and 
express AFP weakly. 
 
Flow Cytometry of EpCAM+ Cells 
 By flow cytometry we observed EpCAM+ cells in human liver cell suspensions of all 
donor ages (Figure 4.2A). Suspensions from fetal livers from which hemopoietic cells had 
been purged contained, on average, 12% EpCAM+ cells. However, the percentage could be 
as high as 20% depending on the gestational age of the fetus. Most of the EpCAM- cells in 
fetal livers were of non-hepatic lineage and were predominantly hemopoietic. The vast 
majority (>90%) of the EpCAM+ cells in fetal livers co-express AFP, albumin (ALB), and 
CK19 (Figure 4.2). They could be subdivided into two subpopulations: 1) Hepatoblasts 
showed expression of ICAM-1, AFP, ALB, CK19, CD133/1, P450A7 and CD44H 
(hyaluronan receptor);  2) hHpSCs, constituting ~5% of EpCAM+ cells from fetal livers, had 
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an overlapping but distinct profile: they were positive for ALB (weak), CK19, CD44H, 
CD133/1, NCAM, and claudin 3, but negative for AFP and for P450A7.   
Cell suspensions from adult human livers averaged 1.3% EpCAM+ cells, and those 
from neonatal and pediatric donors two to three-fold higher. Preparations having EpCAM+ 
cell populations at levels above 1.5% were obtained typically from livers subjected to 
ischemia (cold or warm) prior to organ procurement and/or during transportation. This 
suggests that the EpCAM+ liver cells are more resistant to ischemia than mature liver cells.  
The postnatal EpCAM+ liver cells also co-express CK19 and ALB (data not shown) but have 
no detectable AFP+ cells (by flow cytometry), except in rare cases of overt hepatic disease 
(e.g. cirrhosis; data not shown). Neonatal livers, including some from premature births, 
showed rapidly decreasing levels of AFP+ cells as a function of age, falling below detection 
level by a few months after birth. Based on considerations detailed below and from our 
previously published work (Schmelzer et al., 2006), we identify the EpCAM+ cells from 
pediatric and adult livers as almost exclusively hHpSCs, not hepatoblasts.  
 
Culture Selection on Plastic and in Serum-free KM isolates hHpSCs but not Hepatoblasts 
 Suspensions of liver cells plated in Kubota’s Medium (KM), a serum-free medium 
optimized for ex vivo expansion of hepatic progenitors (Kubota and Reid, 2000), either on 
tissue culture plastic or on embryonic stromal cell feeders, yielded parenchymal cell colonies 
with two distinct morphologies. Type I colonies consisted of cells forming a cord-like 
morphology interspersed with clear channels and expressing EpCAM, albumin, CK19, 
ICAM, and AFP but not NCAM (Figures 4.9-12). Type 2 colonies consisted of densely 
packed, morphologically uniform cells, strongly expressing EpCAM, NCAM, CD44H, 
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claudin 3, weakly expressing or negative for ALB, and negative for AFP and ICAM-1 
(Figures 4.3 and 4.11). We interpret the type I colonies as corresponding to hepatoblasts and 
the type 2 colonies as corresponding to hHpSCs (Table 4.1).  
 In cultures on plastic, by 5-7 days (mean 5.2 ± 1.6; maximum of days), the 
hepatoblast colonies disappeared.  However, if cultured on STO feeders, hepatoblasts 
survived for up to two months, continuing to show co-expression of ALB, AFP and CK19 
(Figures 4.9 and 4.10). The hepatoblast colonies typically contained fewer than ~100 cells.   
 By contrast to hepatoblasts, hHpSC colonies on plastic continued to expand. A time 
lapse sequence of a growing hHpSC colony is shown in Figure 4.3A-E in which the 
expansion of hHpScs seeded at very low density is shown on day 1, day 3 and day 8. The 
hHpSCs can be subcultured after mechanical disaggregation and continue to multiply 
extensively. Their doubling time on plastic is ~36 hours. That doubling time decreased to less 
than 24 hours if they are plated on specific extracellular matrix substrata (McClelland et al., 
submitted). By 2-3 weeks, hHpSC colonies typically contained many thousands of cells.   
 The hHpSC colonies were assessed for expression of lineage markers by 
immunofluorescent staining. The expression pattern closely resembled that of ductal plate 
cells in vivo. They were positive for CK19, NCAM, EpCAM, and CD44H (Figure 3F-L). In 
addition, they were positive for ALB (weak), E-Cadherin, N-Cadherin, CK8 and 18, 
CD133/1, integrin β-1 (CD29), claudin 3, and telomerase (data not shown). They were 
negative for AFP, any form of cytochrome P450, hemopoietic markers (CD34, CD45, CD38, 
CD14, CD90, and glycophorin A), endothelial cell markers (VEGFr, von Willebrand factor, 
and PECAM or CD31), and mesenchymal markers such as those for hepatic stellate cells 
(CD146, desmin, and α-smooth muscle actin). The expression of NCAM by the hHpSCs is 
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significant, since previous studies have shown that this marker is present on the ductal plate 
in fetal livers and evident on liver cell populations proliferating under various disease states 
(Libbrecht et al., 2001; Roskams et al., 1998; Fujimoto et al., 2001; Van Den Heuvel et al., 
2001).  
 
Immunoselection using EpCAM Isolates Hepatoblasts from Fetal and Neonatal Livers; 
Immunoselection Using EpCAM or NCAM Isolates hHpSCs from Livers of All Donor 
Ages 
 To enrich for hepatic progenitors from liver cell suspensions, we explored a number 
of fractionation strategies, including separation by buoyant density on Ficoll gradients (Table 
4.3) and by immunoselection. The most satisfactory results were obtained using magnetic 
immunoselection. While fluorescence activated cell sorting (FACS) was able to yield highly 
purified cellular subpopulations, the shear forces and the use of buffers (e.g. phosphate 
buffered saline) that are not optimal resulted in low yields of viable cells. We used magnetic 
microspheres conjugated with monoclonal antibody to EpCAM (Miltenyi Biotec, Auburn, 
CA) to immunoselect EpCAM+ cells from liver cell suspensions and obtained robust, highly 
viable sorted cells that survived and expanded well when cultured (Figures 4.4 and 4.9-12, 
Table 4.4). From postnatal livers up to 10 billion viable cells were processed in a single pass 
using the CliniMACS apparatus (Miltenyi Biotec) and yielded over 100 million EpCAM+ 
cells. Purity of the enriched EpCAM+ cells was typically 75 to 90% and recovery usually 
exceeded 90%. Representative fractionations of a fetal liver and of a postnatal liver are 
depicted in Figure 4. A cell suspension from the liver of a two year-old donor was found to 
contain 0.7% EpCAM+ cells. The immunoselected population contained 81% EpCAM+ cells, 
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while the flow-through fraction was almost entirely depleted of EpCAM+ cells.  The majority 
of hepatic EpCAM+ cells were of 8-10 µm diameter, as judged by Coulter Counter analysis, 
in contrast to 18-20 µm for diploid hepatocytes, the predominant population in the initial 
liver cell suspension. A small peak of presumptive tetraploid cells also is evident, measuring 
~25 µm in diameter. Light scatter (“Side Scatter”) profiles indicate that the EpCAM+ liver 
cells are considerably smaller and less granular than the bulk of the parenchymal cell 
population.  
 Magnetic immunoselection for NCAM+ cells from fetal livers enriched for cells 
capable of forming only hHpSC colonies (Figure 4.4). The majority of EpCAM+ cells from 
fetal liver co-expressed NCAM, whereas only ~40% of those from adult liver were also 
NCAM+. Therefore, sorting for NCAM+ cells proved useful for isolation of hHpSCs from 
fetal livers but less so from adult livers. It is unknown at this time whether NCAM and 
EpCAM co-expression is a definitive property of hHpSCs. An alternative hypothesis, now 
being tested, is that NCAM is present on angioblasts or other mesenchymal companion cells 
tightly bound to the hHpSCs such that immunoselection for it results in co-selection of the 
two cell types (see below for more on this theme). Sorts for KDR (VEGFR2) resulted mostly 
in angioblasts (Figure 4.4). However, these sorts also yielded an increase in hHpSC colonies 
due, we assume, to co-selection of hHpSCs and angioblasts.   
 
Proteins and Genes Expressed by EpCAM+ Cells 
 Immunoselected EpCAM+ cells from fetal and postnatal livers were examined by 
flow cytometry for expression of lineage markers characteristic of various cell types that 
reside in the liver (Figures 4.2 and 4.4). As judged by double label flow cytometry, about 
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95% of the immunoselected EpCAM+ cells expressed CK19, and comparable percentages 
expressed ALB and CD133. Evaluations of many preparations indicated that over 90% of the 
EpCAM+ cells are positive for CD133, detected with monoclonal antibodies to two distinct 
epitopes (CD133-1 with monoclonal antibody AC133; CD133-2 with monoclonal antibody 
AC141). Virtually all CD133-1+ cells in adult liver cell suspensions were found in the 
EpCAM+ selected fraction, and mature hepatocytes were clearly negative. However, it 
appeared that ~40% of liver cells with light scatter profiles consistent with mature 
hepatocytes were positive for CD133-2. Examination by immunofluorescent microscopy 
showed that staining for CD133-1 clearly outlines cell membranes, whereas that for CD133-2 
shows a more diffuse pattern (data not shown). It is likely that the staining of many more 
liver cells by CD133-2 results from a known cross-reactivity with CK18 (Potgens et al., 2002) 
which is expressed by hepatocytes and reportedly can be found on the cell surface (Wells et 
al., 1997).  Based on the more specific CD133-1 antibody, we conclude that EpCAM and 
CD133 (prominin) are co-expressed by the vast majority of hHpSCs.  
 Neural cell adhesion molecule, NCAM (CD56), shown previously to be expressed by 
glia, muscle cells and by neurons (Goridis and Brunet, 1992), was found on the majority of 
hHpSCs derived from fetal and neonatal livers, but only ~40% of the EpCAM+ cells from 
adult livers.  In our prior studies NCAM mRNA was enriched strongly in EpCAM+ cells 
from both fetal and postnatal livers, but expression at the protein level was variable 
(Schmelzer et al., 2006).  NCAM staining was most evident at the borders of the hHpSC 
colonies (Figure 4.3).   
 Less than 1% of the enriched EpCAM+ cells stained for the hemopoietic marker 
CD45 (leucocyte common antigen), which is found on Kupffer cells (tissue macrophages) 
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and lymphocytes in the liver. The EpCAM+ cells were negative for expression of other 
hemopoietic markers assayed (CD34, CD14, CD38, CD4, CD90, and glycophorin A), for 
endothelial cell markers (CD34, VEGFR2 or KDR, von Willebrand factor, and CD31), and 
for mesenchymal markers, especially those associated with hepatic stellate cells (CD146, 
also called Mel-CAM, desmin, α-smooth muscle actin) (data not shown). Finally, we found 
AFP expression at RNA and protein levels in EpCAM+ cells from fetal and neonatal livers, 
but not from pediatric or adult livers. As noted above, small numbers of cells weakly positive 
for AFP, as judged by immunohistochemistry, were observed tethered to the ends of the 
canals of Hering in sections from pediatric and adult livers (Figure 4.1E). From our 
experience, these cells are too few and express AFP too weakly to permit recognition as a 
defined subpopulation by flow cytometry.  
Assessment by RT-PCR of RNA expression in the EpCAM+ liver cells (Figure 4.2) 
gave results consistent with the flow cytometry data.  Further details of these findings are 
reported elsewhere (Schmelzer et al., 2006). In brief, EpCAM+ selection from fetal livers 
more than doubled the expression levels of albumin, AFP and CK19. Immunoselection for 
EpCAM+ cells from postnatal livers strongly enriched for transcripts encoding EpCAM, 
CK19, CD133 and CD117 (c-Kit); these transcripts were barely detectable in the EpCAM-
negative cells. AFP transcripts were not detectable in EpCAM+ or EpCAM-negative cells 
from postnatal livers.   
Although immunoselected cells are enriched for relative expression of CD117 mRNA, 
we have not observed the corresponding protein by immunostaining of freshly isolated cells 
from fetal or postnatal livers nor on cultured cells from postnatal livers. However, we 
occasionally have observed low levels of CD117 staining on cells at the periphery of hHpSC 
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colonies from fetal livers, located in regions where hHpSCs overlap with mesenchymal 
companion cells. 
Cytochrome P450 3A4 (CYP3A4), a protein expressed by mature hepatocytes, was 
not found at all in parenchymal cells, either EpCAM+ or EpCAM-, from fetal livers in terms 
of both mRNA and protein level of it. The level of mRNA for cytochrome P450 in EpCAM+ 
cells was twenty-fold lower relative to EpCAM-negative cells from postnatal livers. The 
small amount of CYP3A4 RNA in the EpCAM+ cell fraction from postnatal livers could be 
accounted for by residual hepatocyte contaminants. By contrast, the hepatoblasts, but not the 
hHpSCs, were found to express P450A7, a protein found in fetal livers (data not shown). 
EpCAM+ cells from postnatal livers also showed eight-fold lower relative expression of 
albumin RNA than the flow-through (EpCAM-negative) population. Again, some transcripts 
can be attributed to incomplete removal of hepatocytes. However, the detection of albumin 
protein in EpCAM+ cells by flow cytometry, taken together with the transcript data, 
demonstrates that these progenitor cells express the albumin gene, albeit at a significantly 
lower level than differentiated hepatocytes. 
Assays for telomerase activity indicate significant levels in freshly isolated EpCAM+ 
cells from livers of all donor ages and in cultures of colonies of both hHpSCs and 
hepatoblasts. Full characterization of telomerase activity and its regulation in various 
fractions of human liver cells from fetal and postnatal donors is presented elsewhere 
(Schmelzer E and Reid L, submitted) as are studies on the effects of purified matrix substrata 
on telomerase activity in cultures of hHpSCs (McClelland et al, submitted).  
 
Ex Vivo Clonogenic Expansion—Evidence for Self Renewal 
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Colony formation by committed hepatic progenitors or diploid adult parenchyma 
involves a limited number of divisions (typically 5-7 divisions) over a relatively short period 
of time (e.g.  2 to 3 weeks)  (Kubota and Reid, 2000). By contrast, self-renewal involves 
clonogenic expansion that can go on for more than 100 population doublings with phenotypic 
stability, properties associated with stem cells. We found previously that rat hepatoblasts 
multiply far more extensively in KM with STO feeder cells than on tissue culture plastic 
(Kubota and Reid, 2000). However, STO feeders and KM were not permissive for 
clonogenic expansion of human hepatoblasts. Under these conditions the hepatoblasts 
survived for a few months but demonstrated limited growth. By contrast, hHpSCs from livers 
of all donor ages could undergo clonogenic expansion for more than 6 months (>150 
population doublings) in culture on tissue culture plastic and in KM with only the native 
feeders (the companion cells) (Table 4.2). The cells maintained phenotypic stability as 
assessed by morphology and by antigenic and biochemical profiles (Tables 4.1 and 4.2). 
hHpSC colonies starting from 1-3 cells grew to cover 4.9+0.3 mm2 in area and contained an 
average of 1400 + 520 cells (three independent counts of total cells from 50 dispersed 
colonies). Thus, the cells in this representative experiment had gone through 10-11 
population doublings in 2 weeks corresponding to an average doubling time of 31-34 hours 
(Figure 4.3, Table 4.2). 
 
Mesenchymal Companion Cells Provide Critical Paracrine Signaling for hHpSCs  
The tightly packed colonies of hHpSCs have a prominent ridge at the perimeter 
(Figures 4.3, 4.4 and 4.6) at which we have identified mesenchymal companion cells (Figure 
4.5).  As the colonies grow, the companion cells penetrate the colonies and become found 
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throughout them. When removed from a culture dish, the attachment to the plastic surface is 
evident only at the edge of the colonies, not in the center. This suggests that attachment to the 
plastic is mediated either by mesenchymal cells or by cooperative interactions between the 
hHpSCs and the mesenchymal cells.  
Phenotypic analyses of the companion cells indicates at least two distinct populations: 
angioblasts (KDR+, CD133/1+, CD117+, von Willebrand factor+, CD31weak); and hepatic 
stellate cells (desmin+, α-smooth muscle actin+, CD146+) (Figure 4.5). A comparison of their 
morphological and antigenic phenotypes is given in Figure 5. Cells rigorously purified away 
from the companion cells (e.g. by repeated immunoselection for EpCAM+ cells) did not 
survive on culture plastic but only on STO feeders (data not shown). Immunoselection of 
CD117+ cells yielded angioblasts but neither hepatic stellate cells nor hHpSCs (data not 
shown). Immunoselection for other markers found on the companion cells (e.g. VEGFr) 
resulted mostly in selection of the companion cells alone, though we did find co-selection for 
hHpSCs to occur at low and variable frequency (Figure 4.4). We still cannot rule out that the 
consistent enrichment of hHpSCs from fetal liver by immunoselection for NCAM could 
actually result from co-selection of the stem cells via tight association with NCAM+ 
companion cells.  
 
Proof of Pluripotency of hHpSCs 
Passaging (transfer) of colonies of hHpSCs (whether derived from fetal or adult livers) 
from culture plastic onto feeder layers of STO cells resulted within hours in eruption of 
hepatoblasts from the periphery of hHpSC colonies (Figure.6 and 4.7; Table 4.1).  After the 
transfer, the morphology and antigenic profile of the cells within the hHpSC colonies proper 
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did not change in most of the cells, though there were occasional cells with distinct gene 
expression within the colony (Figure7). Rather the colonies of hHpSCs gave rise to cord-like 
eruptions from their edges, yielding cells with morphology, antigenic and biochemical 
profiles identical to that of hepatoblasts. The cells in these erupted areas strongly expressed 
AFP, ICAM-1, ALB, and were positive for cytochrome P450-A7 (data not shown), but were 
negative for NCAM (Figure7). In addition, committed progenitors biliary progenitors were 
sometimes observed erupting from a colony of hHpSCs, as shown by staining for CK19 but 
not albumin (Figure7).   
In cultures of cells from postnatal livers, in colonies stained by double label 
immunofluorescence for CK19 and ALB, we have observed distinct sectors positive for one 
or the other marker but not both (Figure12). This was found most frequently in colonies of 
hepatoblast morphology. We interpret such sectors as deriving from unipotent cells, 
corresponding to committed progenitors for biliary and hepatocytic lineages, respectively. 
The sectoring could occur if at division a bipotent cell gives rise to a daughter cell restricted 
to the biliary or to the hepatocytic lineage. Occasional small colonies showed expression of 
only one of the lineage markers (CK19 or albumin) and are assumed to have arisen from 
committed progenitors for the corresponding cell type.  
  
EpCAM+ Cells and Colonies of hHpSCs Give Rise to Human Liver Tissue in vivo 
 Transplantation of freshly isolated EpCAM+ cells or of hHpSC colonies, from either 
fetal or postnatal livers, into livers of NOD/SCID mice resulted in engraftment and the 
formation of human liver tissue (Figure8). Islands of cells staining positive for human ALB, 
CK19 and AFP were found within 2 days of transplantation (Figure 8A, C, and E) and 
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persisted within the livers for  weeks (Figure 4.8F). The extent of engraftment and expansion 
of human liver cells in vivo was enhanced by treatment of the mice with carbon tetrachloride, 
CCl4, a poison for the pericentral zone of the liver acinus, often used to create a cellular 
vacuum in transplanted hosts (Figure 4.8B, D and G). Human-specific DNA sequences were 
found in the liver of animals that received the human cell transplants, but not in other tissues, 
nor in control animals that did not receive human cells (data not shown). Prior to 
transplantation, as expected, the cells were shown to express EpCAM and CK19 strongly and 
ALB weakly, but were negative for AFP at both RNA and protein levels. The liver sections 
from mice transplanted with hHpSCs contained cells strongly expressing human-specific 
forms of ALB, CK19, and AFP but were negative for EpCAM. However, human cytochrome 
P450 3A was not detectable. Therefore, it appears that after transplantation and expansion in 
recipient livers, the human cells lost expression of a marker (EpCAM) found only on stem 
and progenitor cells, and, acquired some, but not yet all, of the functions specific to mature 
hepatocytes. We think it logical that transferrin is expressed by not yet P450 3A in 
transplanted cells given that in mature liver,  transferrin is expressed by zone 2 parenchymal 
cells, whereas P450 3A by zone 3 parenchymal cells within the acinus. Thus, P450 3A is a 
late gene produced by cells at the end of the liver’s maturational lineage.  
As an independent test of engraftment, we assessed expression of the human 
transferrin gene, encoding a protein characteristic of mature hepatocytes.  We found by 
quantitative RT-PCR analysis with human-specific primers that the livers of mice sampled 
one week after injection of the EpCAM+ cells derived from postnatal human livers contained 
significant levels (2100 ± 1140 strands per 100 ng) of human transferrin RNA. Such 
sequences were undetectable in RNA from livers of control mice (<100 strands per 100 ng 
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RNA). Although prior to transplantation over 80% of cells in the test cell population 
expressed EpCAM and CK19, cells in recipient animals were positive for human ALB and 
were negative for both of the progenitor cell markers. Taken together, the data suggest that 
within seven days in vivo, the engrafted hHpSCs gave rise to mature human liver cells. 
 
DISCUSSION 
Cells in the ductal plates in fetal and neonatal livers and in the Canals of Hering in 
pediatric and adult livers are hHpSCs. They can be isolated efficiently by selective culture 
conditions and by immunoselection for EpCAM (CD326) and/or NCAM (CD56).  The 
hHpSCs have features typical of stem cells including Sonic and Indian Hedgehog signaling 
(Sicklick et al., 2005) and high telomerase activity (Schmelzer and Reid, submitted). They 
are capable of self-renewal, as shown by clonogenic expansion for over 150 population 
doublings, and are pluripotent, with the ability to give rise directly to committed biliary 
progenitors and to hepatoblasts and thence to hepatocytic and biliary lineages, as well as to 
other endodermal cell types (our unpublished data). The hHpSCs express certain markers of 
both hepatocytic and the biliary lineages but lack expression of mature liver functions 
(Schmelzer et al., 2006). They yield human liver tissue when transplanted intrahepatically in 
immune deficient mice. Hepatoblasts, expressing AFP, ALB and CK19, and emerging in 
newly forming liver tissue, have long been considered hepatic stem cells (Fausto et al., 1993). 
However, AFP-negative hHpSCs are actually precursors to hepatoblasts.  
Recognition of the ductal plate as the liver’s stem cell niche provides a new insight 
into organogenesis. The specification of foregut cells to hepatic fate is associated with 
expansion of endoderm into the surrounding cardiac mesenchyme, a process leading to ductal 
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plate formation (Sicklick et al., 2005). Our data suggests that ductal plates are directly 
antecedent to the Canals of Hering, which have been identified as the reservoir of stem cells 
in postnatal livers (Theise et al, 1999; Roskams et al., 2004).  
The liver at all ages displays a remarkable capacity to regenerate after physical or 
toxic injury (Michalopoulos and DeFrances, 1997). Two forms of regenerative response are 
known. The first is a hypertrophic cellular response by mature hepatocytes that undergo 
DNA synthesis with minimal cytokinesis, the predominant mechanism of regeneration after 
partial hepatectomy in postnatal livers (Forbes et al., 2002; Sigal et al., 1999). The other is a 
hyperplastic response by both progenitor cells and diploid hepatocytes following significant 
loss of liver cells in zones 2 and 3, as detailed in a number of review articles (Thorgeirsson et 
al., 2004; Grisham and Thorgeirsson, 1997; Thorgeirsson and Grisham, 2003). Contributions 
of progenitors to regeneration after partial hepatectomy have been presumed negligible based 
on assumptions that they should be AFP+ (Michalopoulos and DeFrances, 1997). Since 
hHpSCs are AFP-, their role in liver regeneration in adults requires re-evaluation by tracking 
the involvement of EpCAM+ and NCAM+ cells. The frequency of EpCAM+ cells in 
suspensions prepared from postnatal human livers is consistent at all ages beyond a few 
months, in the range of 0.5 to 2.5%. We infer that a substantial pool of hHpSCs is maintained 
throughout life. The number of hHpSCs is much higher than estimates based on the 
frequency of AFP+ cells (<0.01%).  Some authors have argued that the mature liver contains 
only “facultative” stem cells, activated in response to pathological states and injuries that 
invoke a hyperplastic response (Alison et al., 1996; Alison et al., 2004; Theise et al, 1999; 
Thorgeirsson and Grisham, 2003).  We have previously raised the alternative hypothesis that 
hHpSCs function routinely to replenish the liver as mature cells are lost slowly through 
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terminal differentiation (Schmelzer et al., 2006; Sigal et al., 1992; Sigal et al., 1999). The 
presence of a much larger pool of hHpSCs than previously suspected in normal adult livers 
provides a further rationale to examine this possibility more carefully. 
During development a limited number of hHpSCs are associated with developing 
portal tracts and steadily give rise to hepatoblasts that we hypothesize are the liver’s transit 
amplifying cells. The hepatoblasts, in turn, are precursors to committed hepatocytic and 
biliary progenitors. Further evidence for hepatoblasts in normal adult livers is given 
elsewhere (Zhang et al., submitted). In the findings reported here, we show the generation of 
hepatoblasts and unipotent progenitors from hHpSC colonies in culture. This occurs 
spontaneously from discrete regions at the periphery of hHpSC colonies and may correspond 
to a localized signal that triggers a rapid burst of expansion from one or more cells. As noted 
below, cell-cell interactions are keys to both maintenance and differentiation of hHpSCs. 
STO feeder cells promote differentiation of hHpSCs, whereas they contribute primarily to 
survival and expansion of rodent hepatoblasts, and may offer a tool to identify some of the 
differentiation-promoting signals for hHsPCs. 
 
Functions of Cell Surface Markers of hHpSCs 
Characteristic cell surface antigens of hHpSCs and hepatoblasts overlap extensively, 
with both populations expressing EpCAM, E-Cadherin, integrin β-1 (CD29), and CD133.  
The hHpSCs and hepatoblasts are negative for markers of hematopoietic (CD34, CD45, 
CD38, CD14, CD90, glycophorin A), endothelial (VEGFRr, von Willebrand factor, CD31) 
and mesenchymal (CD146, desmin, and α-smooth muscle actin) cell lineages.   
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EpCAM is present on proliferating epithelial cells in most, if not all, organs derived 
from endoderm (e.g. liver, lung, pancreas, intestine). The extracellular domain of EpCAM is 
thought to generate a relatively weak homotypic bond between adjacent cells (Balzar et al., 
1999). Conversely, the cytosolic domain of EpCAM is believed to diminish the effectiveness 
of E-cadherin binding through impairment of the interaction between beta-catenin and the 
actin cytoskeleton (Balzar et al., 1998). This role may be physiologically relevant for 
hHpSCs and hepatoblasts, as E-cadherin was expressed with the same distribution as 
EpCAM.   
The role of NCAM in the biology of hHpSCs requires further elucidation.  We found 
that the hHpSCs from fetal and neonatal liver consistently show strong NCAM expression 
and that immunoselection for NCAM enriches for hHpSCs. However, only ~40% of hHpSCs 
from adult livers are positive for this antigen.  In cultures of hHpSCs, NCAM expression is 
observed in a characteristic scalloped pattern located most prominently at the borders of the 
colonies. Thus far we have not been able to ascertain unequivocally whether NCAM is 
expressed by hHpSCs, by tightly associated mesenchymal companion cells, or both. 
Ultrastructural studies by electron microscopy are needed to resolve this point. NCAM is a 
member of the Ig superfamily, with more than 20 alternatively spliced mRNAs encoding 
multiple protein isoforms (Fujimoto et al., 2001; Cunningham et al., 1987). It is the only 
sialated cell adhesion molecule and forms homotypic cell/cell attachments that are inversely 
proportional to the degree of sialation; an increase in sialation results in muted cell-cell 
adhesion and consequent increase in migration and invasion (Fujimoto et al., 2001). Several 
groups have reported that NCAM is expressed by ductal plate cells within the fetal liver and, 
interestingly, also by proliferative ductular cells that characterize pathologies collectively 
 129
termed ductal plate malformations, such as primary biliary atresia (Libbrecht et al., 2001; 
Fabris et al., 2000; Van Den Heuvel et al., 2001; Neubauer et al., 1996; Anatskaya et al., 
1994). Thus, positive staining for NCAM, in addition to ALB, CK19 and CK8/18, supports 
the interpretation of these cells as ones derived from the ductal plate.   
We found consistent expression of CD133 (prominin-1) by hHpSCs cultured on both 
plastic and on STO substrata, and by >90% of EpCAM  cells immunoselected from adult 
livers. Although angioblasts also are CD133 , the staining in hHpSC colonies was associated 
with most or all cells, indicating that CD133 is expressed by the hHpSCs and not only by 
companion cells. This pentaspan transmembrane glycoprotein was first identified on 
hematopoietic stem cells, and its expression also has been observed on stem/progenitor cells 
of a variety of lineages, including endothelia, muscle, neural, prostatic, epidermal, and others 
(
+
+
Jiang et al., 2002; Bhatia, 2001). The role, if any, of CD133 in the self-renewal and 
differentiative capacity of hHpSCs is not yet understood.  However, it may be significant that 
an isoform of CD133 specifically associated with stem cells was found in cells of the basal 
layer of human neonatal epidermis, and co-expressed there with integrin β-1, which also is 
expressed by hHpSCs and hepatoblasts.  Furthermore, CD133 expression was lost as the 
epidermal cells stopped proliferating and acquired a differentiated phenotype in culture (Yu 
et al., 2002).   
 
Association of Mesenchymal “Companion” Cells with hHpSCs 
The specific association of multiple adhesion molecules with hHpSCs and 
hepatoblasts suggests that they play important regulatory functions in modulating interactions 
with cells that comprise local inductive environments and/or stem cell niches.  A critical, 
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enabling event, required for formation of the liver, is that angioblasts from the septum 
transversum induce the hepatic bud to form (Matsumoto et al., 2001). Such key interactions 
are now amenable to study in vitro using hHpSCs. We observed that colony expansion and 
cell outgrowth of hHpSCs depends on mesenchymal companion cells prominent at the 
periphery of hHpSC colonies and identified by antigenic profiles as angioblasts (positive for 
VEGFR , CD31 or PECAM, CD117, CD 133) or hepatic stellate cell precursors (positive for 
CD146 (MEL-CAM, MCAM), desmin and α-smooth muscle actin). These findings parallel 
our prior work defining hepatic stellate cell precursors supportive of rodent hepatic 
progenitors (Kubota et al., 2007).  
CD146 forms homotypic cell-cell connections that were first localized on melanoma 
cells and subsequently at cell junctions within endothelial cell layers (Bardin et al., 2001). 
CD146 has now been identified on many different cell types including keratinocytes and hair 
follicle epithelia, stromal cells in adipose tissue and bone marrow, and most cell types in the 
thymus (Gronthos et al., 2001; Seftalioglu and Karakoc, 2000). The expression of CD146 on 
cells at the periphery of colonies of hHpSCs, and extending to the innermost cells of aging 
colonies on plastic, is consistent with the known anti-cohesive activity of CD146. In this 
capacity CD146 functions as an outside-in transducer that suppresses gap junction 
connections, inhibits β-1-mediated integrin binding, and disturbs E-cadherin-based adherens 
junctions (Bardin et al., 2001; Johnson, 1999). Furthermore, the strong expression of ICAM-
1 by more differentiated cells emerging from hHpSC colonies may also reflect modulation of 
cell-cell interactions. ICAM has been shown to act in conjunction with CD146 to disturb E-
cadherin-based cell junctions (Benveniste et al., 1999). The dramatic increase in expression 
of CD146 in association with differentiation of the hHpSCs into hepatoblasts is assumed to 
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model angiogenesis in the forming liver, an interpretation supported by the findings of Sonic 
and Indian Hedgehog signaling and the Patched receptor in the ridge formed by the 
angioblasts and the hepatic stellate cells (Sicklick et al., 2005).   
The possibility of co-isolation of hHpSCs with mesenchymal cells may account for 
some apparent differences between the hHpSCs described here and candidate hHpSCs 
reported by others (Dan et al., 2006). For example, liver-derived, stem-like cells have been 
reported to express markers shared with hematopoietic progenitors, including CD45 
(leucocyte common antigen), CD34, and CD117, and/or to be capable of giving rise to both 
hepatic and endothelial cells (Crosby et al., 2002). Another report describes candidate hepatic 
stem cells found in regeneration after massive hepatic necrosis as “lymphoid blastlike” cells 
that express CD133 and CD117 but not CD45 (Craig et al., 2004). We suspect that the 
multipotent stem cells found in fetal liver and reported to give rise to liver and also 
mesenchymal lineages (e.g. cartilage) and that co-express EpCAM and various mesenchymal 
cell markers are also an example of co-selection (Macdonald et al., 2002).  
The hHpSC populations from both fetal and adult livers appear essentially negative 
for CD45, CD34 and CD117.  However, CD34 and CD117 are expressed by angioblasts, 
which we have found in companion cells associated with hHpSCs. Based on 
immunofluorescent staining CD117 was variably present in the border zone between the 
companion cells and some (but not all) hHpSC colonies cultured on plastic. Also, transcript 
analysis revealed a slight enrichment in CD117 mRNA in EpCAM+ cell populations from 
fetal livers and a significantly greater enrichment in EpCAM+ cells from postnatal livers 
(Schmelzer et al., 2006). Nonetheless, immunoselection for CD117 or CD34 yielded 
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angioblasts, not hHpSCs. In summary, our data remain inconclusive; we cannot rule out that 
a minor subpopulation of hHpSCs cells express CD117. 
It is conceivable that phenotypic differences between hHpSCs obtained by different 
isolation procedures reflect varying stages within a common lineage and/or subtle effects of 
in vitro selection protocols. However, it is clearly important to be aware of the physical and 
functional interaction of hepatic (endodermal lineage) and mesenchymal lineage cells both in 
the developing liver and the adult organ, and the possibility of ascribing properties to a single 
cell type that actually correspond to a mixed population. In any case we argue that the 
relative frequency and anatomical location of EpCAM+, CD133+. CD34-negative cells, and 
the growth and differentiation capacity of these cells, provide strong evidence that the 
hHpSCs described here are authentic stem cells in fetal and postnatal livers. 
Purified EpCAM+ cells, from fetal or postnatal livers, are able to engraft the livers of 
immunodeficient adult mice, with or without prior injury, yielding mature human liver tissue. 
The engrafted cells lose expression of stem cell markers (e.g., EpCAM, CD133, and CK19) 
and show enhanced expression of mature human proteins and mRNAs characteristic of 
hepatocytes (e.g. albumin and transferrin). The use of human-specific antibodies and 
sequence probes confirmed that these were made by donor-origin cells.  The extent of 
humanization of the murine livers was greatly enhanced by treatment of mice with CCl4, 
known to selectively kill mature parenchymal cells and, thereby, to create a cellular vacuum 
in the host. 
The efficiency with which EpCAM+ cells can be isolated from human livers, their 
ability to clonogenically expand ex vivo, their pluripotency, and the evidence that they yield 
mature liver tissue after transplantation encourage consideration of their clinical utility.  
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Potential applications include cell-based therapies of liver disease and generation of cells for 
bioartificial livers. 
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TABLES 
Table 4.1. Antigenic Profiles of Human Hepatic Stem Cell (hHpSC) and Hepatoblasts 
 
Markers 
hHpSC on 
Plastic and in 
KM1
hHpSC on 
STO feeders 
within KM1
Hepatoblasts  
 
α- fetoprotein2
 
Negative 
 
+++ in those from fetal liver; 
± in those from postnatal 
livers 
Albumin2 Negative or ± ++ 
P450-3A42 Negative 
P450-A72 Negative Positive 
CK 8/18, CD29, 
CAM 5.2 
+++ 
CK192  +++ + found as particular staining 
in cytoplasm 
EpCAM2 +++ cytoplasmically and at 
membrane 
++ at membrane surface but 
not cytoplasm 
NCAM2 Strongly positive especially at 
edge of colonies 
Negative 
Indian and Sonic 
Hedgehog and 
Patch3
+++; Sonic is at periphery and 
Indian in center of cells  
 
++ 
ICAM-12 Negative 
 
Positive (see Figure 6 ) 
Claudin 32 +++ Negative 
CD44H 4 +++ 
CD133/12 +++ 
Telomerase5 +++ 
CD1172 Debatable**  Negative 
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Mesenchymal6 
Cell Markers  
Negative 
Endothelial Cell 
Markers7
Negative 
Hemopoietic 
Markers8
Negative  
 
**It is not detected on freshly isolated EpCAM+ cells from fetal or postnatal livers; RNA for 
it is  enriched in EpCAM+ cells (Balzar et al., 1998) ; it is variably found in HpSC colonies 
from fetal but not adult livers and when found, is always near or overlapping with the 
companion cells; immunoselection for it does not yield hHpSCs. We suspect it is on 
angioblasts but not the hHpSCs (and for certain is not on hepatoblasts). 
1Kubota’s Medium. (Tanimizu et al., 2003) 
2Phenotypic characterization of more than 20 genes by RT-PCR and Western blot analyses 
was done on hHpSCs, hepatoblasts and hepatocytes from livers from varying donor ages 
(Balzar et al., 1998).  
3More extensive studies on hedgehog signaling are presented elsewhere (Van Den Heuvel et 
al., 2001)  
4More extensive studies on hyaluronan receptors and their relevance to use of hyaluronan 
hydrogels for ex vivo maintenance of hHpSCs are given elsewhere 
5Telomerase activity has been measured in hHpSCs, hepatoblasts versus in mature liver cells 
(Schmelzer E. and Reid L submitted) 
6Mesenchymal markers: CD146, desmin, α-smooth muscle actin 
7Endothelial cell markers: VEGFR2 (also called KDR), von Willebrand factor, CD31 
8Hemopoietic cell markers: CD45, CD34, CD14, CD38, Thy 1 (CD90), Glycophorin A 
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Table 4.2. Evidence for Self-Renewal 
  hHpSCs Hepatoblasts 
Minimum 
Conditions for 
survival  
 
KM1 + Culture plastic 
 
 
KM1 + STO Feeders  
Life-span of cells Culture plastic:>6 months 
STO Feeders: indefinite 
Plastic: No survival after 
~5-8 days 
STO Feeders: ~2 months 
Doubling Time on 
Plastic or feeders2
Plastic : 1.5-2 days   
STO Feeders: 12-24 days 
(<24 hours on certain matrix 
substrata4) 
 
 
Plastic: No survival  
STO Feeders: essentially no 
growth 
2Cell number/colony 
after 2 weeks 
(“clonogenic” 
expansion)  
Plastic: 1.4X103 + 5.2 X 102 
(derived from a single 
hHpSC partnered with a 
single companion cell—see 
movies) 
 
 
Plastic: No survival 
Phenotype of  
hHpSCs after > 150 
divisions (>6 months 
in culture) 
Identical to that of cells after 
initial plating; 
characterization summarized 
in Table 1 
 
Within the ~ 2 months of 
survival time on STO 
feeders, cells retained 
expression of albumin,  a- 
fetoprotein and CK19  
Ability to form liver 
tissue after 
transplantation 3
Capable after 1-2 months in 
culture on plastic  
and in KM1
Only if transplanted within 
~7 days of culture on plastic 
(not tested with cells on 
STO feeders) 
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1KM =Kubota’s Medium,  serum-free RPMI 1640 with no copper, low calcium (0.3 mM) 
and supplemented with zinc, selenium, insulin, transferrin, HDL and lipids (Kubota et al., 
2002).    
2Clonogenic expansion occurs but requires each hHpSC to be partnered with at least one 
companion cell; the companion cells proved to be angioblasts or hepatic stellate cell 
precursors (see Figure 4.5; see also the movies in supplemental data for colony formation at 
low seeding densities and on days 1-8).  
3In Figure 4.8 are shown images from liver sections from animals transplanted with human 
hepatic stem cells.  
4Elsewhere we report that plating the stem cells onto specific forms of extracellular matrix, 
found in abundance in embryonic or fetal tissues enables them to go for months through  
rapid divisions with doubling times of <24 hours for months (McClelland et al.,  submitted).  
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Table 4.3. Antigenic profile of freshly isolated cells in the Ficoll interface fraction versus 
Ficoll pellet fraction derived from suspensions of human fetal liver cells 
 Marker* Interface cell fraction Pellet cell fraction 
α- fetoprotein  26.0 + 7.6 72.3 + 3.9 
Albumin  33.7 + 5.4  79.8 + 9.2 
CD117 (c-kit) 5.4 + 3.0  2.2 + 1.7 
E-Cadherin 57.9 + 6.2 70.8 + 1.5 
NCAM 5.7 + 1.8  2.0 + 0.9 
EpCAM 63.9 + 9.4 61.2 + 9.5 
CD146  7.5 + 1.5 0.6 + 0.2 
CD133 4.9 + 1.3 3.0 + 1.9 
CD31  11.0 + 1.9 3.7 + 2.0 
ICAM-1 33.2 ± 15.3 22.6 ± 7.5 
N-Cadherin 0.9 +  0.4   1.0+0.3 
CD45 10.5 + 1.8 2.2 + 1.2 
CD14 3.0 + 2.6 0.3 + 0.2 
CD34  12.2 + 0.8 2.6 + 0.8 
HLA  28.4 + 8.1 6.4 + 3.9 
 
 
 
 
 
 
 
 
 
 
 
 
Mean + SEM.  N=3 
*All data are calculated for the glycophorin A-negative population (gated out by flow 
cytometric analyses). Glycophorin A was present at 57.5 + 7.6% in the interface fraction and 
at 39.5 + 7.0% in the pellet.  The pellet fraction was found to be predominantly hepatoblasts.   
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Table 4.4. Colony forming Cells in Postnatal Human Livers 
Donor 
Age (yr) 
Samples 
Analyzed 
EpCAM+ 
Cells (%) 
Hepatoblast 
Colonies 
HpSC 
Colonies 
 
0.75 
1Unfractionated 
2EpCAM+ 
3Flow-Through 
1.8 
84.7 
< 0.05 
1209 
18 
1293 
2 
199 
0 
 
3 
Unfractionated 
EpCAM+ 
Flow-Through 
0.5 
75.0 
< 0.05 
339 
237 
308 
0.5 
76.2 
0 
 
9 
Unfractionated 
EpCAM+
Flow-Through 
0.73 
80.9 
< 0.05 
169 
1.3 
101 
1.3 
52.3 
0.3 
 
36 
Unfractionated 
EpCAM+
Flow-Through 
3.9 
93.2 
< 0.05 
> 500 
1.7 
> 500 
11 
27.7 
3.3 
1 Unfractionated: starting cell suspension after cell isolation 
2 EpCAM+ cells: positive fraction from immunoselection 
3 Flow-Through: cells not retained during magnetic selection for EpCAM 
Data are means of triplicate wells seeded with 20,000 live cells. 
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FIGURE LEGENDS 
Figure 4.1.  Immunohistochemical Studies on Human Fetal Livers   
Confocal microscopic images  on 5 µm liver sections.  The antigenic profiles are 
given in the Table. Sections were stained for: 
 Human Fetal Livers: A. EpCAM (green) and CK19 (red); B. EpCAM (green) and 
AFP (red); C. CK19 (green) and albumin (red); D. CK19 (green) and AFP (red) 
Adult Livers: E. EpCAM.  Probable hepatoblasts at the end of a canal of Hering; F. 
Canals of Hering around portal triad with EpCAM (green) and CK19 (red); G. A canal of 
Hering showing EpCAM+ cells (green) some of which also express albumin (red).   
 
Figure 4.2. Flow Cytometric Characterization of EpCAM+ Cells   
A. The % of EpCAM+ cells in livers of varying donor ages. The numbers for fetal 
livers have been reported previously (Fausto et al., 1993) but are presented here for 
comparison to findings in livers from older donors. B. Analyses of EpCAM+ cells from fetal 
livers (similar findings occur with EpCAM+ cells from adult livers except that few cells 
express AFP).  C. Quantitative RT-PCR Assays on freshly isolated EpCAM+ versus EpCAM- 
cells from fetal versus postnatal livers. These data are compared to the findings from colonies 
of hHpSC grown on plastic and in serum-free KM for 30-60 days.  
 
Figure 4.3. hHpSCs in culture 
A-E show a stem cell colony forming at 2 days (A),  4 days (B), 7 days (C), 10 days 
(D), and 14 days (E) in culture  on plastic and in KM.  Scale bar: 20 um.   Phase contrast 
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coupled with image of cells with staining for NCAM (H and I), CK19 (F and GH), EpCAM 
(J and K), and CD44H (L).   
 
Figure 4.4. Magnetic immunoselection  
A-F.  Flow cytometry on human fetal liver cells stained for EpCAM (Panel D; Panel 
A is the isotype control for D used for setting the gate shown in pink) indicated 20.7 % of the 
cell suspension were positive for EpCAM. The cells were subjected to  magnetic bead sorting 
and yielded a suspension enriched for EpCAM to 54.6% of the cells (Panel B is the isotype 
control used for the data in panel E).  The flow-through cells (Panel F; Panel C is the isotype 
control for Panel F) were depleted in EpCAM yielding 7.15% of the cells. G-I. Flow 
cytometry on cells from adult livers.  EpCAM expression (Y axis ) vs side scatter (X axis) .  
In the original, unfractionated cell suspension were found 0.73% EpCAM+ cells.  H. a single 
pass through Miltenyi microbead sorting resulted in enrichment for EpCAM+ cells to 80.9%. 
I. In the flow through were found only 0.06% EpCAM+ cells.  J. The EpCAM+ cells were 
~9-10 µm in diameter vs 18-22 µm for mature parenchyma and had low side scatter (K) 
relative to that found for mature cells in the unfractionated mixture (UMIX) of liver cells (L).  
Table: summary of profiles of cells immunoselected for EpCAM, NCAM, KDR (VEGFr) or 
for KDR-/EpCAM- cells. Phase micrograph images are of an hHpSC colony from an 
EpCAM+ sort and one from an NCAM+ sort.  
 
Figure 4.5. Companion cells to the HpSC Colonies comprise Hepatic Stellate cells and 
Angioblasts 
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hHpSCs are associated with mesenchymal companion cells with distinct antigenic 
profiles.  See movies in the Supplement. Two types of companion cells are evident: 
angioblasts (positive for VEGF-R, CD133/1, CD117, weakly positive for CD31 and von 
Willebrand factor) and hepatic stellate cells (positive for desmin and α-smooth muscle actin 
(αSMA)).    
 
Figure 4.6. hHpSCs shifted to STO Feeders Erupt Hepatoblasts 
Passage of hHpSCs from plastic to STO feeders results in cord-like eruptions that 
morphologically and antigenically are identical to hepatoblasts.  A. An hHpSC colony shortly 
after passaging.  B-E. A small group of passaged stem cells appears as a tightly compacted 
group of cells that erupts cords of hepatoblasts at the periphery of the colonies.  Shown is a 
colony and the steady eruption of hepatoblasts by the end of day 1 (B), day 3 (C), day 5 (D) 
and day 7 (E) after passaging.   
 
Figure 4.7. Shift in Antigenic Profile from hHpSCs to Hepatoblasts when on STO 
Feeders  
The border between the hHpSC colony and hepatoblast outgrowths is marked by 
arrowheads. A and B. The antigenic profile of the cords of cells erupting from the parent 
colony is identical to that of hepatoblasts and includes a shift from expression of NCAM 
(green) to ICAM (red). C and D. Lineage restriction to committed biliary progenitors (CBPs) 
indicated by staining for CK19 (green) and albumin (red). E and F expression of AFP (green) 
and albumin (red) indicates that erupting cells are hepatoblasts. 
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Figure 4.8. Transplantation of EpCAM+ Cells (or Colonies of Stem Cells in culture) 
results in Engrafted Liver Tissue in NOD/scid mice   
 NOD/scid mice were transplanted with 106 cells of either freshly isolated and 
immunoselected EpCAM+ cells or colonies of hHpSCs from culture on plastic for 30-60 days 
(>~40 population doublings). Similar results were obtained with both populations.  After 
transplantation, half the mice were treated with carbon tetrachloride (CCL4) (representative 
results shown in Fig. 8B, D, and F; representative results from transplanted mice not treated 
with CCL4 are shown in Fig. 8A, C, E and F).  In Fig 8A, C, and E are shown sections of 
murine livers stained for human-specific proteins two days (Fig. A, C, and E), 8 days (Fig. 
8F) or 8 days after transplantation and 7 days after CCL4 treatment (Fig. B, D, G).  Control is 
a section of mice not transplanted (H). Control for albumin indicated some cross-reactivity 
between human and mouse albumin.  
 
Figures 4.9 and 4.10.  Hepatoblasts cultured on tissue culture plastic and in Kubota’s 
Medium.  
The cells form cords and intensely co- express alpha- fetoprotein, albumin and 
cytokeratin 19. The cells survive only for 7-10 days. Hepatoblasts colonies do not survive on 
culture plastic (Fig. 9) but only on embryonic stromal feeders (Fig. 10). Cultures in Figs A-H 
are plated onto tissue culture plastic and those on I-N are on feeders of murine embryonic 
stromal cells, STO cells.  Figs A, C. E and G are cells after 1 day in culture; those in B, D.F 
and H are after 5 days; all Figs on STO cells are after 14 days in culture. A, B, J, and N are 
phase micrographs. Those in C, D and I are stained for albumin; those in E, F and K are 
stained for  a- fetoprotein; those in G, H, and M are stained for CK 19. On day 1 the cells are 
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tightly aggregated and show strong immunofluorescent staining for ALB,  a- fetoprotein and 
CK19. By day 5 the cells have disaggregated and died. Immunostaining for albumin and  a- 
fetoprotein is reduced to background levels; however residual cells still stain strongly for 
CK19. Scale bar = 20 µm.  
Hepatoblasts plated directly onto a STO feeder layer, fixed, immunostained and 
imaged at day 14. Upper panels Phase contrast images of three groups of hepatoblasts. Lower 
panels: Immunofluorescent staining of ALB, a- fetoprotein, and CK19. Note how 
morphology and immunogenic profile is sustained on STO feeders, unlike the cultures on 
plastic. The cells survived for more than 2 months and grew very slowly when on STO 
feeder cells. Table in Fig. 9 is a survey of markers on the cells on culture plastic; Table in Fig. 
10 is a survey of the markers on the hepatoblasts on STO feeders.  
 
Figure 4.11.  Colonies of hepatic progenitors 
Phase microscopy shows the colonies of hepatic progenitors from postnatal livers that 
include hepatoblasts (A) and hHpSCs (B, C). Immunochemistry studies show expression in 
HpSC colony of albumin (D), CK19 (E), and merged image (F).      
 
Figure 4.12. Cell culture of hepatoblasts and unipotent progenitor colony 
Hepatoblasts (A-F), sectored colonies (G, H, K, L) and unipotent progenitor colony (I, 
J) shown in phase microscopy (A, E, G, I, K) or for immunochemistry for albumin (green) 
and CK19 (red). Note that CK19 in hepatoblasts are filamentous and in hHpSCs (Fig. 11) are 
particulate; in parallel, albumin expression is also distinct in hHpSCs and hepatoblasts, 
implicating distinctions in processing of these proteins in these two lineage stages.  
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CHAPTER V 
HUMAN HEPATIC STEM CELLS SELF-REPLICATE ON FEEDERS OF 
ANGIOBLASTS/ENDOTHELIA AND LINEAGE RESTRICT TO HEPATOBLASTS 
ON FEEDERS OF ACTIVATED HEPATIC STELLATE CELLS 
(Refereed article submitted to Tissue Engineering) 
 
In vivo tissue engineering (TE) involving transplantation of purified hepatic cells 
into the liver and the ex vivo tissue engineering using an extracorporeal liver support 
system (bioartificial liver) have been considered as alternative therapeutic approaches for 
patients with fulminant hepatic failure. Both approaches require substantial numbers of 
functional hepatic cells. The pluripotent human hepatic progenitors, especially hepatic 
stem cells (HpSCs), cells that can self-renew, should be an ideal cell source for liver TE. 
Understanding the mechanisms increasing cell growth of HpSCs and/or inducing 
differentiation of these cells into functional hepatocytes or cholangiocytes would help to 
accelerate success of protocols for liver TE. Paracrine signaling from adjacent 
mesenchymal cells is thought to govern the proliferation/differentiation state of the 
hepatic epithelial cells. This chapter identifies distinct categories of mesenchymal feeders, 
implicating overlapping but also distinct paracrine signals among them.  The feeders are 
being used to identify the paracrine signals so that eventually one can expand and 
differentiate the HpSCs in the absence of feeder cells.   
 
 
Hsin-Lei Yao,1,2 Randall McClelland, 2 Marnisa Sricholpech,3 Mitsuo Yamauchi,3 Eliane 
Wauthier, 2 Nicholas Moss,2  Elizabeth Loboa1 and Lola M. Reid,1,2 
 
1Departments of Biomedical Engineering, and 2Cell and Molecular Physiology,  
2Program in Molecular Biology and Biotechnology, 2Lineberger Comprehensive Cancer 
Center and Center for Gastrointestinal Biology and Disease (CGIBD), School of 
Medicine, 3Department of Periodontology, School of Dentistry,  
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Abbreviations:  AFP=α-fetoprotein; ALB= albumin; CK= cytokeratin; EC= 
endothelial cell; hHpSCs= human hepatic stem cells; HpSTCs= hepatic stellate 
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cells; HUVEC= human umbilical vein endothelial cells; hMSCs= human 
mesenchymal stem cells from bone marrow; KM= Kubota’s Medium, a 
serum-free, hormonally defined medium tailored for hepatic progenitors; STO 
cells= murine embryonic stromal feeder cells; TE= tissue engineering; ECM= 
extracellular matrix. 
ABSTRACT 
Human hepatic stem cells, hHpSCs (NCAM+, Claudin3+, albumin±, AFP-) in vivo or 
on plastic and in a serum-free medium tailored for hepatic progenitors, Kubota’s Medium 
(KM), are closely associated with angioblasts (VEGFR2+, CD31+, CD117+, von 
Willebrand Factor (vWF)+) and hepatic stellate cells (hHpSTCs) (ICAM-1+, desmin+, 
vitamin A+, α-smooth muscle actin (αSMA)+).  Various embryonic/fetal mesenchymal 
feeders were tested with KM for influence on hHpSCs. The hHpSCs exhibited minimal 
differentiation on plastic or with feeders of angioblasts/endothelia or of human umbilical 
vein endothelial cells (HUVECs); they lineage restriction to hepatoblasts (ICAM-1+, 
Claudin 3-, Albumin ++, AFP++) on feeders dominated by activated hHpSTCs; they slowed 
in growth and underwent differentiation when on STO feeders.  All feeders produced 
multiple families of matrix components (collagens, basal adhesion proteins, 
proteoglycans) with the angioblasts/endothelia producing the lowest levels; hHpSTCs 
feeders producing intermediate levels; and STO cells the maximum levels and also being 
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the only feeders to produce heparan sulfate proteoglycans. Specific matrix components, 
used in combination with KM, could mimic, in part, the feeder effects.  Type III collagen 
resulted in minimal differentiation; laminin or type IV collagen yielded expansion with 
restriction to hepatoblasts; and embedding in type I collagen resulted in slowing of 
growth and more extensive differentiation.   
 
INTRODUCTION 
Tissue engineering of human liver necessitates expansion of the available liver cells 
to yield sufficient numbers of cells for bioartificial livers or for cell therapy programs 
(Gerlach, 1996; Gupta et al., 1999; Kulig and Vacanti, 2004; Selden and Hodgson, 2004; 
Strom et al., 1997; Susick et al., 2001). The hope has become to make use of human 
hepatic stem cells (hHpSCs) (EpCAM+, NCAM+, Claudin 3+, cytokeratin 19+, albumin±, 
alpha-fetoprotein (AFP)-) that can be expanded and then lineage restricted to mature liver 
cells. In our recent studies, we reported on the antigenic profile permitting 
immunoselection of hHpSCs from livers of all donor ages and on conditions for ex vivo 
expansion of the cells (Schmelzer et al., 2006 and 2007; Sicklick et al., 2006). In these 
reports we showed that survival and ex vivo expansion of the hHpSCs is dependent on 
paracrine signals from mesenchymal companion cells defined to be angioblasts (CD31+, 
von Willebrand Factor (vWF)+, CD133/1+, CD117+, Vascular Endothelial Growth Factor 
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Receptor 2 (VEGFR2)+), and/or hepatic stellate cell precursors (ICAM-1+, VCAM-1+, 
vitamin A+, desmin+, α-smooth muscle actin (αSMA)+, CD146+) (Schmelzer et al., 2007). 
  Liver development is induced in a step-wise process with signals from cardiac 
mesoderm and then from endothelia (Jung et al., 1999; Lemaigre et al., 2004; Zaret, 
1998). During liver organogenesis, endodermal cells are induced by cardiac mesoderm to 
differentiate into hHpSCs within the ventral endoderm (Gualdi et al., 1996; Lammert et 
al., 2003). Subsequently, newly specified hepatic cells delaminate and migrate into the 
surrounding septum transversum mesenchyme and intermingle with endothelia which 
remain in contact with hepatic cells throughout development. A receptor for VEGF, flk-1, 
is essential for endothelia to form. Flk-1 mutant mouse embryos, lacking endothelia, 
show initial hepatic induction but without the proliferation of hepatic cells into the 
surrounding septum transversum mesenchyme, indicating the importance of endothelia 
for liver organogenesis (Matsumoto et al., 2001; Roberts et al., 2004; Shalaby et al., 1995 
and 1997).  
The stem cell niche in human livers has recently been determined to be the ductal 
plates in fetal and neonatal livers that proved to be the antecedents to the canals of Hering 
in pediatric and adult livers (Schmelzer et al., 2007; Zhang et al., 2007). The canals of 
Hering have long been considered to be the probable stem cell compartment in the liver 
(Roskams et al., 2004; Saxena and Theise, 2004; Theise et al., 1999). The cell 
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subpopulations found within ductal plates and canals of Hering include hHpSCs, 
angioblasts, and hHpSTC precursors. Culture conditions that select for the hHpSCs 
co-select for these same populations (Schmelzer et al., 2007). Little is known about the 
paracrine signaling between these stem cell niche cell populations, but it is presumed to 
be important. Therefore, we sought to establish model systems for defining the paracrine 
signals. 
We show that feeders representative of angioblasts/endothelia cause hHpSCs to 
remain as stem cells, whereas those replete with hHpSTCs result in lineage restriction to 
hepatoblasts, effects that can be mimicked, in part, by purified paracrine matrix signals 
produced by the feeders. A separate report is being prepared on the soluble signals from 
the feeders (Yao et al., in preparation).   
 
RESULTS 
Native Mesenchymal Companion Cells for Human hHpSCs (hHpSCs)   
Freshly isolated hHpSCs survived ex vivo on culture plastic in KM, when the 
colonies of hHpSCs are surrounded by companion cells defined to be angioblasts 
(VEGFR2+, CD31+, CD133/1+, CD117+) and quiescent hHpSTCs (low levels of CD146, 
desmin and αSMA) (Figures 5.1-3, Table 5.1). The hHpSC colonies consist of cells very 
tightly bound to each other on their lateral borders but with minimal attachment to the 
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culture dish except at the perimeter of the colonies, the site at which the mesenchymal 
companion cells were located. Thus, the attachment to the dish was either by the 
mesenchymal companion cells alone or by the combination of them with the hHpSCs. 
When passaging, a colony could be detached at its perimeter and lifted off as a sheet of 
cells. Efforts to disperse the sheet into single cells were not successful with the customary 
enzymes (e.g. trypsin, chymotrypsin, dyspase, collagenase IV) that caused variable extent 
of dissociation but with rapid loss of viability of the cells. Mechanical passaging, as used 
for human ES cells in culture (Reubinoff et al., 2000), resulted in efficient passaging of 
hHpSCs. 
 
Feeder Cell Lines and Primary Cultures used to Model the Native Feeders   
Several forms of embryonic mesenchymal cells, either primary cultures or cell lines, 
were prepared as models of the native feeders, the angioblasts and hHpSTCs, and were 
used in combination with serum-free KM. Minimizing exposure to serum was essential, 
given its profound effects on the phenotype of the hHpSCs but proved a challenge for 
handling the mesenchymal feeders with requirements for serum factors. The strategy 
finally adopted was to grow the stocks of mesenchymal feeders in a serum-supplemented 
medium such as EGM-2 with 2% serum before switching them to serum-free KM for the 
assays in co-cultures of feeders with the hHpSCs. When maintained in serum-free 
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medium (Figures 5.1-3), any hHpSTCs present were found to be quiescent with low 
levels of CD146, desmin and α-smooth muscle actin (αSMA). Exposure to serum, even at 
low levels (1-2%) or for short periods (a few days), resulted in activation of the hHpSTCs 
as evidenced by very high levels of CD146, desmin and αSMA) (Figure 5.4). Exposure to 
serum also induced primary cultures of fetal liver cells, or immunoselected cells (e.g. 
KDR+ or CD31+ cells), to transition to mesenchymal cell populations dominated by 
hHpSTCs. Efforts are still ongoing to develop serum-free conditions for mesenchymal 
cells to obviate this problem for future studies.  
The cell lines included human umbilical vein endothelial cells (HUVECs) (Figure 
5.5B), human bone marrow derived mesenchymal stem cells (hMSCs) (Figure 5.5A), and 
murine embryonic stromal cells or STO cells, used routinely for maintenance of ES cell 
cultures. Primary cultures were prepared from cell suspensions of 16-20 wks human fetal 
livers by immunoselection using magnetically-activated cell sorting (MACS) for: 1) cells 
expressing KDR (flk-1/VEGFR2); 2) cells expressing CD31 (PECAM); or 3) cells left 
behind after negative sorting for fibroblasts to reduce or eliminate stromal cells. The 
percentages of sorted KDR+ and CD31+ cells within the whole liver sample were found to 
be about 0.5% and 1% respectively.  
Immunoselected KDR+ cells changed rapidly in culture. In the first week, the cells 
morphologically and antigenically were angioblasts or endothelia (Figure 5.3D). However, 
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by the second week, all markers for angioblasts/endothelia disappeared, and the cells 
remaining were dominated by HpSTCs. Even if the cell suspension was negatively 
fractionated to eliminate stroma, the same phenomenon occurred (Figure 5.5C-E and G). 
After 11 days of culture, the cultures were completely confluent, and most of the cells 
were strongly positive for αSMA, a marker for hHpSTCs and negative for vWF, an 
intracellular marker for endothelial cells (Figure 5.5F and H and 5.6I and K).  
CD31+ cells appeared as cobblestone-like cells in morphology in EGM-2 medium 
before day 5 and were positive for CD31 and vWF, indicating a phenotype of endothelial 
cells. After 5-7 days of culture, fibroblast-like cells that proved to be hepatic stellate cells 
started to dominate the dish and quickly reached complete confluency by day 9-10 in 
EGM-2 medium with strong expression of αSMA and desmin (data not shown). The 
culture conditions (EGM-2), though specifically designed for endothelial cells are 
nevertheless permissive for outgrowth of hHpSTCs that eventually dominate the cultures.  
An alternative interpretation is that the immunoselected angioblasts (KDR+) and 
endothelial cells (CD31+) lineage restricted to hHpSTCs, since they share certain markers 
(e.g. VCAM1, ICAM1, CD146) , and this hypothesis is suggested also by the findings 
that there were clusters of the endothelia surrounded by a ring of hHpSTCs. The data to 
date cannot distinguish between the two interpretations of culture selection for a minor 
subpopulation of preexisting hHpSTCs or lineage restriction of angioblasts or endothelia 
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to hHpSTCs.  
 
Effects of Feeders in co-Cultures with hHpSCs 
Preliminary studies were done with primary cultures of mesenchymal feeders from 
adult rat livers or adult human livers and of purified HpSTCs prepared from adult rat 
livers and adult human livers by previously published protocols (Hellerbrand et al., 1996).  
However, these feeders in combination with KM showed minimal, if any, effects on the 
hHpSCs in terms of survival, growth or gene expression (data not shown). This 
complements prior studies in which feeder cells had to derive from embryonic livers for 
support of rat hepatoblasts (Agelli et al., 1997; Brill et al., 1995; Kubota and Reid, 2000; 
Reid et al., 1994; Sigal et al., 1994 and 1995). All of the biologically active feeders 
utilized in these studies are from fetal tissues.  
 
hHpSCs on feeders of Liver-derived Angioblasts or HUVEC cells remain as stem cells  
Isolation and clonogenic expansion of hHpSCs on culture plastic and in close 
association with angioblasts (Figure 5.3) resulted in cells that remained as hHpSCs with 
minimal differentiation (Schmelzer et al., 2007). The hHpSC colonies can be seen 2 
weeks after plating and are positive for NCAM, EpCAM, albumin, CK19 and CLDN-3 
and negative for AFP. Plating of cells in KM and on top of HUVEC cells or on feeders of 
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KDR+ cells immediately after sorting and plating also resulted in maintenance of the stem 
cell colony phenotype (Figure 5.7B) with an antigenic profile of EpCAM+, NCAM+, 
ICAM-1-, AFP-, CLDN-3+ (Table 5.1).  
 
The hHpSCs cultured on feeders of activated hepatic stellate cells lineage restrict to 
hepatoblasts.  
Feeders replete with activated hHpSTCs (high levels of expression of desmin, αSMA 
and CD146) caused rapid transition, within hours, of hHpSCs to hepatoblasts (Figure 5.4).  
This included the hMSCs, the primary cultures of human fetal liver stroma, the primary 
cultures of human fetal liver stroma depleted of fibroblasts by immunoselection, and the 
primary cultures of KDR+ cells or of CD31+ cells that were maintained in culture for 
more than a week. After 8-9 days of co-culture with one of these feeders, the hepatic 
progenitor colony morphology consisted of cord-like structures interspersed with clear 
channels, the presumptive biliary canaliculi (Figures 5.7 and 5.8) and with an antigenic 
profile indicative of hepatoblasts (EpCAM+, NCAM-, ICAM-1+, AFP+) (Table 5.1, Figure 
5.1). Moreover, the morphology of hepatoblast colonies was more 3-dimensional causing 
them to be refractile when evaluated by bright field (Figures 5.7 and 5.8) possibly caused 
by multiple layers of cells and/or accumulation of extracellular matrix.  
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The hHpSCs plated onto STO Feeders 
The feeder model system resulting in the maximum differentiation proved to be STO 
feeders, used routinely for embryonic stem (ES) cell cultures. The hHpSCs plated onto 
these feeders significantly slowed their growth and then gave rise to eruptions of 
hepatoblasts and committed progenitors from the edges of the colonies, findings 
corroborating our earlier reports (Schmelzer et al., 2007).  
 
Expression of Genes Encoding Matrix Molecules by the different Feeders  
Three feeder cell types were chosen to represent feeders that sustained the hHpSC 
phenotype (HUVEC cells) versus two that resulted in lineage restriction to hepatoblasts 
(primary cultures of human fetal liver mesenchymal cells and CD31+ cells, fetal 
liver-derived endothelia, cultured for more than a week, both assayed at time points at 
which hHpSTCs were the dominant cell population). Using quantitative real-time PCR, it 
was found that fibronectin mRNA encoding the type I module of the fibronectin molecule 
was the highest-expressed matrix component among the three feeders assayed, especially 
in HUVECs (Figure 5.9). The HUVEC feeders, supportive of maintenance of the hHpSC 
phenotype produced collagen type IV, laminin (α4, β1 and γ1 chains), and little or no 
collagen types I and III, other laminin chain isoforms, or proteoglycan core proteins.  
Those that induced lineage restriction to hepatoblasts (human fetal liver-derived αSMA+ 
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fibroblast-like and CD31+ cells) produced type I, III and IV collagen, laminin (β1, γ 1), 
but not collagen type V, other laminin chains or any of the proteoglycan core protein 
genes assayed (Glypican-3 and -5 and Syndecan-1 and -2).  
 
Expression of Extracellular Matrix Proteins by different Feeders 
Immunohistochemistry (IHC) was done on different feeders for 7 different matrix 
molecules: types I, III and IV collagens, laminin, fibronectin, and heparan sulfate 
proteoglycans (HS-PG, perlecan) and chondroitin sulfate proteoglycans (CS-PG). All 
feeders produced a mix of extracellular matrix molecules, but the lowest levels observed 
were in the primary cultures of angioblast/endothelia; intermediate in the HUVECs cell 
line or in primary cultures in which hHpSTCs had been culture selected, and with the 
highest levels of all found in the STO cells (Table 5.2). The basal adhesion molecule, 
fibronectin, was found in all of them and with the highest levels by protein assays found 
in STO cells. By IHC, collagen type III was found only in STO cells. Since it was found 
in other feeders by quantitative real-time PCR and there are few reports of matrix 
components expressing mRNA but not the protein, it is likely that the epitope recognized 
by the antibody is buried or masked by other matrix molecules and not available for 
binding in the IHC assays.  HS-PGs were absent in all of the feeders by IHC and by 
quantitative real-time PCR except for STO cells.   
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The distinctions appear to be that the feeders supportive of the hHpSC phenotype 
produce an extracellular matrix containing forms of laminin (with integrins α4 and, by 
inference, β6), type IV collagen, CS-PG, and no forms of HS-PGs. Those that induced 
lineage restriction to hepatoblasts have elevated levels of type I, III and IV collagens, 
laminin (no α4 and an increase in β1), CS-PG and no HS-PGs. The STO feeders that 
induced the most striking differentiation also produced all of the matrix components 
assayed but at the highest levels of them observed by immunohistochemistry, and were 
unique among the feeders assayed in making HS-PGS.   
 
Effects of purified Matrix Molecules on hHpSCs versus Hepatoblasts 
The hHpSCs were cultured in serum-free KM and on each of 5 different types of 
matrix components that were coated onto plastic dishes: fibronectin, laminin and type I, 
III or IV collagens. Few of the hHpSCs cells attached to fibronectin, and those that 
attached did not grow, surviving for only a few days (data not shown). hHpSCs lineage 
restricted to hepatoblasts if cultured on laminin, type IV collagen or if plated on the 
surface of type I collagen gels (Figure 5.10). Alternatively, the conditions were not 
permissive for hHpSCS and resulted in selection of hepatoblasts. Lineage tracking studies 
are required to decide between these two interpretations.   
When embedded into type I collagen, the hHpSCs differentiated the most, with the 
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morphology and antigenic profile of the colonies resembling mature hepatocytes  The 
data also complement and corroborate the findings of McClelland et al (submitted) that 
notes the response of hHpSCs to matrix components found in vivo in the periportal versus 
pericentral zone of the liver acinus.  
 
DISCUSSION 
Human hHpSCs remain as stem cells, undergo lineage restriction to hepatoblasts or 
more extensively differentiate depending on the mesenchymal feeder cells used in 
co-cultures. Three distinct classes of feeders have been identified: 1) minimal 
differentiation, that is maintenance of the stem cell state, occurs with feeders of 
endothelia or angioblasts without hHpSTCs or with quiescent hHpSTCs; 2) feeders 
replete with activated hHpSTCs yield lineage restriction to hepatoblasts; and 3) murine 
embryonic stroma, STO cells, yield more differentiated parenchymal cells. The behavior 
of the co-cultures parallels that observed during liver development governed by paracrine 
signals from mesenchyme adjacent to the epithelium (Lemaigre and Zaret, 2004; 
Matsumoto et al., 2001; Zaret, 2002) and is paralleled by our findings of the effects of 
specific and purified matrix factors used for cultures of hHpSCs.    
Interactions between endodermal and mesodermal tissues are important for hepatic 
development (Lammert et al., 2003; Matsumoto et al., 2001). Prior to hepatic induction, 
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septum transversum mesenchymal cells surround the developing cardiac region near the 
ventral foregut endoderm and are thought to be the source of various embryological 
inductive signals (Zaret, 2002). After these inductive signals, the hepatic endodermal 
epithelium becomes more proliferative, and the cells begin to bud into the mesenchymal 
environment. Mouse embryonic stem (ES) cells co-cultured with chick cardiogenic 
mesoderm could be induced to express endodermal transcription factors and several early 
liver-specific genes (Fair et al., 2003). We reported that mesenchymal “companion” cells, 
including angioblasts and quiescent hHpSTCs, are required for the survival and growth of 
hHpSC colonies in vitro (McClelland et al., 2007) and also reported that hedgehog 
signaling, long known to be important in angiogenesis and to regulate liver development, 
is important for ex vivo maintenance of hHpSCs derived from livers of all donor ages 
(Sicklick et al., 2006).  
Hepatic stellate cells have only recently been determined to be different in fetal 
versus adult tissues (Kubota et al., 2007), though this can be inferred by the studies on 
Lhx2-/- (Wandzioch et al., 2004) and those with striking biological activity on hHpSCs are 
from fetal tissues. The known distinctions are that HpSTC precursors found in fetal or 
embryonic tissues do not express GFAP, have low content of lipids, and express very low 
levels of desmin, vitamin A, and αSMA. By contrast, the HpSTCs from adult livers are 
GFAP+, have much higher levels of desmin, vitamin A, αSMA, and lipids; indeed it is the 
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lipid content of adult liver-derived hHpSTCs that has been utilized as a key feature in 
protocols for their purification (Geerts, 2001). Efforts are ongoing to discern distinctions 
in soluble paracrine signals from the fetal tissue-derived versus adult tissue-derived cells.  
Attempts to establish primary cultures of purified angioblasts or endothelia (KDR+, 
CD31+) from human fetal liver under serum-free conditions to enable them remain as 
angioblasts/endothelial cells were minimally successful. The cultures were positive for 
endothelial cell markers for ~5-7 days and then rapidly converted thereafter to 
stromal/stellate cultures uniformly expressing high levels of desmin and αSMA and losing 
entirely the endothelial cell markers (CD31, KDR, vWF). Although we cannot rule out 
culture selection for a pre-existing, initially minor subpopulation, we suspect that the 
hHpSTCs are lineage restricted from angioblasts based on shared markers (e.g. VCAM-1, 
β3 integrin) and on observations of hHpSTCs encircling clusters of angioblasts.  
It has been reported that HpSTCs (both rat and human) express low levels of αSMA 
in a quiescent state versus high levels of αSMA and collagen type I when activated during 
inflammation processes in vitro or in vivo (Abergel et al., 2006; Geerts, 2001; Shi et al., 
2006). Our culture conditions for the immunoselected cells from human fetal liver cell 
suspensions are hypothesized to have activated the hHpSTCs, leading to significant 
growth, and high αSMA and collagen type I expression.  
Signals produced by “activated hHpSTCs” overlap with but also are distinct from 
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those produced by the “quiescent stellate cells” surrounding the hHpSCs in our cultures. 
Brenner et al. found that activated hHpSTCs upregulated adhesion molecules such as 
ICAM-1 and secrete cytokines such as IL-6, IL-8, and RANTES (regulated on activation, 
normal T-cell expressed, and presumably secreted), and increase NF-κB activation 
(Hellerbrand et al., 1996; Paik et al., 2006; Schwabe et al., 2003). Other cytokines such as 
IL-10 and MCP-1 (monocyte chemo-attractant protein-1) also have been reported to be 
upregulated in activated hHpSTCs (Kisseleva and Brenner, 2006; Wang et al., 1998). It is 
hypothesized that signals produced by the hHpSTCs in the activated status dictate lineage 
restriction of the hHpSCs to hepatoblasts, an hypothesis now under investigation. 
     Matrix chemistry has long been known to be relevant to embryonic development 
(Corda et al., 2000; Davis and Senger, 2005; Dou and Levine, 1995). Fibronectin proved 
to be the matrix component that was expressed by all the feeders and the one produced at 
the highest levels by HUVECs. Given its universality among the feeders, it cannot be the 
explanation for the distinctions among them in their effects on hHpSCs in vitro.  
Moreover, the hHpSCs did not bind to fibronectin to any significant extent in the assays 
utilizing purified matrix components. Those that did bind did not grow. Indeed, 
fibronectin may be a critical matrix molecules needed by the feeders themselves. 
Fibronectin is widely used as a substratum for culturing HUVECs (Baudin et al., 2007).   
By contrast, the cells were able to bind to laminin and to several types of collagens 
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(type I, III and IV). We found that the HUVECs make laminin and type IV collagen, 
corroborating an earlier report that HUVECs produce collagen type IV and laminin in 
vitro (Corda et al., 2000).  
The αSMA+ fibroblast-like, human fetal liver-derived cells expressed collagen type I 
at both mRNA and protein levels suggesting these cells may be activated hHpSTCs. 
HpSTCs are known to express αSMA, collagen types I, III and IV, fibronectin, and 
laminin α1 and γ1 chains (Kikkawa et al., 2005; Schlaf et al., 2004; Shi et al., 2006; 
Uemura et al., 2005). TGF-β1-stimulated hHpSTCs upregulate collagen types I and III, 
fibronectin and αSMA. Expression of collagen type III was detected in the human fetal 
liver-derived CD31+ and αSMA+ cells, suggesting possible ECM remodeling events 
occurred in the culture of these two cell types.  
Chondroitin sulfate proteoglycan (CS-PG) was present at protein levels in both 
human fibroblast-like, fetal liver-derived cells and bone marrow-derived mesenchymal 
stem cells (hMSCs). The two feeders found to have CS-PGs caused lineage restriction of 
hHpSCs into hepatoblasts. So, CS-PGs are candidate signals for that process. It has been 
reported that CS-PGs can interact with chemokines, and their structure can be modified in 
TGF-β1-treated fibroblasts (Kawashima et al., 2002; Tiedemann et al., 2005). Therefore, 
CS-PGs, like heparan sulfate proteoglycans, are scaffolds for growth factors and other 
signals dictating how the factors are presented to the cells (Bernfield et al., 1992; 
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Kawashima et al., 2002; Ruoslahti and Yamaguchi, 1991; Vongchan et al., 2005). 
Interestingly, there appear to be distinct forms of CS-PGs present in many types of stem 
cell niches, ones with little to no sulphate groups (Caterson et al., personal 
communication). Caterson hypothesizes that the stem cell niche is dominated by GAGs 
with little to no sulfation such as hyaluronans and these minimally sulphated CS-PGS and 
could, therefore, act as a barrier minimizing the presentation of signals to the stem cells. 
As the stem cells are pushed out of the niche, they come into contact with GAGs and 
proteoglycans with more extensive sulfation and bound growth factors that could 
influence the stem cells either with respect to growth or with respect to lineage restriction 
to various differentiated cell fates. 
 The culture conditions used for growing HUVECs, typically containing serum, are 
not permissive for the expression of collagen type III at mRNA and/or in protein level. It 
has been reported that HUVECs have no expression of collagen type III at mRNA level 
(Hitraya et al., 1995). However, other studies showed positive expression of type III 
collagen in mRNA or protein level by endothelial cells (Maher and McGuire, 1990; Sales 
et al., 2006). Maher et al. showed that mRNA amount of type III collagen in rat sinusoidal 
endothelial cells was 15-fold higher than in hepatocytes, and was downregulated 45% 5 
days after bile duct ligation and upregulated 25% after tetrachloride administration 
(Maher and McGuire, 1990). Immunohistochemistry on normal human fetal livers 
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revealed positive staining of type III collagen at perisinusoidal endothelium (Couvelard et 
al., 1998). Endothelium is known to be heterogeneous in different tissues. It is not 
surprising that HUVECs may have different cellular characteristics than human fetal 
liver-derived endothelial cells.  
The most extensive differentiation, accompanied by a loss in growth potential, was 
observed in hHpSCs plated onto STO feeder cells; the hHpSCs went into growth arrest 
and erupted hepatoblasts and unipotent progenitors (committed biliary and hepatocytic 
progenitors). The STO feeders produced the highest levels of extracellular matrix and 
were unique in producing HS-PGs, forms of proteoglycans renown for operating as high 
affinity chemical scaffolds for growth factors (Bernfield et al., 1992; Kallunki and 
Tryggvason, 1992; Kim et al., 1994). HS-PGs have been purified and characterized from 
rodent livers by Gebhardt and associates (Pierce et al., 1992) and from human liver by 
Linhardt and associates (Vongchan et al., 2005). Maturation of the parenchymal cells is 
associated with heparan sulfates with higher degrees of sulfation (Geerts et al., 1986; 
Pierce et al., 1992; Roskams et al., 1995). Indeed, a form has been isolated that is a true 
heparin proteoglycan and is located in association with the most mature cells in the liver 
(Pierce et al., 1992; Vongchan et al., 2005).   
 The matrix substrata tested that induced such differentiation comprised ones with 
type I collagen. The extent of differentiation was found to differ depending on whether the 
 178
cells were plated on top of or embedded into the type I collagen. Indeed, cells 
morphologically similar to mature hepatocytes were found in those cultures embedded in 
the collagen (Figure 5.10). This is likely due both to a direct effect of type I collagen and 
also an indirect effect via stabilization of HS-PGs by type I collagen, an effect reported 
years ago by Bernfield and associates (Bernfield et al., 1992). Mature hepatocytes are 
known to bind directly to collagens, especially type I collagen, via an integrin unique to the 
hepatocytes, αVβ1 and not on biliary epithelia (Couvelard et al., 1998). Therefore, the 
differentiative response of the hHpSCs on or in type I collagen is likely to occur through 
direct effects and not through another ligand. More detailed characterizations of the cells 
on substrata of purified matrix components are given in two separate reports (McClelland 
et al., submitted).  
 In Figure 5.11, we summarize the known sequential changes in matrix 
components and matrix receptors that occur with the transitions from hHpSCs through 
hepatoblasts and ultimately to mature parenchymal cells and that combine our own data 
with that in the literature on mature parenchymal and non-parenchymal cells (Couvelard et 
al., 1998; Eichmann et al., 1997; Fornaro et al., 1998; Kikuchi et al., 2005). Our studies to 
date allow us to begin to transition to feeder-free cultures at least with respect to matrix 
requirements.  Completion of these efforts will be achieved with the identification of the 
soluble signals and assessment of synergies between them and the matrix signals.   
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TABLES 
Table 5.1. Effects of feeders/substratum on human hepatic stem/progenitors 
 
Substratum/Feeder 
Colony Morphology/Antigenic Profile of 
Cells Maintained for Feeders for a Week 
or more 
Plastic*** hHpSC 
HUVECs hHpSC 
hMSCs Hepatoblasts 
KDR+ Cells in first 
week 
hHpSCs 
KDR+ cells after 
7-10 days 
Initially mixture of hHpSCs and 
hepatoblasts that transitions rapidly to only 
hepatoblasts 
CD31+ Cells Hepatoblasts 
 
 
Liver Cell 
Suspensions 
immunoselected 
for: 
Depleted of 
stromal cells 
Hepatoblasts 
 
STO cells 
Growth-arrested hHpSCs with eruptions of 
hepatoblasts and committed (unipotent) 
progenitors 
Fibronectin Few cells attached; those that did rapidly 
lost viability 
Laminin Hepatoblasts 
Type III collagen hHpSCs 
Type IV collagen Hepatoblasts 
 Growth-arrested cells that are a mixture of 
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On surface of Type I collagen Hepatoblasts and committed (unipotent) 
progenitors 
Embedded in Type I collagen Mature hepatocytes 
All cultures were in serum-free KM.  
***Note: when cells are on culture plastic, the hHpSC colonies survive only when they 
are in association with companion cells comprised of angioblasts and/or hepatic stellate 
cell precursors.  
*Culture Morphology and antigenic profile: 
 hHpSC=colonies are monolayers with cells of uniform morphology, high nucleus to 
cytoplasmic ratio, ~7-9 µm in diameter, tightly packed and surrounded by companion 
cells that include angioblasts and hHpSTCs.  Unique Antigenic profile:  NCAM+, 
Claudin 3+, albumin±, AFP-. 
 Hepatoblasts= colonies that are more 3-dimensional, with cord-like structure 
interspersed by clear channels (bile canaliculi) and with cells that are slightly larger 
(10-12 µm) in diameter. Unique antigenic profile: ICAM+, Claudin 3-, albumin++, AFP++.  
 
Shared antigenic profile between hHpSCs and hepatoblasts: positive for EpCAM, 
CK-8, -18, and -19, Sonic hedgehog (shh), Indian hedgehog (ihh), telomerase; negative 
for hemopoietic markers (CD34, CD45, CD38, glycophorin A), for hepatic stellate cell 
markers (desmin and αSMA) and for endothelial cell markers (VEGFR2, CD31, vWF). 
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Table 5.2. Extracellular matrix components produced by different feeders: 
Immunohistochemistry (IHC) Assays  
 
Human fetal liver-derived ECM 
Molecules 
hHpSCs w/ 
companion 
cells 
 
HUVECs 
 
hMSCs CD31+ KDR+ Depletion 
of stroma 
STO 
Type III 
collagen 
 
++ 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
Type IV 
collagen 
 
+ 
 
+ 
 
- 
 
+ 
 
+ 
 
+ 
 
++ 
Type I 
collagen 
 
- 
 
- 
 
- 
 
- 
 
- 
 
+ 
 
++ 
Laminin - - - + + + ++ 
Fibronectin - + + + + + ++ 
Heparan 
sulfate-PG 
 
n.d. 
 
- 
 
- 
 
- 
 
- 
 
- 
 
++ 
Chondroitin 
sulfate-PG 
 
n.d. 
 
- 
 
+ 
 
- 
 
- 
 
+ 
 
n.d. 
Effects of 
feeder on 
hHpScs 
 
Self-replication 
 
Lineage restriction to hepatoblasts 
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FIGURE LEGENDS 
Figure 5.1. Colony of hHpSCs and human hepatoblasts in culture: 
 Both hHpSC colony (A) and human hepatoblasts (B) expressed EpCAM (shown in 
green). NCAM (shown in red, A) was expressed near peripheral region and the center of 
the colony. Hepatoblasts expressed strongly alpha-fetoprotein (AFP, shown in red, B). 
Both cells were stained with DAPI (blue). Scale bar, 100 µm. 
 
Figure 5.2.  Cell surrounding a colony of hHpSCs are αSMA+ hHpSTCs: 
Cells surrounding a colony of human hepatic stem cells (hHpSCs) are αSMA+ 
hHpSTCs. A typical human hepatic stem cell colony (A) is positive for NCAM inside the 
colony (B, D) and for αSMA in the companion cells at the edge of colony (C, D). 
Magnification, 10x. 
 
Figure 5.3. Primary culture of hHpSCs with Angioblasts: 
  KDR+ selected cells cultured in EGM-2 for 7 days expressed vWF (green) (A and 
B). CD31+ selected cells cultured in EGM-2 for 4 days expressed both vWF (green) and 
CD31 (red) (C). Scale bar, 100 µm. Angioblasts associated with hHpSC colony in culture 
(D). Magnification, 10x. 
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Figure 5.4.  Quiescent versus Activated hHpSTCs 
 Quiescent hHpSTCs express low levels of desmin, αSMA, CD146, type I collagen, 
and other matrix molecules (fibronectin, proteoglycans). Injury processes, especially 
exposure to serum or to certain factors (e.g. PDGF and TGF-β1), causes them to activate 
and to transition to myofibroblast-like stromal cells with greatly elevated production of 
αSMA, matrix components, and release of various growth factors such as HGF. Shown is 
a colony of hHpSCs encircled by companion cells expressing low levels of CD146. On 
the same plate, there is an adjacent colony with companion cells that have undergone 
activation resulting in very high levels of CD146.   
  
Figure 5.5  Morphology and immunohistochemistry of different feeders: 
A: hMSCs. B: HUVECs. C-D: human fetal liver-derived feeder cells on days 4 (C) 
and 7 (D). E-H: day-11 culture of magnetically immunoselected KDR+ cells (E-F) and 
supernatant cells depleted of fibroblasts (G-H) in serum-free (or low-serum; data not 
shown) condition were positive for αSMA (F and H). Magnification, 10x. 
 
Figure 5.6.  Immunohistochemistry on fibroblast-depleted supernatant cells 
cultured in EGM-2 medium for 8 days:  
Cells are positive for desmin (B and H), αSMA (I), laminin (C), fibronectin (F), 
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collagen types I (L) and IV (E), and negative for endothelial marker, vWF (K). Note that 
more cells express αSMA than desmin. Phase contrast image for each double staining is 
shown (A, D, G, and J). Bar, 50µm. 
 
Figure 5.7.  Human hHpSCs co-cultured with different feeders.  
A-F: human hHpSCs cultured alone (A ), co-cultured with HUVECs (B), hMSCs (C), 
or human fetal liver-derived feeders (D). Magnification, 10x. 
 
Figure 5.8.  Human hHpSCs co-cultured with αSMA+ supernatant cells, from 
which fibroblasts were depleted, derived from human fetal livers.   
Use of these feeders resulted in lineage restriction to hepatoblasts. 
Immunohistochemistry for human AFP on human hepatic stem cell colonies (A and B) 
and on co-culture of hHpSCs and human fetal liver-derived feeders (C and D) at day 8. 
Magnification, 10x. 
 
Figure 5.9.  Normalized mRNA expression of matrix molecules 
Fold changes of the mRNA expression levels in each cell type were normalized to the 
ribosomal RNA (18S) of the same cell type. 
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Figure 5.10.  Behavior of hHpSCs on substrata of purified matrix components: 
 The hHpSCs maintain their stem cell characteristic on plastic or on type III collagen 
(A and B). hHpSCs lineage restricted to hepatoblasts on top of type IV collagen or on 
laminin (C and D). hHpSCs further differentiated into mature hepatocytes when 
embedded in type I collagen gel. Higher magnification for D. 
 
Figure 5.11. Summary of the changes in matrix mhemistry and matrix receptors in 
the hHpSCs and their mesenchymal cell partners during differentiation.   
The summary is prepared from a combination of our findings (data on the hHpSCs, 
hepatoblasts, hHpSTCs and other human liver-derived feeders) and those in the literature 
(angioblasts and endothelia from other sources and mature biliary epithelia). 
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CHAPTER VI 
IMMUNOSELECTION OF CELLS BY ENDOTHELIAL MARKERS AND THE 
DEVELOPMENT OF THE SERUM-FREE DEFINED MEDIUM FOR ANGIOBLASTS 
 
 Endothelial cells play an important role in normal liver development and during liver 
regeneration. Through paracrine signaling, the endothelial cells release key cytokines and 
growth factors that induce hepatic progenitor cells to grow and/or differentiate during 
organogenesis. To study the effects of paracrine signals from endothelial cells on hepatic 
progenitor cells in vitro, establishing a model system utilizing liver-derived angioblasts or 
endothelial cells is critical. To achieve this requires methods for purifying the angioblasts or 
endothelial cells as well as wholly defined culture conditions permissive for these two 
categories of cells. In this chapter I describe my findings for both of these methodologies, 
methods that were partially successful and that should lead relatively quickly to completed 
ones for use with human fetal liver-derived angioblasts and endothelia.  Further, the model 
systems being established should facilitate analyses of paracrine signaling events between 
liver-specific angioblasts/endothelia and hepatic parenchymal cells.  
 
 
 
 
RESULTS 
Isolation and expansion of endothelial progenitor cells from human fetal livers 
The first attempt on isolation and expansion of endothelial progenitor cells (EPCs) 
from human fetal livers was done by density gradient separation method and with EndoCult 
Liquid Medium from StemCell Technologies, Inc. The density gradient separation 
methodologies have been widely used to isolate endothelial cells from human peripheral 
blood. The EndoCult Liquid Medium Kit is designed specifically for growth of human EPCs 
isolated from human peripheral blood, cord blood and bone marrow. Cells at the interface 
layer after density gradient separation presented as fibroblast-like cells in the EndoCult 
Liquid Medium on plastic and on collagen type I-coated plates. Possible contamination of  
the cell suspensions with fibroblastic cells could allow for their selection over that of the  
endothelial cells. To eliminate contamination by fibroblastic cells, anti-human fibroblast 
microbeads were used with the magnetically activated cell sorting system from Miltenyi 
Biotec to debulk or deplete these cells after density gradient separation. Yet, the fibroblast-
depleted cell population cultured in EndoCult Liquid Medium on plastic and on collagen type 
I-coated plates still gave rise to fibroblast-like cells. Immunohistochemistry on the fibroblast-
depleted population cultured on plastic showed negative staining for the endothelial marker, 
von Willebrand factor (vWF), but positive for α-smooth muscle actin (αSMA) and desmin, 
markers indicating hepatic stellate cells (HpSTCs) (Figure 6.1). Whether or not the 
immunoselection method worked cannot be determined, since the culture conditions strongly 
selected for HpSTCs or caused any angioblasts/endothelia present to transition into HpSTCs.  
The failure of this strategy led to attempts to immunoselect angioblasts/endothelia using 
endothelial marker-specific antibodies. 
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Cell surface markers that have been used for immunoselection of 
angioblasts/endothelia include CD133/1, CD34, CD105 (endoglin), KDR (VEGFR2/flk-1) 
and CD31 (PECAM). The percentage of each antigenic positive cell population in human 
fetal liver cell suspensions is shown in the Table 6.1. In primary cell cultures, CD105+-, 
CD133/1+-, and EpCAM-/KDR+-sorted cells plated onto culture plastic gave rise to 
fibroblast-like cells in both serum-supplemented KM and in EndoCult Liquid Medium. By 
contrast, CD133/1+-sorted cells yielded parenchymal-like cells (Figure 6.2). Since CD133/1 
is expressed also on HpSCs, it was necessary to learn if the immunoselection had isolated 
them or the angioblasts. Immunochemical staining on the 6-day primary culture of CD133/1+ 
cells showed that both parenchymal-like cells and fibroblast-like cells are negative for 
CD146, KDR, CD133/1 and CD34, and that the parenchymal-like cells are positive for 
NCAM and weakly expressed EpCAM, indicating that these are HpSCs (Figure 6.2). In the 
passage 1 cell cultures of both CD133/1+ and EpCAM-/KDR+ sorted cells in low-serum 
media, only fibroblast-like cells were observed and these grew very fast under the culture 
conditions used. Immunohistochemistry staining indicated that the cells were negative for 
endothelial markers (CD31 (PECAM), CD133/1 and KDR), negative for HpSC markers 
(EpCAM and NCAM), but positive for CD29f (β1 integrin), a membrane protein expressed 
on fibroblasts and various other cell types, but not on the endothelial cells. CD34-selected 
cells resulted in minimum attachment after plating.  
To debulk the cell suspensions of parenchymal cells prior to immunoselection for 
angioblasts/endothelia, the human fetal livers were processed to permit the parenchymal cells 
to remain as clumps and then fractionated them into a pellet with slow-speed centrifugation 
spins. The supernatent was then used for immunoselection using endothelial cell markers.  
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KDR+ cells selected from supernatant cells after slow-speed spin using indirect isolation 
method occupied 0.33% of total liver cells in the supernatent. Immunohistochemistry on 
paraffin-embedded human fetal liver sections using monoclonal anti-human KDR antibody 
showed positive expression of KDR at blood vessels including those associated with ductal 
plates (Figure 6.3). The KDR-selected cells cultured within EGM-2 (Endothelial Growth 
Medium supplemented with 2% of FBS (fetal bovine serum) from Cambrex Inc.) gave rise to 
cultures of endothelial cells as recognized morphologically (Figure 6.3). 
Immunohistochemistry showed positive expression of CD31, KDR and vWF by these cells in 
7-day cultures, indicating their identity as endothelial cells (Figure 6.3). However, the culture 
is dominated by HpSTCs recognizable by αSMA+/vWF- non-endothelial cells. These 
fibroblast-like cells could be hepatic stellate cells.  
CD31+ cells selected from supernatant cells after slow speed-spins using direct 
isolation method yielded 1.6% of total liver cells. The CD31-selected cells cultured within 
EGM-2 on plastic gave rise to endothelial cells with the majority of cells expressing both 
CD31 and vWF for the first 4-5 days (Figure 6.4). After 5 days of culture, fibroblast-like 
cells began to appear, grew rapidly and quickly dominated the cultures within another 3 days 
(by 8 days of culture). Passaging of the endothelial cells at 4 days, prior to the take-over of 
the stroma, did not help. After 4 days of culture, fibroblast-like cells began to outgrowth the 
passaged endothelial cells. Clearly, immunoselection using endothelial cell markers can 
enrich for angioblasts/endothelial subpopulations, but they are outcompeted by stroma and 
HpSTCs by the culture conditions used: culture plastic and medium with any serum.  
Efforts to convert to serum-free medium were not successful initially. EGM without 
serum was tried with the CD31+ sorted cells but only after 4 days of culture in 2% FBS-
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supplemented EGM (EGM-2). The endothelial population was sustained for a few days 
without cell growth, but then gradually died off in the culture. When changed back to EGM-2, 
fibroblast-like cells had survived the few days without serum and began to grow rapidly, 
quickly dominating the culture. The stroma/fibroblast-like cells seem to survive better than 
the angioblasts/endothelia under short-term serum-free conditions.  As has been shown 
previously, it is not logical to culture for several days with serum and then convert to serum 
free conditions.  Rather, one has to develop a serum-free, wholly defined medium into which 
one can plate cells immediately.  To do that requires ideally that one use an endothelial cell 
line, already adapted to culture, as a model and develop a hormonally defined medium for it.  
That hormonally defined medium can be used as a starting point for establishing serum-free, 
wholly defined conditions for primary cultures of angioblasts/endothelia.  
 
Partial Development of Serum-free medium for maintaining HUVECs in vitro 
A serum-free medium has been developed for maintaining HUVECs (human 
umbilical vein endothelial cells) on tissue culture plastic and on fibronectin for up to three 
weeks. Components of this medium include RPMI 1640 basal medium (85%), Invitrogen’s 
knock-out serum-replacement reagent (15%), L-glutamine (1mM), 2-mercaptoethanol (0.1 
mM), and 10 ng/ml each of FGF-basic, LIF, VEGF, and EGF. In three test runs of using this 
medium for HUVEC cells, one round completely failed (no cell survival in 48 hours after 
changing to serum-free medium); one showed 4 days of survival but no cell growth, followed 
by cell death; and the third run showed 26 days of survival with similar cell growth compared 
with HUVECs in EGM-2 medium (Figure 6.5). The HUVECs cultured in the serum-free 
medium expressed vWF and CD31. Whether the cells survived or not was due, presumably, 
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to when the switch to the hormonally defined medium occurred after plating. This hints that 
matrix substrata must be identified to complete the definition of the serum-free conditions. 
Preliminary results testing this medium on immunoselected endothelial cells (CD133+ and 
KDR+) indicated failure: no endothelial cells survived in the culture.  Although the results 
seem a failure, it is more likely that the medium as is (or with perhaps a factor or two) could 
still be valuable if an appropriate extracellular matrix substrata is found to use in combination 
with the medium. Matrix substrata are the primary determinants of attachment and survival 
of cells. Thus, there is considerable hope that matrix components plus the medium developed 
thus far will enable wholly defined conditions for angioblasts/endothelia to be established.  
Candidate matrix substrata, based on evidence in the literature (including the integrins 
expressed by angioblasts/endothelia) include at least three types of collagen (type III, type IV 
and type VI), laminin, and hyaluronans (or a combination of these matrix molecules).  
 
DISCUSSION 
Isolation and expansion of endothelial progenitor cells from human fetal livers 
Previous studies showed that both the endothelial progenitor cells (EPCs, or 
angioblasts) and hemangioblasts express KDR, CD133/1, CD34, and CD117, where 
expression of CD34 and CD117 are also shared with hematopoietic stem cells and expression 
of KDR is also shared with mature endothelial cells. As EPCs differentiate into mature 
endothelial cells, CD133/1 expression is downregulated. Therefore, immunoselection of 
CD133/1+ or KDR+ cells should be able to fish out the EPCs. The results from my 
experiments, however, did not prove this hypothesis due, in part, to inefficiency of the 
magnetically activated cell sorting (MACS) selection method, and, more importantly, to the 
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fact that I did not have serum-free defined culture conditions that could be selective for the 
cells.  
Any culture medium supplemented with serum results in rapid selection for 
stroma/fibroblasts or HpSTCs more efficiently than for the EPCs and committed/mature 
endothelial cells. CD133/1, prominin, has been reported to be expressed by not only the 
EPCs, but also variety of tissue-specific precursor cells as well as many cancer cells. 
Previous studies in our lab showed that hHpSCs express CD133/1. Cells selected by anti-
human CD133/1 microbeads gave rise to both non-parenchymal cells and hepatic 
parenchymal cells, supporting the concept that CD133/1 is shared by at least two cell types 
within the human fetal livers: angioblasts and HpSCs. 
The term, EPC, encompasses subpopulations of endothelial cells ranging from 
hemangioblasts to fully differentiated endothelial cells.  Angioblasts are immature EPCs that 
express CD133/1, whereas mature endothelial cells do not express CD133/1. There also 
might be distinctions in the phenotype of angioblasts or endothelia from different tissues (e.g. 
hepatic and pancreatic associated EPCs).   Thus, it is possible that angioblasts could give rise 
to committed EPCs that have tissue-specificity. If so, the antigenic profile of these candidate 
tissue-specific EPCs may not be exactly the same as the antigenic profile of angioblasts. 
Testing this hypothesis must await the completion of the establishment of serum-free, wholly 
defined conditions for angioblasts/endothelia, so that model systems of any tissue-specific 
forms might be established.  
KDR and CD31 were found to be the most efficient markers among those tested for 
immunoselection of endothelial cells from human fetal livers. The EpCAM-/KDR+ sorted 
cells gave rise only to fibroblast-like cells in the culture, whereas KDR+ cells selected from 
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the total cell population gave rise to both endothelial cells and hHpSTCs (αSMA+ fibroblast-
like cells). Two possible reasons could be considered to explain the paradox. First, 
endothelial cells tend to form aggregates with parenchymal cells that are positive for EpCAM. 
Isolation method involving depletion of EpCAM+ parenchymal cells may in fact also deplete 
endothelial cells. Secondly, the antibody used for selecting endothelial cells from the 
interface layer of density gradient separations was rabbit anti-human KDR IgG where the one 
used for selecting EPCs from supernatant after slow-spin was mouse monoclonal anti-human 
KDR IgG1. The monoclonal antibody generated from mice may be more specific than the 
polyclonal antibody generated from rabbit. Less specific antibody could result in lower purity 
of the interesting cells and higher contamination from other cell types.  
The reason that fibroblast-like cells always dominated the culture after one week is 
most likely to be the use of serum, a problem noted by investigators for more than 50 years. 
Serum supplied in the culture media could either select for specific subpopulations (that is 
the stroma) or could lineage restrict the angioblasts/endothelia to cell types with a stromal/ 
fibroblastic and/or hHpSTCs phenotype. Either interpretation indicates that there is a strong 
need for completing the development of serum-free conditions that would select for and 
would sustain angioblasts and their descendents, endothelia. The lack of appropriate culture 
conditions is compounded by the fact that magnetic immunoselection technologies do not 
result in high purity of endothelial cell subpopulations. The extent of contamination of the 
endothelia/angioblasts by smooth muscle cells, HpSTCs, and other mesenchymal cell types 
in combination with culture conditions that strongly select for these contaminating cell types 
can obviate the efforts to establish model systems of angioblasts and endothelia.  
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Development of Serum-free Conditions for maintaining HUVECs in vitro 
 HUVECs were able to survive and expand in both EGM-2 and in the partially defined 
conditions that included a serum-free medium supplemented with four growth factors. FGF-
basic and LIF have been used widely in culturing human and mouse embryonic stem (ES) 
cells. VEGF and EGF have been reported to promote cell growth of endothelial progenitor 
cells. Combination of these four growth factors enabled HUVECs to grow on plastic or on 
fibronectin-coated plates. However, the preliminary studies testing this serum-free medium 
on primary cutures of endothelial cells immunoselected from human fetal livers were not 
successful. EGM-2 could be used to grow immunomagnetically sorted CD31+ cells on plastic, 
although fibroblast-like cells grow fast after 5 days in the same medium. Compared with 
HUVECs, a mature endothelial cell type, the human fetal liver-derived endothelial progenitor 
cells (EPCs) may need more key molecules in order to proliferate in vitro. These key 
molecules could be provided by serum. Components of EGM-2 that are not in the newly 
developed serum-free medium include IGF-1 (insulin-like growth factor-1), heparin, 
hydrocortisone, ascorbic acid and FBS. The concentrations of each ingredient in the EGM-2 
as well as the exact components of the basal medium of EGM-2 are proprietary information 
of the manufacturer. Perhaps this information could also help to develop further the serum-
free conditions for human fetal liver-derived EPCs.  
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TABLE 
Table 6.1. Percentages of cells selected by magnetically activated cell sorting (MACS) 
method using surface marker-specific antibodies in human fetal liver cell suspension 
Surface markers Cell populations before selection Average of 3 
Experiments
Cells after slow speed spin without Ficoll 0.4% 
Interface cells after Ficoll-density gradient 
separation, no slow-speed spin 
0.48% 
CD133/1 
(direct selection using 
anti-human CD133/1 
microbeads) Interface cells after Ficoll-density gradient 
separation of supernatant cells after slow-spin 
 
0.22% 
KDR 
(indirect selection with 
rabbit anti-human KDR 
IgG, Assay Designs) 
EpCAM- interface cells after Ficoll-density 
gradient separation of supernatant cells after 
slow-speed spin 
 
0.5% 
KDR 
(indirect selection with 
mouse anti-human KDR 
IgG1, Cell Sciences) 
 
Supernatant cells after slow-speed spin 
 
0.33% 
CD31 
(direct selection using 
anti-human CD31 
microbeads) 
 
Supernatant cells after slow-speed spin 
 
1.6% 
CD105 
(direct selection using 
anti-human CD105 
microbeads) 
 
Fibroblast-depleted interface cells after 
Ficoll-density gradient separation 
 
4% 
CD34 
(indirect selection) 
Interface cells after Ficoll-density gradient 
separation 
1% 
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FIGURE LEGENDS 
Figure 6.1. Fibroblast-depleted human fetal liver-derived cell population cultured on 
plastic 
 Most cells presented as fibroblast-like cells and expressed both αSMA and desmin 
indicating that they are mostly HpSTCs. Scale bar, 100 µm. Phase contrast (A) and 
fluorescent (B) images are different regions of the cell culture. 
 
Figure 6.2. CD133/1+ cells selected by magnetically activated cell sorting (MACS) from 
human fetal livers 
 Phase contrast (A and C) and fluorescent (B and D) images of the CD133+ human 
fetal liver-derived cells cultured on plastic. Some cells are positive for NCAM (A and B), 
one marker of human hepatic stem cells (hHpSCs). A few cells are positive for EpCAM (C 
and D), another marker for hHpSCs. Scale bar, 100 µm. 
 
Figure 6.3. In vivo and in vitro identification of angioblasts/endothelial cells from 
human fetal livers 
 KDR+ cells are located mostly at blood vessels including that associated with ductal 
plate (B). Negative control (A) was done with secondary antibody only. KDR+ cells selected 
by MACS method and cultured on plastic for 7 days were positive for CD31 (PECAM) (C 
and D), vWF (von Willebrand factor) (E and F) and KDR (G and H), three endothelial 
markers. Scale bar, 100 µm. 
 
Figure 6.4. Cells selected by anti-human CD31 microbeads from human fetal livers 
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 CD31+ cells cultured in EGM-2 on plstic for 4 days strongly expressed CD31 (red) 
and vWF (green). Scale bar, 100 µm. Phase contrast (A) and fluorescent (B) images are 
different regions of the cell culture. 
 
Figure 6.5 HUVECs cultured in two different media on plastic for 26 days. 
 HUVECs cultured on tissue culture plastic and in EGM-2 (A) versus in partially 
developed serum-free medium (B). Magnification, 10x. 
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CHAPTER VII 
MOUSE EMBRYONIC FIBROBLAST-SECRETED SIGNALS PROMOTE CELL 
GROWTH OF LIVER PROGENITORS 
(Data was produced by Mr. Joshua Uronis, research analyst in the lab. Results were 
organized and discussion prepared by Hsin-Lei Yao.) 
 
 Mouse embryonic fibroblasts, STO cells from SIM (Sandos Inbred Mice) embryonic 
mouse stroma, have long been used as a feeder to support a variety of cells in culture, 
including embryonic stem cell (Martin and Evans, 1975), rodent hepatoblasts (Kubota and 
Reid, 2000), spermatogonial stem cells (Kubota et al, 2004; Kubota and Brinster, 2006); 
human hepatic stem cells and hepatoblasts (Schmelzer et al, 2007), and rodent HpSTCS 
(Kubuto et al, 2007). The molecular mechanism by which STO cells maintain the supported 
cell types in vitro is still understood though facets of the paracrine signaling are described 
below. Here we showed that a serum-free hormonally defined medium conditioned by STO 
cells was able to promote expansion of two hepatoblast-like, cloned cell lines, one from fetal 
rat livers, RTER6, and the other from a well differentiated human hepatoma, HepG2. Precise 
combinations of different STO cell-secreted matrix components (embryonic collagens, 
laminin, certain proteoglycans) and soluble signals, such as leukemia inhibitory factor (LIF), 
interleukin-6 or -11 (IL-6 or -11) and transforming growth factor-β1 (TGF-β1), may be 
crticial factors in regulation of the associated hepatic progenitor cells.  
 
RESULTS 
Effects of Mesenchymal Cells Conditioned Media on Colony Formation of Rat Hepatic 
Progenitor (rter6) Cells and Human Hepatoblastoma (HepG2) Cells 
 Rat hepatic progenitor cells (rter6) are unable to generate colonies efficiently on inert 
substrata such as plastic or on extracellular matrix-coated plates but will produce colonies if 
on STO feeders (Kubota and Reid, 2000). In this experiment rter6 cells were cultured on top 
of either mouse embryonic fibroblast cell line (STO cells) or human fetal lung fibroblast cell 
line (MRC5). The stocks of feeders were grown in serum supplemented medium until 
confluence, were rinsed thoroughly, and then switched to serum-free KM for 48 hours to 
generate a serum-free, conditioned medium. The colony numbers of rter6 cells co-cultured 
for 10 days with STO feeder cells in serum-free medim supplemented with STO conditioned 
medium increased 2.39-fold compared with KM (Table 7.1). Colony number of rter6 cells 
co-cultured for 10 days with MRC5 feeder cells in serum-free mouse embryonic fibroblast 
(STO) conditioned medium increased 1.57-fold compared with in hormonally-defined 
medium (HDM) (Table 7.1). In serum-free HDM, MRC5 cells seemed to promote more 
colony formation of rter6 cells compared with STO feeder. In STO conditioned medium, 
rter6 cells on both feeders had the similar colony formation ability. 
 Human hepatoblastoma (HepG2) cells can form colony on uncoated tissue culture 
plastic. Serum-free conditioned media from four different feeder cell types were used to test 
the colony formation of HepG2 cells. These four feeder cells include (1) mouse embryonic 
fibroblast cell line (STO cells); (2) human fetal lung fibroblast cell line (MRC5 cells); (3) 
immortalized adult human hepatic stellate cell line (h-tert-HSC); and (4) primary human fetal 
liver-derived stromal cells. Compared with hormonally-defined medium (HDM), the serum-
 217
free STO conditioned medium increased colony formation of HepG2 cells, while the serum-
free media conditioned by MRC5 cells, h-tert-HSC or primary human fetal liver-derived 
stromal cells had inhibitory effects on HepG2 cell colony formation. 
 
Enzyme-Linked Immunoabsorbent Assay (ELISA) on Conditioned Media from STO 
Cells, Human Fetal Liver Cells, and Co-culture of Both 
 Concentration of 23 human cytokines, 17 mouse cytokines and 2 non-species specific 
cytokines were tested on cultured media conditioned by STO feeder, human fetal liver-
derived progenitor cells and co-culture of both. For human cytokines, increased 
concentration of soluble interleukin-1 receptorα (IL-1Rα), interleukin-1α (IL-1α), IL-2, IL-4, 
IL-5, IL-10, IL-12, IL-13, macrophage chemoattractant protein-2 (MCP-2), eotaxin, soluble 
tumor necrosis factor receptor2 (sTNF-R2), and regulated on activation, normal T-cell 
expressed, and presumably secreted (RANTES) was observed in co-culture compare with 
human fetal liver-derived progenitor cells cultured alone (Figure 7.1, Table 7.2). Those with 
decreased concentration in co-culture include interleukin-11 (IL-11), granulocye 
macrophage-colony stimulating factor (GM-CSF), macrophage inflammatory protein-1α 
(MIP-1α), MIP-1β, soluble TNF receptor1 (sTNF-R1) and hepatocyte growth factor (HGF) 
(Figure 7.2). 
For mouse cytokines, increased concentration of interleukin-2 (IL-2), IL-4, IL-5, IL-6, 
IL-10, IL-11, IL-12, granulocye macrophage-colony stimulating factor (GM-CSF), eotaxin, 
granulocyte-colony stimulating factor (G-CSF), macrophage inflammatory protein-1α (MIP-
1α), interferon-γ (IFN-γ) and lipopolysaccharide-induced CXC chemokine (LIX) were 
observed in co-culture compared with STO cells cultured alone (Figure 7.2, Table 7.2). There 
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was no significant decrease of concentration of any mouse cytokines tested in co-culture.  
For non-species specific cytokines, transforming growth factor-β1 (TGF-β1) was increased in 
co-culture (532.3 pg/ml) compared with STO cells cultured alone (10.2 pg/ml) and with 
human fetal liver-derived progenitor cells cultured alone (22.3 pg/ml).  
Human hepatic stem cells have been found to differentiate into hepatoblasts when co-
cultured with STO feeder cells (Schmelzer et al, 2007 JEM). Combined concentration of 
human and mouse cytokines in co-culture revealed that interleukin-4 (IL-4), IL-5, IL-10, 
CXC chemokine (mouse keratinocyte-derived chemokines (KC) and human IL-8), eotaxin, 
macrophage chemoattractant protein-1 (MCP-1) and regulated on activation, normal T-cell 
expressed, and presumably secreted (RANTES) had dramatic increase (≥ 5-fold and > 50 
pg/ml) of protein concentration compared with human fetal liver cells cultured alone (Table 
7.2).  
 
Effects of Soluble Cytokines on Colony Formation of Rat Hepatic Progenitor 
(rter6)  Cells and Human Hepatocarcinoma (HepG2) Cells 
Nine cytokines have been added individually into serum-free, hormonally-defined 
medium (HDM) used for 10 days to test their effect on colony formation of rat hepatic 
progenitor cells (rter6 cells) grown on STO feeder layers. Leukemia inhibitory factor (LIF, 
0.5 ng/ml), interleukin-11 (IL-11, 10 ng/ml), and transforming growth factor-β1 (TGF-β1, 
0.05 ng/ml) increased the colony number and colony area of rter6 cells compared with 
controls (Figure 7.3). Interleukin-6 (IL-6), interleukin-13 (IL-13), hepatocyte growth factor 
(HGF), growth related oncogene-α (GRO-α), macrophage inflammatory protein-1α (MIP-1α) 
and tumor necrosis factor-α (TNF-α) had no effect on colony formation of rter6 cells.   
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 Several cytokines and candidate stimulatory molecules were added individually into 
HDM and STO conditioned medium to test their effects on colony formation of HepG2 cells. 
Hydrocortisone increased colony formation 25% in both HDM and STO conditioned medium 
compared with control. Insulin-like growth factor-II (IGF-II), interleukin-6 (IL-6), 
interleukin-11 (IL-11), interleukin-13 (IL-13), tumor necrosis factor-α (TNF-α), growth 
related oncogene (GRO; CXC chemokine), human growth hormones, and high density 
lipoproteins (HDL) had no effects on HepG2 cell colony formation. Transforming growth 
factor-β1 (TGF-β1) had inhibitory effect on HepG2 cell growth as well as survival. 
Epidermal growth factor (EGF) significantly decreased HepG2 colony formation and caused 
the cells to migrate away from colonies. Soon after separated from colonies, the dispersed 
cells died quickly.  
 
DISCUSSION 
Mouse embryonic fibroblast (STO) conditioned medium increased colony formation 
of both rat hepatic progenitor (rter6) cells and a well differentiated human hepatoma (HepG2) 
cells when compared with non-conditioned medium. This finding suggests soluble signals 
secreted by STO cells could promote proliferation of hepatic progenitors derived from two 
mammalian species in vitro. However, our previous study showed that primary human 
hepatic stem cells (hHpSCs) derived from human fetal livers cultured on top of STO feeder 
demonstrated slower cell growth and differentiated into hepatoblasts (Schmelzer et al., 2007 
JEM). Two possible reasons could explain these conflictive results. HepG2 cells are derived 
from adult liver-derived hepatoma, thus representing an abnormal human cell type that is 
different than freshly isolated human fetal liver-derived HpSCs. Rter6 cells are derived from 
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fetal rat liver and are partially transformed to be able to establish them as a clonogenic cell 
line; they are also a different species than human. Some signals produced by STO cells that 
induce differentiation and reduce cell growth of primary human hepatic stem cells may have 
no effect on rter6 and HepG2 cells.  
Interleukin-11 (IL-11) and leukemia inhibitory factor (LIF) promoted colony 
formation of rat hepatic progenitor (rter6) cells on top of STO feeder. IL-11 and LIF are two 
members of IL-6 cytokine superfamily. LIF has been shown to support mouse ES cells 
sufficiently in vitro in feeder-free condition (Smith et al., 1988; Williams et al., 1988). Our 
finding supports the positive role of IL-6 cytokine family in promoting growth of progenitor 
cells in vitro. The inhibitory effect of EGF on HepG2 cells compliments our previous study 
that EGF reduced colony formation of rat hepatoblasts but increased colony formation of   
diploid adult rat hepatocytes (Kubota and Reid, 2000).  
TGF-beta1 increased colony number and area of rter6 cells on top of STO feeder, but 
inhibited cell growth of HepG2 cells on plastic. It seems that TGF-beta1 has biphasic effects 
on hepatic progenitor cells derived from two different species. However, the concentration 
used for stimulating HepG2 cells (5 ng/ml) was 100-fold higher than that for rter6 cells (0.05 
ng/ml). It is possible that cytokine effect from TGF-beta1 is dosage dependent where limited 
amount of TGF-beta1 could promote proliferation of hepatic progenitor cells but too much 
dosage would have inhibitory effect on cell growth. There might be a threshold concentration 
of TGF-beta1 below which thehepatic progenitor cells could benefit from it.  
 This is the first report of large screening of protein concentration of over forty human 
and mouse cytokines produced by mouse embryonic fibroblast (STO) cell line and human 
hepatic stem cells in vitro using emzyme-linked immunoabsorbent assay (ELISA). Co-
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culture of human hepatic stem cells (hHpSCs) and STO feeder cells induced higher 
expression of several human and mouse cytokines including in majority the inflammatory 
signals and some factors known to be hepatic growth stimulating. Interleukin-4 (IL-4) is one 
of the inflammatory cytokines that elevated dramatically in the co-culture. The biological 
activities of interleukin-4 (IL-4) and IL-13 overlap as they bind the same receptor, IL-13 
receptor (IL-13R), a heterodimer consisting of IL-13Rα1 chain and IL-4 receptor α chain (IL-
4α) (Mentink-Kane and Wynn, 2004; Umeshita-Suyama et al., 2000). Both IL-4 and IL-13 
utilize IL-4α/Stat6 signaling pathway and mediate inflammation of the liver. Liver fibrosis is 
significantly reduced in the combined absence of IL-4 and IL-13 (Chiaramonte et al. 1999). 
Interleukin-5 (IL-5) and eotaxin are two inflammatory cytokines triggering liver fibrosis. 
Expression of IL-5 and eotaxin is induced by IL-4/Stat6 signaling pathway (Duran et al., 
2004). Stat6 deficient mice had reduced serum IL-5 and eotaxin level (Jaruga et al., 2003). 
Mouse keratinocyte-derived chemokines (KC) and human IL-8 are two CXC 
chemokines related to liver cirrhosis and inflammation process. Injection of recombinant 
adenoviruses carrying KC gene resulted in activation of proinflammatory genes in the liver 
such as IL-1α and IL-1β and stimulation of profibrotic genes including type I collagen, 
leading to massive liver necrosis (Stefanovic and Stefanovic, 2006). Overexpression of KC 
gene also upregulated TGF-β1 and alpha smooth muscle actin (αSMA) genes, indicating 
activated hepatic stellate cells. Macrophage chemoattractant protein-1 (MCP-1) is a cytokine 
involved in the attraction of monocytes and activated T lymphocytes. Upregulation of MCP-
1 is associated with neutrophil infiltration in the lung and liver after trauma hemorrhage. 
Neutrophil infiltration is a critical step in the development of organ damage.  
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IL-11 is one of IL-6 cytokine family and has been shown to promote colony 
formation of rat hepatic progenitor cells co-cultured with STO feeder. Significant reduction 
of IL-11 concentration in the culture without enough compensation from other IL-6 family 
cytokines may have detrimental effects on hepatic progenitor cell growth. Elevation of these 
inflammatory cytokines and reduction of proliferative cytokine in the STO-hHpSCs co-
culture medium may retard proliferation of hHpSCs and lineage restrict hHpSCs into more 
committed parenchymal cells.  
 In addition to the increase of inflammatory cytokines, anti-inflammatory cytokines 
and those proven to be therapeutic after hepatic injury were also elevated in STO-hHpSCs 
co-culture by STO cells. These include mouse interleukin-10 (IL-10), mouse interferon-γ 
(IFN-γ), mouse macrophage inflammatory protein-2 (MIP-2) and lipopolysaccharide-induced 
CXC chemokine (LIX). IL-10 is an anti-inflammatory cytokine (Kim et al., 2007). IFN-γ can 
diminish IL-13 signaling by rapidly mobilizing IL-13Rα2 to cell surface as non-signaling a 
decoy receptor for IL-13 (Daines and Hershey, 2002). LIX is a mouse homologue of human 
epithelial neutrophil activating protein (ENA-78), a CXC chemokine. ENA-78 and another 
CXC chemokine, MIP-2, are important for hepatic regeneration after liver injury (Ren et al., 
2003). Co-elevation of inflammatory and therapeutic cytokines in the co-culture raises 
interesting questions: do those inflammatory cytokines trigger the expression of the 
therapeutic cytokines by STO to rescue hHpSCs from detrimental effects caused by the 
inflammatory cytokines? Or do hHpSCs after exposing to the inflammatory cytokines secret 
some messenger molecules to signal STO producing “rescuing” cytokines? The answers for 
above questions could provide helpful information for developing therapeutic methods for 
liver fibrosis and for improving bioreactor design in liver tissue engineering. 
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TABLES 
Table 7.1. Effect of STO conditioned medium on colony formation of rter6 cells (rat 
cloned hepatoblast cell line) on STO or MRC5 feeder 
On STO feeder (murine embryonic stroma): 
Rter6 seeding density (cells/cm2) 100 200 400 
HDM 7.25 15.25 27.25 Average colony 
no. + STO-CM 18 34.5 66 
Fold increase 2.49 2.26 2.42 
P-value **0.0065 ***0.0009 ***0.0003 
Average fold 
increase of 
colony no. 
2.39 
 
On MRC5 feeder (human fetal lung stromal cell line): 
Rter6 seeding density (cells/cm2) 100 200 400 
HDM 14.75 23.5 42.5 Average colony 
no. + STO-CM 23 37.25 66.5 
Fold increase 1.56 1.59 1.56 
P-value not significant    
Average fold 
increase of 
colony no. 
1.57 
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Table 7.2  ELISA analyses of conditioned medium from STO cells and from human 
fetal liver cells 
Concentration 
(pg/ml) Concentration (pg/ml) 
STO/hFLC co-culture 
Mouse 
cytokines STO 
STO/hFLC
co-culture 
Human 
Cytokines  hFLCs 
Human 
cytokine 
Human and 
mouse 
TNF-α 0 1.4 TNF-α 0 0.5 1.9 
IL-1β 0 3 IFN-γ 0.8 2.5 23.4 
IL-12 0 11.3 IL-10 1 4 62.8 
IL-2 7.7 12 IL-1β 3 4.8 7.8 
IFN-γ 0 20.9 IL-5 0 7.5 133.7 
GM-CSF 5.8 35.3 IL-12 1 8 19.3 
IL-11 0 46.2 IL-2 0.8 10 22 
IL-10 0 58.8 GM-CSF 73 11 46.3 
Eotaxin 33.96 68.3 IL-13 0 16 n/a 
G-CSF 2.6 118.7 MCP-2 10 18 n/a 
IL-5 3.8 126.2 IL-1α 13.8 24.1 n/a 
MIP-2 0 182 IL-4 5.2 34.3 317.8 
IL-6 28.2 192.3 Eotaxin 15.5 34.4 102.7 
MIP-1α 86.7 283.17 IL-1Rα 24 34.7 n/a 
IL-4 2.3 283.5 IL-11 1221 43.1 89.3 
LIX 299 499 MIP-1β 292 111 n/a 
KC 800 794 sTNFR2 66 166 n/a 
MCP-1 2095 2094 IL-8 172 177 971 
HGF 399.9 253.8 n/a 
sTNFR1 687 283 n/a 
TGF-β1 136.3 n/a 287.8 
 
IL-6 327 290 482.3 
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RANTES 67 320 n/a 
MIP-1α 981 360 643.17 
MCP-1 539 531 2625 
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FIGURE LEGENDS 
Figure 7.1. Comparison of human cytokines produced in co-culture and in human fetal 
liver cell culture.  
 Concentration (pg/ml) of human cytokines produced in human fetal liver cell single 
culture and in co-culture of STO feeder cells and human fetal liver cells at low (top) and high 
(bottom) levels.  
 
Figure 7.2. Comparison of mouse cytokines produced in co-culture and in STO feeder 
cell culture. 
 Concentration (pg/ml) of mouse cytokines produced in STO feeder cell single culture 
and in co-culture of STO feeder cells and human fetal liver cells at low (top) and high 
(bottom) levels.  
 
Figure 7.3. Cytokine effects on colony formation of rter6 cells 
 Colony number (top) and area (in pixels; bottom) of rat hepatic progenitor (rter6) 
cells in hormonally defined medium (HDM) with or without cytokine are shown. 
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 Figure 7.2 
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 Figure 7.3 
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CHAPTER VIII 
FUTURE DIRECTIONS 
 
 Human hepatic stem cells (hHpSCs) differentiated into hepatoblasts when co-cultured 
with activated hepatic stellate cells (HpSTCs) from human fetal livers or with bone marrow-
derived human mesenchymal stem cells (hMSCs) that contained HpSTCs. These feeder cells 
were assumed to release matrix and soluble signals that induce hHpSCs to differentiate. A 
high-throughput screening of different cytokines/growth factors present in the medium of co-
culture and the medium of hHpSCs cultured alone using proteomic approaches, such as 
enzyme-linked immunoabsorbent assay (ELISA), were done on STO feeder cells and now 
could be done on feeders of angioblasts/endothelia versus HpSTC feeders to test which 
cytokines/growth factors are upregulated in the co-culture compared with single culture.  
 Primary cultures of HpSTCs isolated from human fetal liver were activated in serum-
containing medium and grew rapidly in cultures. However, when cells were on culture plastic 
and in Kubota’s Medium, the αSMA+/desmin+ cells surrounding hHpSCs colonies did not 
grow fast, and had minimal or no effect on differentiation of hHpSCs, thus indicating that 
they are quiescent hHpSCs. Activated hHpSTCs are known to be critical components 
associated with liver fibrosis. Understanding the activation mechanism by which the 
quiescent cells convert to cells releasing key matrix and soluble signals could help to develop 
a method to suppress the activation process in these non-parenchymal cells, leading to new 
therapeutic approaches in clinical treatment of liver fibrosis. It would be interesting to isolate 
these hHpSTCs in quiescent form and to compare their gene expression profile with that of 
activated hHpSTCs. The cDNA microarray could be a useful tool to achieve this goal. 
Transcription factors involved in several inflammatory signaling pathways during liver 
fibrosis would be important target genes to be examined in the microarray analyses. 
 Primary cultures of HpSTCs derived from adult human or rodent livers did not 
support survival and growth of hHpSCs in vitro whereas quiescent hHpSTCs from fetal 
livers did. This raises a question: do fetal liver-derived hHpSTCs have different properties 
than adult liver-derived ones? Our paper on HpSTC precursors from E13 rat embryos 
(Kubota et al., 2007 in press) versus papers on HpSTCs from adult rodent livers indicate 
some critical distinctions that, presumably, are paralleled in distinctions to be found from 
HpSTCS from fetal versus adult human livers. Comparison of gene expression profiles from 
these model systems could provide answers to these questions.  
 Proinflammatory cytokines such as interleukin-4 (IL-4), IL-5 and eotaxin were 
upregulated by both hHpSCs and STO cells in co-culture and could be factors in the 
phenomenon we describe in which hHpSCs differentiate into hepatoblasts when co-cultured 
with STO feeders. Understanding the downstream signaling pathways of these cytokines 
inside the hHpSCs would help to unfold the differentiation mechanism by which hepatic 
stem cells (HpSCs) utilize. STO cells derived from mutant mouse embryos deficient in target 
cytokine/growth factor gene(s) may be used to see if hHpSCs grown on top of the genetically 
modified STO feeder could maintain their stemness in serum-free medium.  
Serum supplementation in the first twenty four hours of plating could be a factor 
affecting the hHpSCs given that serum contains variety of growth factors and cytokines, and 
it varies from batch to batch in lots provided commercially. It would be interesting to test if 
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some of the proinflammatory cytokines in serum are factors in differentiation of hHpSCs 
either by direct assays of the factors on the cells or by blocking the effects of the factors to 
learn what happens in their absence. Antibodies or antiserum specific against particular 
cytokines could be used to quench binding efficiency of the target cytokines to their 
corresponding receptors on the hHpSCs, resulting in reduction of their signaling pathway.  
 Primary cultures of hHpSCs can be maintained for several months on culture plastic 
and in serum-free condition. Addition of the proinflammatory cytokines individually or in 
different combination into the serum-free medium and test of the differentiation state of the 
hHpSCs could be done to know if the target cytokine(s) can lineage restrict the hHpSCs to 
more committed cells. Alternatively transfection of the hHpSCs using adenoviruses carrying 
target cytokine gene(s) can overexpress the target cytokine(s) constitutively as autocrine 
signals, thus is a way to test the differentiation effects of particular cytokines.  
 My minimal success in isolation and long-term expansion of endothelial progenitor 
cells, angioblasts, from human fetal livers means that more robust purification methods and 
more highly defined, serum-free culture conditions need to be developed. Magnetically 
activated cell sorting (MACS) method can be used to isolate particular surface marker-
specific cells, but without high purity and with other cell types contaminated in the selected 
cell population. Flow cytometry-activated cell sorting (FACS) method is the most accurate 
purification technology in today’s biomedical research and could be used in the future to sort 
out the endothelial progenitor cells from human fetal livers. Our previous study showed that 
shear stress introduced by flow cytometry is detrimental to the survival of hepatic epithelial 
cells. However, unlike parenchymal cells, endothelial cells are constantly exposed to 
hemodynamic, thus are potentially capable of bearing shear stress. HUVECs grown on the 
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micropatterned strips of fibronectin and subjected to a pulsatile shear stress (12 ± 4 dyn/cm2) 
parallel to micropatterned strips for 12 hours had significantly reduced apoptosis induced by 
micropatterned anisotropic substrata (Wu et al., 2007).  
 Any serum, even low concentrations of serum, that was used in my study is the 
probable could cause of overgrowth of fibroblastic cells in human fetal liver-derived 
endothelial cell cultures. The partially developed serum-free medium, developed using   
HUVECs as a model system, needs to be further developed so that it can be used for primary 
cultures of liver-derived endothelial cells. This would be helpful to reduce overgrowth of 
fibroblastic cells and to select the endothelial cells for long-term culture.  
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